syndrome	score	normalized_score
SYNDACTYLY, TYPE IV; SDTY4	2.0243902	100.0
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	1.33869117	66.12811947024836
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	1.15244574	56.92804381289734
POLYDACTYLY, PREAXIAL IV; PPD4	1.142857	56.45438315202277
KLIPPEL-FEIL SYNDROME 1, AUTOSOMAL DOMINANT; KFS1	1.077381	53.22002645537406
PETERS-PLUS SYNDROME; PTRPLS	1.076608482	53.18186592683565
#186500 MULTIPLE SYNOSTOSES SYNDROME 1; SYNS1;;SYNOSTOSES, MULTIPLE, WITH BRACHYDACTYLY;;SYMPHALANGISM-BRACHYDACTYLY SYNDROME;;WL SYNDROME;;DEAFNESS-SYMPHALANGISM SYNDROME OF HERRMANN;;FACIOAUDIOSYMPHALANGISM SYNDROME	1.0666292	52.68891343180776
OTOSCLEROSIS 7	1.06490139	52.60356377935439
TOWNES-BROCKS SYNDROME 1; TBS1	1.064721282	52.594666877956634
DEAFNESS, AUTOSOMAL DOMINANT 1	1.05810013	52.2675979166467
DEAFNESS, AUTOSOMAL DOMINANT 6	1.03125	50.94126616499132
ABLEPHARON-MACROSTOMIA SYNDROME	1.0208333	50.426706274314114
%164220 SCHILBACH-ROTT SYNDROME;;OCULAR HYPOTELORISM, SUBMUCOSAL CLEFT PALATE, AND HYPOSPADIAS;;CLEFT PALATE, HYPOTELORISM, AND HYPOSPADIAS;;BLEPHAROFACIOSKELETAL SYNDROME; BRSS	1.0185555	50.314188440548655
PEROXISOME BIOGENESIS DISORDER 11B	1.0027933	49.53557372486787
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	1.000843882	49.43927717097228
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL DOMINANT	1.0	49.397591432718855
HAIRY EARS	1.0	49.397591432718855
DEAFNESS, AMINOGLYCOSIDE-INDUCED	1.0	49.397591432718855
%608645 DEAFNESS, AUTOSOMAL DOMINANT 31; DFNA31	1.0	49.397591432718855
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	1.0	49.397591432718855
SYNDACTYLY-POLYDACTYLY-EARLOBE SYNDROME	1.0	49.397591432718855
#611390 SPASTIC ATAXIA 3, AUTOSOMAL RECESSIVE; SPAX3;;AUTOSOMAL RECESSIVE SPASTIC ATAXIA WITH LEUKOENCEPHALOPATHY; ARSAL	1.0	49.397591432718855
EARLOBES, THICKENED, WITH CONDUCTIVE DEAFNESS FROM INCUDOSTAPEDIALABNORMALITIES	0.70970874	35.05790237474969
OCULODENTODIGITAL DYSPLASIA; ODDD	0.68897786	34.03384683446897
#219000 FRASER SYNDROME;;CRYPTOPHTHALMOS WITH OTHER MALFORMATIONSCRYPTOPHTHALMOS-SYNDACTYLY SYNDROME, INCLUDED	0.5953271099999999	29.40772534860127
FILIPPI SYNDROME; FLPIS	0.5701809600000001	28.165566104795413
SCALP-EAR-NIPPLE SYNDROME; SENS	0.55604336	27.4672027161562
SYNDACTYLY, TYPE V	0.53125	26.242470448631888
ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 1	0.53125	26.242470448631888
227210 EYEBROWS, DUPLICATION OF, WITH STRETCHABLE SKIN AND SYNDACTYLY	0.5243902	25.903612850921725
POTOCKI-SHAFFER SYNDROME	0.51788269	25.58215753069739
ARTHROGRYPOSIS, DISTAL, TYPE 4; DA4	0.510989	25.241625848613573
DEAFNESS AND MYOPIA; DFNMYP	0.50934579	25.160455232395417
#300831 CK SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH THIN BODY HABITUS AND CORTICALMALFORMATION	0.5041012119999999	24.901385711114386
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.5027933	24.83677800850844
HYPOGONADISM WITH LOW-GRADE MENTAL DEFICIENCY AND MICROCEPHALY	0.5	24.698795716359427
DEAFNESS, AUTOSOMAL RECESSIVE 102; DFNB102	0.5	24.698795716359427
#601152 HEREDITARY MOTOR AND SENSORY NEUROPATHY VI;;HMSN6;;HMSN VI;;PERIPHERAL NEUROPATHY AND OPTIC ATROPHY;;CHARCOT-MARIE-TOOTH DISEASE, TYPE 6; CMT6	0.5	24.698795716359427
OSSICULAR MALFORMATIONS, FAMILIAL	0.5	24.698795716359427
DEAFNESS, UNILATERAL	0.5	24.698795716359427
ECTODERMAL DYSPLASIA, TRICHOODONTOONYCHIAL TYPE	0.5	24.698795716359427
DEAFNESS, UNILATERAL, WITH DELAYED ENDOLYMPHATIC HYDROPS	0.5	24.698795716359427
Split hand/foot malformation 1 (SHFM1)	0.46294633	22.86843366461663
#260660 COUSIN SYNDROME;;CRANIOFACIAL DYSMORPHISM, HYPOPLASIA OF SCAPULA AND PELVIS, AND SHORTSTATURE;;PELVISCAPULAR DYSPLASIA	0.46189050000000004	22.81627820565423
BRANCHIOOTORENAL SYNDROME 1	0.44674918999999996	22.068333960518082
#610706 DEAFNESS, CONGENITAL, WITH INNER EAR AGENESIS, MICROTIA, AND MICRODONTIA;;DEAFNESS, CONGENITAL, WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA;;DEAFNESS WITH LAMM	0.416667	20.582346229496665
SYNPOLYDACTYLY 1	0.3928573	19.40620439676106
#304700 MOHR-TRANEBJAERG SYNDROME; MTS;;DYSTONIA-DEAFNESS SYNDROME; DDS;;DEAFNESS-DYSTONIA-OPTIC ATROPHY SYNDROME; DDP;;DEAFNESS SYNDROME, PROGRESSIVE, WITH BLINDNESS, DYSTONIA, FRACTURES,AND MENTAL DEFICIENCY	0.364583	18.009522077314934
OROFACIODIGITAL SYNDROME I; OFD1	0.35359541	17.46676159566471
SMITH-MAGENIS SYNDROME; SMS	0.336898862	16.641992339223933
#305450 OPITZ-KAVEGGIA SYNDROME; OKS;;FG SYNDROME 1; FGS1;;FG SYNDROME; FGS;;MENTAL RETARDATION, LARGE HEAD, IMPERFORATE ANUS, CONGENITAL HYPOTONIA,AND PARTIAL AGENESIS OF CORPUS CALLOSUM;;KELLER SYNDROME	0.335712922	16.583409759640215
SYNDACTYLY, TYPE III	0.333333	16.465847345042473
CLEFT LIP/PALATE WITH ABNORMAL THUMBS AND MICROCEPHALY	0.333333	16.465847345042473
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.333333	16.465847345042473
#601369 DEAFNESS, AUTOSOMAL DOMINANT 9; DFNA9	0.333333	16.465847345042473
CURRY-JONES SYNDROME	0.31221326200000005	15.422583156152408
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.2916667	14.40763248112938
FRYNS SYNDROME; FRNS	0.28962778	14.30691474400538
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.28887224	14.269592887774305
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.267191052	13.198594421174336
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.26424633	13.053132246935398
#308940 LEIOMYOMATOSIS, DIFFUSE, WITH ALPORT SYNDROME; DL-ATS;;LEIOMYOMATOSIS, ESOPHAGEAL AND VULVAL, WITH NEPHROPATHY;;ALPORT SYNDROME AND DIFFUSE LEIOMYOMATOSIS; ATS-DL;;CHROMOSOME Xq22.3 CENTROMERIC DELETION SYNDROME	0.25819672	12.754296083828107
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.254480242	12.570711022015422
YEMENITE DEAF-BLIND HYPOPIGMENTATION SYNDROME	0.25	12.349397858179714
FECHTNER SYNDROME	0.25	12.349397858179714
#612643 DEAFNESS, AUTOSOMAL DOMINANT 3B; DFNA3B	0.25	12.349397858179714
CATARACT-ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.25	12.349397858179714
ALBINISM, OCULAR, WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.25	12.349397858179714
#604213 CHUDLEY-MCCULLOUGH SYNDROME; CMCS;;DEAFNESS, SENSORINEURAL, WITH PARTIAL AGENESIS OF THE CORPUS CALLOSUMAND ARACHNOID CYSTS;;DEAFNESS, AUTOSOMAL RECESSIVE 82; DFNB82	0.25	12.349397858179714
%603964 DEAFNESS, AUTOSOMAL DOMINANT 16; DFNA16	0.25	12.349397858179714
MALE PSEUDOHERMAPHRODITISM/MENTAL RETARDATION SYNDROME, VERLOES TYPE	0.25	12.349397858179714
DEAFNESS, AUTOSOMAL RECESSIVE 28	0.25	12.349397858179714
#615706 AURICULOCONDYLAR SYNDROME 3; ARCND3	0.24545450000000002	12.12486110632229
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.24189792999999998	11.949175114560424
MICROPHTHALMIA, SYNDROMIC 1	0.2354501	11.630667842592796
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.2252829	11.128432650978057
CHROMOSOME 2q35 DUPLICATION SYNDROME	0.2228028	11.00592168446577
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.2197425	10.854750235404222
ROSSELLI-GULIENETTI SYNDROME	0.20525388199999997	10.139047403015484
CLEFT LIP/PALATE-ECTODERMAL DYSPLASIA SYNDROME; CLPED1	0.20440999999999998	10.097361664762058
FEINGOLD SYNDROME 1; FGLDS1	0.20284503	10.020055916097599
RENAL, GENITAL, AND MIDDLE EAR ANOMALIES	0.2027933	10.017500578692784
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.20118656	9.938131492634177
CLEFT PALATE, DEAFNESS, AND OLIGODONTIA	0.2	9.879518286543771
PAGET DISEASE OF BONE 2, EARLY-ONSET; PDB2	0.2	9.879518286543771
CONGENITAL LIPOMATOUS OVERGROWTH, VASCULAR MALFORMATIONS, AND EPIDERMAL NEVI	0.2	9.879518286543771
DEAFNESS, PROGRESSIVE, WITH STAPES FIXATION	0.2	9.879518286543771
AGNATHIA-OTOCEPHALY COMPLEX	0.18990139	9.380671275725401
WITTEVEEN-KOLK SYNDROME	0.18943455199999998	9.357610602936132
WHITE-SUTTON SYNDROME; WHSUS	0.18614144199999996	9.194938900613131
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.18230637	9.005495580842073
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.18016324	8.89963012071487
BRACHYDACTYLY, TYPE B2	0.17665152999999997	8.726160104904675
DEAFNESS, AUTOSOMAL DOMINANT 39, WITH DENTINOGENESIS IMPERFECTA 1	0.175	8.644578500725798
SCLEROSTEOSIS 1; SOST1	0.17309666	8.550558089048248
AUROCEPHALOSYNDACTYLY	0.1694603	8.370930663465966
Jawad syndrome	0.167510882	8.274634109570378
DEAFNESS, AUTOSOMAL RECESSIVE, 24	0.166667	8.232948371316953
DEAFNESS, AUTOSOMAL RECESSIVE 48	0.166667	8.232948371316953
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 46	0.166667	8.232948371316953
CONGENITAL HEART DEFECTS, HAMARTOMAS OF TONGUE, AND POLYSYNDACTYLY	0.166667	8.232948371316953
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 3	0.166667	8.232948371316953
SYNOSTOSIS, CARPAL, WITH DYSPLASTIC ELBOW JOINTS AND BRACHYDACTYLY	0.166667	8.232948371316953
CRI-DU-CHAT SYNDROME	0.15903372999999998	7.855883218561321
KLEEFSTRA SYNDROME	0.15444342	7.629132960631798
BASAN SYNDROME	0.15384599999999998	7.599621851558064
SYNDACTYLY, MESOAXIAL SYNOSTOTIC, WITH PHALANGEAL REDUCTION	0.15384599999999998	7.599621851558064
MULTIPLE SYNOSTOSES SYNDROME 3; SYNS3	0.14285699999999998	7.0567917193039165
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.14285699999999998	7.0567917193039165
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.14217090999999998	7.022900525797842
CHROMOSOME 3pter-p25 DELETION SYNDROME	0.137631712	6.798675077561628
ACROCRANIOFACIAL DYSOSTOSIS	0.13689031999999998	6.7620520984541415
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.13518967199999998	6.678044183379271
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.135156942	6.676427400211679
300270 ADRENOMYODYSTROPHY	0.134040602	6.621282892991677
PROGEROID SHORT STATURE WITH PIGMENTED NEVI	0.13349691	6.594425817710439
CURRARINO SYNDROME	0.129631682	6.403492864172135
ACROCALLOSAL SYNDROME; ACLS	0.12951471	6.397714729107067
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.12869621	6.3572828005193855
POTOCKI-LUPSKI SYNDROME	0.128637182	6.354366959492295
PETTIGREW SYNDROME	0.12838841199999998	6.342078320671576
WILDERVANCK SYNDROME	0.1277933	6.312681221238869
DEAFNESS, X-LINKED 4	0.12754453	6.3003925824181515
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.126846002	6.265886981669838
ACRORENAL SYNDROME	0.125	6.174698929089857
#612644 DEAFNESS, AUTOSOMAL DOMINANT 2B; DFNA2B	0.125	6.174698929089857
#614195 CRANIOFACIAL ANOMALIES AND ANTERIOR SEGMENT DYSGENESIS SYNDROME; CAASDS	0.125	6.174698929089857
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 7	0.125	6.174698929089857
#300455 RETINITIS PIGMENTOSA, X-LINKED, AND SINORESPIRATORY INFECTIONS, WITHOR WITHOUT DEAFNESS	0.125	6.174698929089857
#269400 CORNEAL OPACIFICATION WITH OTHER OCULAR ANOMALIES; COPOA;;SCLEROCORNEA WITH OTHER OCULAR ANOMALIES	0.125	6.174698929089857
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 17	0.125	6.174698929089857
PEROXISOME BIOGENESIS DISORDER 14B	0.1222223	6.037487239367193
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.12177595000000002	6.0154386244312
#256520 NEU-LAXOVA SYNDROME; NLS	0.12111580000000001	5.98282880444689
VAN MALDERGEM SYNDROME 2; VMLDS2	0.12088778000000001	5.971565165648402
VAN MALDERGEM SYNDROME 1; VMLDS1	0.12088778000000001	5.971565165648402
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.11989148200000002	5.922350444099167
FOCAL DERMAL HYPOPLASIA; FDH	0.11976408000000001	5.916057092155455
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.11832325200000002	5.8448836592866344
PALLISTER-KILLIAN SYNDROME	0.11753737	5.806062981336305
CHARGE SYNDROME	0.11341619	5.602486615475613
CHROMOSOME 1P36 DELETION SYNDROME	0.10825396200000001	5.347484985849072
ELSAHY-WATERS SYNDROME; ESWS	0.10759118200000001	5.314745250199295
#263750 POSTAXIAL ACROFACIAL DYSOSTOSIS; POADS;;MILLER SYNDROME;;GENEE-WIEDEMANN SYNDROME	0.10658791	5.265186029847407
DEAFNESS, SENSORINEURAL, WITH PERIPHERAL NEUROPATHY AND ARTERIAL DISEASE	0.1055556	5.214192402235498
TURNPENNY-FRY SYNDROME; TPFS	0.10496960200000002	5.185245512451109
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.10417718200000002	5.146101873047993
SPLIT-HAND/FOOT MALFORMATION 6	0.10416660000000001	5.145579147735452
FIBULAR APLASIA OR HYPOPLASIA, FEMORAL BOWING AND POLY-, SYN-, AND OLIGODACTYLY	0.10416660000000001	5.145579147735452
ACROPECTOROVERTEBRAL DYSPLASIA, F-FORM OF	0.10416660000000001	5.145579147735452
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.10299063	5.087489062138316
#600208 MACROTHROMBOCYTOPENIA AND PROGRESSIVE SENSORINEURAL DEAFNESS	0.10267860000000001	5.072075531683566
KAPUR-TORIELLO SYNDROME	0.10206095000000001	5.0415651093351475
ALKAPTONURIA	0.1017316	5.025296012596781
WILLIAMS-BEUREN SYNDROME; WBS	0.09733188000000002	4.8079604416184205
TIETZ SYNDROME	0.0954545	4.7152223914144615
BARDET-BIEDL SYNDROME 1; BBS1	0.094907462	4.68820003179229
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.09270768200000003	4.579536198110425
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.09237390200000002	4.563048270042012
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.09237390200000001	4.563048270042011
#194190 WOLF-HIRSCHHORN SYNDROME; WHS;;CHROMOSOME 4p16.3 DELETION SYNDROME;;PITT-ROGERS-DANKS SYNDROME; PRDS;;PITT SYNDROME	0.09173251200000003	4.531365148872981
KOOLEN-DE VRIES SYNDROME; KDVS	0.09165881200000002	4.5277245463843885
ANAL SPHINCTER DYSPLASIA; ASDP	0.09153002000000002	4.5213625317885855
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.09148477000000002	4.519127290776256
DEAFNESS, AUTOSOMAL DOMINANT 50	0.08935013000000001	4.413681216200316
CHROMOSOME 17q12 DELETION SYNDROME	0.08897163000000001	4.3949842278430316
MEIER-GORLIN SYNDROME 7	0.08878005200000001	4.385520736071535
CHROMOSOME 18Q DELETION SYNDROME	0.08738783000000001	4.316748322531892
DEAFNESS, AUTOSOMAL RECESSIVE 30; DFNB30	0.08680560000000001	4.28798756287202
OHDO SYNDROME	0.08448728	4.173468138701718
MOWAT-WILSON SYNDROME; MOWS	0.08445216000000001	4.171733295290602
#274000 THROMBOCYTOPENIA-ABSENT RADIUS SYNDROME; TAR;;TAR SYNDROME;;CHROMOSOME 1q21.1 DELETION SYNDROME, 200-KB	0.08417718200000002	4.158150044393616
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 47	0.08333330000000001	4.11646430614019
SPLIT-HAND/FOOT MALFORMATION 2	0.08333330000000001	4.11646430614019
BRACHYDACTYLY-SYNDACTYLY SYNDROME	0.08333330000000001	4.11646430614019
#101600 PFEIFFER SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE V; ACS5;;ACS V;;NOACK SYNDROMECRANIOFACIAL-SKELETAL-DERMATOLOGIC DYSPLASIA, INCLUDED	0.08333330000000001	4.11646430614019
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.08289052200000002	4.0945921394007945
TARP SYNDROME; TARPS	0.08247147200000002	4.073892078710913
DEAFNESS, AUTOSOMAL DOMINANT 20	0.08125	4.013554303908407
MITOCHONDRIAL MYOPATHY, ENCEPHALOPATHY, LACTIC ACIDOSIS, AND STROKE-LIKE EPISODES; MELAS	0.08125	4.013554303908407
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.07969129999999999	3.9365582781422273
#218600 BALLER-GEROLD SYNDROME; BGS;;CRANIOSYNOSTOSIS WITH RADIAL DEFECTS;;CRANIOSYNOSTOSIS-RADIAL APLASIA SYNDROME	0.07926981999999999	3.9157381813051653
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.07809738	3.8578224692057885
DEAFNESS, AUTOSOMAL RECESSIVE 62	0.07692310000000001	3.799815865538176
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 39	0.07692310000000001	3.799815865538176
DEAFNESS, AUTOSOMAL RECESSIVE 49	0.07692310000000001	3.799815865538176
DEAFNESS, AUTOSOMAL RECESSIVE 45	0.07692310000000001	3.799815865538176
#601869 DEAFNESS, AUTOSOMAL RECESSIVE 15; DFNB15;;DEAFNESS, AUTOSOMAL RECESSIVE 72; DFNB72;;DEAFNESS, AUTOSOMAL RECESSIVE 95; DFNB95	0.07692310000000001	3.799815865538176
DEAFNESS, AUTOSOMAL RECESSIVE 12; DFNB12	0.07692310000000001	3.799815865538176
DEAFNESS, AUTOSOMAL RECESSIVE 104; DFNB104	0.07692310000000001	3.799815865538176
DEAFNESS, AUTOSOMAL RECESSIVE 44	0.07692310000000001	3.799815865538176
DEAFNESS, AUTOSOMAL RECESSIVE 71	0.07692310000000001	3.799815865538176
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 38	0.07692310000000001	3.799815865538176
DEAFNESS, CONGENITAL NEUROSENSORY, AUTOSOMAL RECESSIVE 40	0.07692310000000001	3.799815865538176
DEAFNESS, AUTOSOMAL RECESSIVE 83	0.07692310000000001	3.799815865538176
DEAFNESS, AUTOSOMAL RECESSIVE 85	0.07692310000000001	3.799815865538176
DUANE-RADIAL RAY SYNDROME; DRRS	0.07668014000000001	3.7878142267236825
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.07440427200000001	3.6753918291048833
SWEENEY-COX SYNDROME; SWCOS	0.07427577200000002	3.6690442386057796
HALLERMANN-STREIFF SYNDROME; HSS	0.07378544000000001	3.6448230188033914
LYMPHEDEMA, HEREDITARY, III	0.073561212	3.633746695671615
MEIER-GORLIN SYNDROME 3; MGORS3	0.07295461000000002	3.6037820179133457
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.07286875200000001	3.5995408395081148
FRASER SYNDROME 2; FRASRS2	0.07250480000000001	3.581562487310994
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.07202487	3.5578551012546895
FRYNS MICROPHTHALMIA SYNDROME	0.0719697	3.555129836135346
CORNELIA DE LANGE SYNDROME 1	0.07145174000000001	3.529543859676856
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO STEROID 11-BETA-HYDROXYLASEDEFICIENCY	0.07142860000000001	3.528400799411102
LEUKODYSTROPHY, DEMYELINATING, ADULT-ONSET, AUTOSOMAL DOMINANT; ADLD	0.07142860000000001	3.528400799411102
MECKEL SYNDROME, TYPE 5	0.07142860000000001	3.528400799411102
CEREBELLAR VERMIS APLASIA WITH ASSOCIATED FEATURES SUGGESTING SMITH-LEMLI-OPITZSYNDROME AND MECKEL SYNDROME	0.07142860000000001	3.528400799411102
#230500 GM1-GANGLIOSIDOSIS, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I;;GANGLIOSIDOSIS, GENERALIZED GM1, INFANTILE FORM;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE 1;;BETA-GALACTOSIDASE-1 DEFICIENCY;;GLB1 DEFICIENCYGM1-GANGLIOSIDOSIS, TYPE I, WITH CARDIAC INVOLVEMENT, INCLUDED;;GANGLIOSIDOSIS, GENERALIZED GM1, TYPE I, WITH CARDIAC INVOLVEMENT,INCLUDED	0.07142860000000001	3.528400799411102
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM	0.07142860000000001	3.528400799411102
#267430 RENAL TUBULAR DYSGENESIS; RTD;;PRIMITIVE RENAL TUBULE SYNDROMERENAL TUBULAR DYSGENESIS WITH CHOANAL ATRESIA AND ATHELIA, INCLUDED	0.07142860000000001	3.528400799411102
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IV; MEN4	0.07142860000000001	3.528400799411102
WEAVER SYNDROME	0.070767912	3.4957644035226014
DESBUQUOIS DYSPLASIA 2; DBQD2	0.07064581200000002	3.4897329576086675
#158350 COWDEN SYNDROME 1; CWS1;;CS; CD;;MULTIPLE HAMARTOMA SYNDROME; MHAMDYSPLASTIC GANGLIOCYTOMA OF THE CEREBELLUM, INCLUDED;;CEREBELLOPARENCHYMAL DISORDER VI, INCLUDED; CPD6, INCLUDED;;CEREBELLAR GRANULE CELL HYPERTROPHY AND MEGALENCEPHALY, INCLUDED;;LHERMITTE-DUCLOS DISEASE, INCLUDED; LDD, INCLUDED;;PROTEUS-LIKE SYNDROME, INCLUDED	0.070303882	3.472842439170077
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.06992403	3.4540786652691757
COWDEN SYNDROME 5; CWS5	0.06946	3.431156700916651
COWDEN SYNDROME 6; CWS6	0.06946	3.431156700916651
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA 2	0.06921123	3.418868062095934
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.06865537000000002	3.391409916922144
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.06808906200000002	3.3634356657130637
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.06799423	3.3587511933223153
CHROMOSOME 16p13.3 DELETION SYNDROME	0.067510582	3.3348601470210633
Lymphatic malformation 1	0.0666667	3.293174408767637
LYMPHEDEMA, HEREDITARY, ID; LMPH1D	0.0666667	3.293174408767637
#608980 BIFID NOSE WITH OR WITHOUT ANORECTAL AND RENAL ANOMALIES; BNAR	0.0666667	3.293174408767637
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.0666667	3.293174408767637
BARDET-BIEDL SYNDROME 11; BBS11	0.0666667	3.293174408767637
NIPPLES, SUPERNUMERARY	0.0666667	3.293174408767637
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 3; HKLLS3	0.0666667	3.293174408767637
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA SYNDROME; HLTS	0.0666667	3.293174408767637
BARDET-BIEDL SYNDROME 12; BBS12	0.0666667	3.293174408767637
#156550 KNIEST DYSPLASIA	0.06490139	3.205972346635545
#150250 LARSEN SYNDROME; LRS	0.06490139	3.205972346635545
MEIER-GORLIN SYNDROME 2; MGORS2	0.06490139	3.205972346635545
TIMOTHY SYNDROME; TS	0.06487406200000001	3.204622409256872
#115470 CAT EYE SYNDROME; CES;;SCHMID-FRACCARO SYNDROME;;CHROMOSOME 22 PARTIAL TETRASOMY;;INV DUP(22)(q11)	0.06450454	3.18636891247547
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.06421123	3.171880104932339
171480 PHOCOMELIA-ECTRODACTYLY, EAR MALFORMATION, DEAFNESS, AND SINUS ARRHYTHMIA;;FACIOAURICULORADIAL DYSPLASIA	0.06414608	3.1686618518504974
MEIER-GORLIN SYNDROME 6; MGORS6	0.06414608	3.1686618518504974
DIAMOND-BLACKFAN ANEMIA 11; DBA11	0.062403700000000006	3.0825924764899577
COSTELLO SYNDROME; CSTLO	0.061757652	3.050679261340032
DIAPHANOSPONDYLODYSOSTOSIS	0.061757652	3.050679261340032
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.06053749	2.9904061973823026
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.060158460000000004	2.97168302830156
BRANCHIOOCULOFACIAL SYNDROME	0.060020830000000004	2.9648844377926746
Temtamy preaxial brachydactyly syndrome	0.059318462	2.9301891502932587
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.05919196	2.923940256181837
MARTSOLF SYNDROME	0.058812930000000006	2.9052170871010934
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.058500322	2.8897750048384943
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.05843665	2.88662976139679
DEAFNESS, MID-TONE NEURAL	0.05810013000000001	2.870006483927852
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 49	0.05810013000000001	2.870006483927852
SPLIT-FOOT MALFORMATION WITH MESOAXIAL POLYDACTYLY; SFMMP	0.05810013000000001	2.870006483927852
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.05783654	2.856985772802101
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.05721454199999999	2.8262605697261325
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.056474079999999996	2.7896835303786784
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.0564435	2.7881729520326664
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.056399482	2.785998568852981
BARTSOCAS-PAPAS SYNDROME; BPS	0.056029920000000004	2.767743096167923
#264470 PEROXISOMAL ACYL-CoA OXIDASE DEFICIENCY;;STRAIGHT-CHAIN ACYL-CoA OXIDASE DEFICIENCY;;PSEUDONEONATAL ADRENOLEUKODYSTROPHY	0.0557372	2.753283433203737
#602588 BRANCHIOOTIC SYNDROME 1; BOS1;;BO SYNDROME 1;;BRANCHIOOTIC DYSPLASIAANTERIOR SEGMENT ANOMALIES WITH OR WITHOUT CATARACT, INCLUDED	0.055657859999999997	2.749364228299465
CHITAYAT SYNDROME	0.055555600000000004	2.7443128305995557
245650 LARSEN-LIKE SYNDROME, LETHAL TYPE	0.055555600000000004	2.7443128305995557
FRASER SYNDROME 3; FRASRS3	0.055555600000000004	2.7443128305995557
DEAFNESS WITH ANHIDROTIC ECTODERMAL DYSPLASIA	0.055555600000000004	2.7443128305995557
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.055555600000000004	2.7443128305995557
BLEPHAROCHEILODONTIC SYNDROME 2; BCDS2	0.055555600000000004	2.7443128305995557
FEINGOLD SYNDROME 2; FGLDS2	0.055555600000000004	2.7443128305995557
%606012 DEAFNESS, AUTOSOMAL DOMINANT 18; DFNA18	0.055555600000000004	2.7443128305995557
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.055555600000000004	2.7443128305995557
CHROMOSOME 2Q31.1 DUPLICATION SYNDROME	0.055555600000000004	2.7443128305995557
DEAFNESS, AUTOSOMAL DOMINANT 65; DFNA65	0.055555600000000004	2.7443128305995557
DEAFNESS, AUTOSOMAL RECESSIVE 112; DFNB112	0.055555600000000004	2.7443128305995557
PERRAULT SYNDROME 4	0.055555600000000004	2.7443128305995557
DIAMOND-BLACKFAN ANEMIA 6; DBA6	0.055555600000000004	2.7443128305995557
#613453 DEAFNESS, AUTOSOMAL RECESSIVE 91; DFNB91	0.055555600000000004	2.7443128305995557
OSTEOGENESIS IMPERFECTA, TYPE XII; OI12	0.055555600000000004	2.7443128305995557
CAMPTOSYNPOLYDACTYLY, COMPLEX	0.055555600000000004	2.7443128305995557
POLYENDOCRINE-POLYNEUROPATHY SYNDROME; PEPNS	0.055555600000000004	2.7443128305995557
BLEPHAROCHEILODONTIC SYNDROME 1; BCDS1	0.055555600000000004	2.7443128305995557
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.055113701999999994	2.722484133740619
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.05504324	2.7190034806530874
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.05488636	2.7112539865091225
185750 SYMPHALANGISM WITH MULTIPLE ANOMALIES OF HANDS AND FEET	0.0548766	2.710771866016739
MANDIBULOFACIAL DYSOSTOSIS WITH PTOSIS, AUTOSOMAL DOMINANT	0.05480029	2.7070023358145083
ATRESIA OF EXTERNAL AUDITORY CANAL AND CONDUCTION DEAFNESS	0.05480029	2.7070023358145083
DIGEORGE SYNDROME; DGS	0.054788022	2.7063963261628117
OROFACIODIGITAL SYNDROME VI	0.053330342	2.6343904450831666
KABUKI SYNDROME 1	0.052728041999999996	2.6046382757632394
MULTINUCLEATED NEURONS, ANHYDRAMNIOS, RENAL DYSPLASIA, CEREBELLAR HYPOPLASIA, AND HYDRANENCEPHALY; MARCH	0.0523284	2.584896923527885
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.05213485	2.5753360197060826
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.05188416	2.562952537509814
SPLIT-FOOT DEFORMITY WITH MANDIBULOFACIAL DYSOSTOSIS	0.051136299999999996	2.5260100547809405
#612290 MICROTIA, HEARING IMPAIRMENT, AND CLEFT PALATEMICROTIA WITH OR WITHOUT HEARING IMPAIRMENT, INCLUDED	0.051012489999999994	2.5198941389856557
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.050792292	2.5090168881473542
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.050581669999999995	2.498612668644612
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.05027027199999999	2.483230357467646
DEAFNESS, AUTOSOMAL RECESSIVE 37; DFNB37	0.05	2.4698795716359427
DEAFNESS, AUTOSOMAL RECESSIVE 77; DFNB77	0.05	2.4698795716359427
DEAFNESS, AUTOSOMAL RECESSIVE 101; DFNB101	0.05	2.4698795716359427
#610265 DEAFNESS, AUTOSOMAL RECESSIVE 67; DFNB67	0.05	2.4698795716359427
DEAFNESS, SENSORINEURAL, AND MALE INFERTILITY	0.05	2.4698795716359427
SPASTIC PARAPLEGIA, SENSORINEURAL DEAFNESS, MENTAL RETARDATION, AND	0.05	2.4698795716359427
DEAFNESS, AUTOSOMAL RECESSIVE 94; DFNB94	0.05	2.4698795716359427
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.05	2.4698795716359427
#602722 RENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE; RTADR;;RTA, DISTAL, AUTOSOMAL RECESSIVE;;RENAL TUBULAR ACIDOSIS, AUTOSOMAL RECESSIVE, WITH PRESERVED HEARINGRENAL TUBULAR ACIDOSIS, DISTAL, AUTOSOMAL RECESSIVE, WITH LATE-ONSETSENSORINEURAL HEARING LOSS, INCLUDED	0.05	2.4698795716359427
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 11	0.05	2.4698795716359427
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.04992159	2.466006306491703
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.04986341999999999	2.4631328485980615
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.04959208	2.4497293061387078
#151100 LEOPARD SYNDROME 1;;LENTIGINOSIS, CARDIOMYOPATHIC;;MULTIPLE LENTIGINES SYNDROME	0.04956938	2.4486079808131853
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.049190672	2.4299007177568828
#193510 WAARDENBURG SYNDROME, TYPE 2A; WS2A;;WAARDENBURG SYNDROME, TYPE IIA;;WAARDENBURG SYNDROME WITHOUT DYSTOPIA CANTHORUM;;WS2	0.04909086	2.4249702453608
ZECHI-CEIDE SYNDROME	0.04909086	2.4249702453608
WAARDENBURG SYNDROME, TYPE 1; WS1	0.04909086	2.4249702453608
#201000 CARPENTER SYNDROME 1; CRPT1;;CARPENTER SYNDROME;;ACROCEPHALOPOLYSYNDACTYLY TYPE II;;ACPS II	0.04779053	2.3607370752930934
603463 HYPOSPADIAS, HYPERTELORISM, UPPER LID COLOBOMA, AND MIXED-TYPE HEARINGLOSS	0.047619079999999994	2.352267858241953
AURICULOCONDYLAR SYNDROME 1; ARCND1	0.04755534	2.349119255764032
KENNERKNECHT SYNDROME	0.047491240000000004	2.3459528701531953
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.046340212	2.289094859281575
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.04596741199999999	2.2706794371954575
FONTAINE PROGEROID SYNDROME; FPS	0.04575895	2.26038191649021
MEIER-GORLIN SYNDROME 1; MGORS1	0.04548993	2.24709297644298
PERRAULT SYNDROME 3	0.0454545	2.2453428197785192
%226500 EPIDERMOLYSIS BULLOSA DYSTROPHICA NEUROTROPHICA;;EPIDERMOLYSIS BULLOSA WITH CONGENITAL DEAFNESS;;EPIDERMOLYSIS BULLOSA PROGRESSIVA, RECESSIVE; EBR3	0.0454545	2.2453428197785192
USHER SYNDROME, TYPE IF	0.0454545	2.2453428197785192
ULNAR-MAMMARY SYNDROME; UMS	0.0454545	2.2453428197785192
DEAFNESS, AUTOSOMAL RECESSIVE 108; DFNB108	0.0454545	2.2453428197785192
NIJMEGEN BREAKAGE SYNDROME	0.0454545	2.2453428197785192
USHER SYNDROME, TYPE IE; USH1E	0.0454545	2.2453428197785192
DEAFNESS, AUTOSOMAL RECESSIVE 63	0.0454545	2.2453428197785192
MANITOBA OCULOTRICHOANAL SYNDROME	0.0454545	2.2453428197785192
USHER SYNDROME, TYPE IC	0.0454545	2.2453428197785192
WAARDENBURG SYNDROME, TYPE 2D; WS2D	0.0454545	2.2453428197785192
DEAFNESS, AUTOSOMAL RECESSIVE 109; DFNB109	0.0454545	2.2453428197785192
PENDRED SYNDROME	0.0454545	2.2453428197785192
USHER SYNDROME, TYPE IIA	0.0454545	2.2453428197785192
ANTERIOR CHAMBER CLEAVAGE DISORDER, CEREBELLAR HYPOPLASIA, HYPOTHYROIDISM, AND TRACHEAL STENOSIS	0.0454545	2.2453428197785192
JERVELL AND LANGE-NIELSEN SYNDROME 1	0.0454545	2.2453428197785192
HOMOZYGOUS 11P15-P14 DELETION SYNDROME	0.0454545	2.2453428197785192
DEAFNESS, X-LINKED 3	0.0454545	2.2453428197785192
JERVELL AND LANGE-NIELSEN SYNDROME 2	0.0454545	2.2453428197785192
%300700 ALBINISM-DEAFNESS SYNDROME; ADFN;;ALDS	0.0454545	2.2453428197785192
DEAFNESS-OLIGODONTIA SYNDROME	0.0454545	2.2453428197785192
USHER SYNDROME, TYPE IIC	0.0454545	2.2453428197785192
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.04530305999999999	2.2378620485319476
#218400 CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL RECESSIVE; CMDR	0.04530305999999999	2.2378620485319476
MULLERIAN DUCT APLASIA, UNILATERAL RENAL AGENESIS, AND CERVICOTHORACICSOMITE ANOMALIES	0.045060090000000004	2.22585991574154
613627 BRACHYDACTYLY, TYPE A1, WITH SHORT STATURE, SCOLIOSIS, MICROCEPHALY,PTOSIS, HEARING LOSS, AND MENTAL RETARDATION;;TSUKAHARA SYNDROME	0.04492403	2.2191388794512044
BARATELA-SCOTT SYNDROME	0.04469700199999999	2.207924243063417
RAINE SYNDROME	0.04461142199999999	2.203696797188605
NATHALIE SYNDROME	0.04445999999999999	2.1962169150986797
#610313 COLD-INDUCED SWEATING SYNDROME 2; CISS2	0.044390200000000005	2.1927689632166762
#303110 CHOROIDEREMIA, DEAFNESS, AND MENTAL RETARDATION;;CHROMOSOME Xq21 DELETION SYNDROME	0.044232971999999995	2.1850022787108925
#215150 OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA; OSMED;;CHONDRODYSTROPHY WITH SENSORINEURAL DEAFNESS;;NANCE-INSLEY SYNDROME;;NANCE-SWEENEY CHONDRODYSPLASIA	0.04421123	2.1839282762779626
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.04421123	2.1839282762779626
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.04421123	2.1839282762779626
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.043925662	2.169821904887704
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.043783461999999995	2.1627975673859714
OTOFACIOCERVICAL SYNDROME 2	0.043767539999999994	2.162011058935179
#309520 LUJAN-FRYNS SYNDROME;;MENTAL RETARDATION, X-LINKED, WITH MARFANOID HABITUS	0.043767539999999994	2.162011058935179
#614976 CARPENTER SYNDROME 2; CRPT2	0.043632942	2.1553622419235188
PSEUDOTRISOMY 13 SYNDROME	0.04344024	2.1458432272592507
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.04332473	2.140137311472857
ACRORENAL-MANDIBULAR SYNDROME	0.04314067	2.131045190793751
YUNIS-VARON SYNDROME	0.042668819999999996	2.1077369372762225
ZTTK SYNDROME; ZTTKS	0.042295382	2.089289999526771
WARSAW BREAKAGE SYNDROME; WABS	0.042273712	2.088219553720424
HUNTER-MACDONALD SYNDROME	0.042232900000000004	2.086203539218872
CALVARIAL DOUGHNUT LESIONS WITH BONE FRAGILITY; CDL	0.041666699999999994	2.058234622949666
LEUKEMIA, ACUTE MYELOCYTIC, WITH POLYPOSIS COLI AND COLON CANCER	0.041666699999999994	2.058234622949666
138790 GOITER, MULTINODULAR, CYSTIC RENAL DISEASE, AND DIGITAL ANOMALIES;;MULTINODULAR GOITER/CYSTIC RENAL DISEASE/DIGITAL ANOMALIES;;MNG/CRD/DA	0.041666699999999994	2.058234622949666
GALACTORRHEA	0.041666699999999994	2.058234622949666
#226730 EPIDERMOLYSIS BULLOSA JUNCTIONALIS WITH PYLORIC ATRESIA;;EPIDERMOLYSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA;;JUNCTIONAL EPIDERMOLYSIS BULLOSA WITH PYLORIC ATRESIA;;JEB-PA;;EPIDERMYLOSIS BULLOSA, JUNCTIONAL, WITH PYLORIC ATRESIA AND APLASIACUTIS CONGENITA;;EB-PA-ACC;;CARMI SYNDROME;;APLASIA CUTIS CONGENITA WITH GASTROINTESTINAL ATRESIA	0.041666699999999994	2.058234622949666
URINARY BLADDER, ATONY OF	0.041666699999999994	2.058234622949666
LABIA MINORA, INCOMPLETE ADHESION OF	0.041666699999999994	2.058234622949666
SPLENOGONADAL FUSION WITH LIMB DEFECTS AND MICROGNATHIA	0.041666699999999994	2.058234622949666
OTOSCLEROSIS 4	0.041666699999999994	2.058234622949666
207620 APHALANGY WITH HEMIVERTEBRAE	0.041666699999999994	2.058234622949666
ADENOMYOSIS	0.041666699999999994	2.058234622949666
PEYRONIE DISEASE	0.041666699999999994	2.058234622949666
OVARIAN HYPERSTIMULATION SYNDROME	0.041666699999999994	2.058234622949666
HYDATIDIFORM MOLE, RECURRENT, 1; HYDM1	0.041666699999999994	2.058234622949666
#193400 VON WILLEBRAND DISEASE, TYPE 1; VWD1;;VON WILLEBRAND DISEASE, TYPE I;;VWD, TYPE 1	0.041666699999999994	2.058234622949666
EDEMA, FAMILIAL IDIOPATHIC, PREPUBERTAL	0.041666699999999994	2.058234622949666
VISCERAL STEATOSIS, CONGENITAL	0.041666699999999994	2.058234622949666
DK PHOCOMELIA SYNDROME	0.041666699999999994	2.058234622949666
HYPERLYSINEMIA, TYPE I	0.041666699999999994	2.058234622949666
TESTICULAR TORSION	0.041666699999999994	2.058234622949666
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT	0.041666699999999994	2.058234622949666
GENITOURINARY TRACT ANOMALIES	0.041666699999999994	2.058234622949666
RENAL CYSTS AND DIABETES SYNDROME; RCAD	0.041666680000000005	2.058233634997838
CHROMOSOME 9P DELETION SYNDROME	0.041628531999999996	2.0563492156798624
TEEBI-SHALTOUT SYNDROME; TBSH	0.041329779999999997	2.0415915864441545
DEAFNESS, X-LINKED 2	0.04059579	2.0053342483084537
PROGEROID FACIAL APPEARANCE WITH HAND ANOMALIES	0.04059579	2.0053342483084537
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.04035967000000001	1.9936704890193602
CREE MENTAL RETARDATION SYNDROME	0.040147102	1.9831701418036898
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.03972458	1.9622985726763549
BRACHYDACTYLY, TYPE B1	0.03972458	1.9622985726763549
%263450 POLYDACTYLY, POSTAXIAL, TYPE A5; PAPA5	0.03972458	1.9622985726763549
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.039351482	1.9438684301079903
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.039102712000000005	1.9315797912872728
VATER-LIKE DEFECTS WITH PULMONARY HYPERTENSION, LARYNGEAL WEBS, AND GROWTH DEFICIENCY	0.03897163000000001	1.9251046562070895
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.038926701999999994	1.9228853212191994
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.038659022	1.9096625739444897
Myhre syndrome	0.03863013	1.9082353787328155
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.0385076	1.9021826918545643
HIRSCHSPRUNG DISEASE WITH POLYDACTYLY, RENAL AGENESIS, AND DEAFNESS	0.0385076	1.9021826918545643
OTOONYCHOPERONEAL SYNDROME	0.038356219999999996	1.8947048844634793
#304120 OTOPALATODIGITAL SYNDROME, TYPE II; OPD2;;OPD II SYNDROME;;OPD SYNDROME 2;;CRANIOORODIGITAL SYNDROME;;FACIOPALATOOSSEOUS SYNDROME; FPO	0.03823231	1.8885840289090512
HEMIFACIAL MICROSOMIA	0.03818531	1.8862623421117133
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.037815140000000004	1.867976835691064
COFFIN-SIRIS SYNDROME 6; CSS6	0.037772721999999995	1.8658814886576707
#148820 WAARDENBURG SYNDROME, TYPE 3; WS3;;WAARDENBURG SYNDROME WITH UPPER LIMB ANOMALIES;;WAARDENBURG SYNDROME, TYPE III;;KLEIN-WAARDENBURG SYNDROME	0.03743089	1.8489958111830418
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.037316552	1.8433477893738077
LATHOSTEROLOSIS	0.03707278	1.8313060397150707
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.03625538	1.7909284484779662
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.036128999999999994	1.784685580872699
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.036080601999999996	1.7822948362425384
EXSTROPHY OF BLADDER	0.035714300000000004	1.764200399705551
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.035714300000000004	1.764200399705551
MICROCEPHALY, CONGENITAL HEART DISEASE, UNILATERAL RENAL AGENESIS,AND HYPOSEGMENTED LUNGS	0.035714300000000004	1.764200399705551
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE; EDSCLL	0.035714300000000004	1.764200399705551
256690 NEUROFACIODIGITORENAL SYNDROME;;NFDR SYNDROME	0.035714300000000004	1.764200399705551
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.035714300000000004	1.764200399705551
ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTORRETARDATION	0.035714300000000004	1.764200399705551
#158330 MULLERIAN APLASIA AND HYPERANDROGENISM;;MULLERIAN DUCT FAILURE AND HYPERANDROGENISM	0.035714300000000004	1.764200399705551
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.035714300000000004	1.764200399705551
AL KAISSI SYNDROME; ALKAS	0.035676151999999996	1.7623159803875754
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.03553726	1.7554550501183024
CORNELIA DE LANGE SYNDROME 3	0.035459482	1.7516130042518483
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.0354017	1.748758712623683
SILVER-RUSSELL SYNDROME; SRS	0.035270842	1.7422946426039798
#101400 SAETHRE-CHOTZEN SYNDROME; SCS;;ACROCEPHALOSYNDACTYLY, TYPE III; ACS3;;ACS III;;CHOTZEN SYNDROME;;ACROCEPHALY, SKULL ASYMMETRY, AND MILD SYNDACTYLYSAETHRE-CHOTZEN SYNDROME WITH EYELID ANOMALIES, INCLUDED;;BLEPHAROPHIMOSIS, EPICANTHUS INVERSUS, AND PTOSIS 3, FORMERLY, INCLUDED;BPES3, FORMERLY, INCLUDED	0.03507323	1.7325330857657775
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.03503395	1.7305927483743007
15q26 overgrowth syndrome	0.034939670000000006	1.7259355434540242
PHELAN-MCDERMID SYNDROME; PHMDS	0.034921072	1.725016847048558
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.034398771999999994	1.699216485043249
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.03425263	1.6919974222360887
#269921 SIALURIA;;SIALURIA, FRENCH TYPE	0.034228612	1.6908109908850575
DEAFNESS, AUTOSOMAL DOMINANT 41; DFNA41	0.0340433	1.6816570244214777
#191900 MUCKLE-WELLS SYNDROME; MWS;;URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME;;UDA SYNDROME;;CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2; CAPS2	0.0340433	1.6816570244214777
#101200 APERT SYNDROME;;ACROCEPHALOSYNDACTYLY, TYPE I; ACS1;;ACS IAPERT-CROUZON DISEASE, INCLUDED;;ACROCEPHALOSYNDACTYLY, TYPE II, INCLUDED;;ACS II, INCLUDED;;VOGT CEPHALODACTYLY, INCLUDED	0.0340433	1.6816570244214777
SCLEROSTEOSIS 2; SOST2	0.0340433	1.6816570244214777
CRANIOECTODERMAL DYSPLASIA 1	0.03401169	1.6800955665562893
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.033939359999999995	1.6765226387679606
#206920 MICROPHTHALMIA WITH LIMB ANOMALIES;;WAARDENBURG ANOPHTHALMIA SYNDROME;;ANOPHTHALMIA-SYNDACTYLY;;OPHTHALMOACROMELIC SYNDROME; OAS	0.03392314	1.675721409834922
FACIOCARDIORENAL SYNDROME	0.03381545	1.6704017832135325
#311300 OTOPALATODIGITAL SYNDROME, TYPE I; OPD1;;OPD I SYNDROME;;OPD SYNDROME 1OTOPALATODIGITAL SPECTRUM DISORDER, INCLUDED;;FRONTOOTOPALATODIGITAL OSTEODYSPLASIA, INCLUDED	0.03381545	1.6704017832135325
CEREBELLAR ATAXIA, AREFLEXIA, PES CAVUS, OPTIC ATROPHY, AND SENSORINEURAL HEARING LOSS; CAPOS	0.03379453	1.6693683856007602
221745 DEAFNESS, SENSORINEURAL, AUTOSOMAL-MITOCHONDRIAL TYPE	0.03379453	1.6693683856007602
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.03379453	1.6693683856007602
DEAFNESS, AUTOSOMAL RECESSIVE 79; DFNB79	0.03379453	1.6693683856007602
%608572 BURN-MCKEOWN SYNDROME	0.03373599	1.6664766505982889
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.033430801999999996	1.65140109846412
CHROMOSOME 10Q26 DELETION SYNDROME	0.033216242	1.640802351246316
#190685 DOWN SYNDROMETRISOMY 21, INCLUDED;;DOWN SYNDROME CHROMOSOME REGION, INCLUDED; DCR, INCLUDED;;DOWN SYNDROME CRITICAL REGION, INCLUDED; DSCR, INCLUDED;;TRANSIENT MYELOPROLIFERATIVE DISORDER OF DOWN SYNDROME, INCLUDED;;LEUKEMIA, MEGAKARYOBLASTIC, OF DOWN SYNDROME, INCLUDED	0.03293791	1.6270534208276646
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.032887110000000004	1.6245440231828827
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.032882282	1.6243055316114454
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.03284753	1.6225888665139754
HEART AND BRAIN MALFORMATION SYNDROME	0.032418822	1.6014117238860375
COFFIN-SIRIS SYNDROME 1; CSS1	0.032388141999999995	1.5998962057808812
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.03214437	1.5878544561221446
ALSTROM SYNDROME; ALMS	0.032093882	1.5853604705258897
SIMOSA CRANIOFACIAL SYNDROME	0.031574939999999996	1.5597259856326116
DIAPHRAGMATIC DEFECTS, LIMB DEFICIENCIES, AND OSSIFICATION DEFECTS OF SKULL	0.03140872	1.5515151179846653
#192350 VATER ASSOCIATIONVACTERL ASSOCIATION, INCLUDED	0.03137616	1.549906732407616
#616351 MENTAL RETARDATION, AUTOSOMAL DOMINANT 34; MRD34	0.031284712	1.5453894214662767
CRANIOFRONTONASAL SYNDROME; CFNS	0.031265922	1.5444612407232559
183802 SPLIT-HAND WITH OBSTRUCTIVE UROPATHY, SPINA BIFIDA, AND DIAPHRAGMATICDEFECTS	0.03125	1.5436747322724642
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.03125	1.5436747322724642
FLYNN-AIRD SYNDROME	0.03125	1.5436747322724642
ACROFACIAL DYSOSTOSIS, PALAGONIA TYPE	0.03125	1.5436747322724642
OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALDOMINANT	0.03125	1.5436747322724642
258650 OPTIC ATROPHY, HEARING LOSS, AND PERIPHERAL NEUROPATHY, AUTOSOMALRECESSIVE	0.03125	1.5436747322724642
172500 PHOTOMYOCLONUS, DIABETES MELLITUS, DEAFNESS, NEPHROPATHY, AND CEREBRALDYSFUNCTION;;HERRMANN SYNDROME	0.03125	1.5436747322724642
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 4	0.03125	1.5436747322724642
CRANIOECTODERMAL DYSPLASIA 4	0.03125	1.5436747322724642
POPLITEAL PTERYGIUM SYNDROME	0.03125	1.5436747322724642
ATAXIA-DEAFNESS-RETARDATION SYNDROME	0.03125	1.5436747322724642
DEAFNESS, AUTOSOMAL DOMINANT 70	0.03125	1.5436747322724642
#615540 DEAFNESS, AUTOSOMAL RECESSIVE 76; DFNB76	0.03125	1.5436747322724642
USHER SYNDROME, TYPE IV; USH4	0.03125	1.5436747322724642
FIBROMATOSIS, GINGIVAL, WITH PROGRESSIVE DEAFNESS	0.03125	1.5436747322724642
#613285 DEAFNESS, AUTOSOMAL RECESSIVE 25; DFNB25	0.03125	1.5436747322724642
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 5	0.03125	1.5436747322724642
DEAFNESS, AUTOSOMAL RECESSIVE 111; DFNB111	0.03125	1.5436747322724642
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.03125	1.5436747322724642
DEAFNESS, AUTOSOMAL DOMINANT 22; DFNA22	0.03125	1.5436747322724642
CINCA SYNDROME; CINCA	0.03125	1.5436747322724642
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.031146881999999997	1.5385809514391047
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.031146881999999997	1.5385809514391047
PALLISTER-HALL SYNDROME	0.031022972	1.5324600958846766
EMANUEL SYNDROME	0.030883942	1.525592348747786
BARBER-SAY SYNDROME; BBRSAY	0.030731879999999996	1.5180808521993434
C SYNDROME	0.030671711999999997	1.5151086979180197
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.03034258	1.4988503698545863
RETINITIS PIGMENTOSA, DEAFNESS, MENTAL RETARDATION, AND HYPOGONADISM	0.030302999999999997	1.4968952131856792
MUSICAL PERFECT PITCH	0.030302999999999997	1.4968952131856792
EAR MALFORMATION	0.030302999999999997	1.4968952131856792
EAR WITHOUT HELIX	0.030302999999999997	1.4968952131856792
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.030302999999999997	1.4968952131856792
EAR ANTITRAGUS, TAG AT BASE OF	0.030302999999999997	1.4968952131856792
#172800 PIEBALD TRAIT; PBT;;PIEBALDISM	0.030302999999999997	1.4968952131856792
BOR-DUANE HYDROCEPHALUS CONTIGUOUS GENE SYNDROME	0.030302999999999997	1.4968952131856792
HAIRY EARS, Y-LINKED	0.030302999999999997	1.4968952131856792
BLAU SYNDROME	0.030302999999999997	1.4968952131856792
DARWINIAN POINT OF PINNA	0.030302999999999997	1.4968952131856792
EXCHONDROSIS OF PINNA, POSTERIOR	0.030302999999999997	1.4968952131856792
EAR FOLDING	0.030302999999999997	1.4968952131856792
DARWINIAN TUBERCLE OF PINNA	0.030302999999999997	1.4968952131856792
VELOCARDIOFACIAL SYNDROME	0.030302999999999997	1.4968952131856792
OSTEOMA OF MIDDLE EAR	0.030302999999999997	1.4968952131856792
OSSIFIED EAR CARTILAGES	0.030302999999999997	1.4968952131856792
AREDYLD	0.030302999999999997	1.4968952131856792
EAR WAX, WET/DRY	0.030302999999999997	1.4968952131856792
PLASMINOGEN DEFICIENCY, TYPE ILIGNEOUS CONJUNCTIVITIS, INCLUDED	0.030302999999999997	1.4968952131856792
#192500 LONG QT SYNDROME 1; LQT1;;WARD-ROMANO SYNDROME; WRS;;ROMANO-WARD SYNDROME; RWS;;VENTRICULAR FIBRILLATION WITH PROLONGED QT INTERVALLONG QT SYNDROME 1/2, DIGENIC, INCLUDED; LQT1/2, DIGENIC, INCLUDED;;LONG QT SYNDROME 1, ACQUIRED, SUSCEPTIBILITY TO, INCLUDED	0.030302999999999997	1.4968952131856792
#184460 STAPES ANKYLOSIS WITH BROAD THUMB AND TOES;;ANKYLOSIS OF STAPES, HYPEROPIA, BROAD THUMBS, BROAD FIRST TOES, ANDSYNDACTYLY;;TEUNISSEN-CREMERS SYNDROME;;STAPES ANKYLOSIS SYNDROME WITHOUT SYMPHALANGISM	0.03017909	1.490774357631251
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.030063741999999994	1.4850764442546696
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.0298729	1.475649309110467
#265000 MULTIPLE PTERYGIUM SYNDROME, ESCOBAR VARIANT; EVMPS;;ESCOBAR SYNDROME;;MULTIPLE PTERYGIUM SYNDROME, NONLETHAL TYPE;;PTERYGIUM SYNDROME;;MULTIPLE PTERYGIUM SYNDROME;;PTERYGIUM COLLI SYNDROME;;PTERYGIUM UNIVERSALE	0.029130919999999998	1.4389972842192182
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.029040602000000002	1.4345357925561981
#218000 AGENESIS OF THE CORPUS CALLOSUM WITH PERIPHERAL NEUROPATHY; ACCPN;;CHARLEVOIX DISEASE;;ANDERMANN SYNDROME;;POLYNEUROPATHY, SENSORIMOTOR, WITH OR WITHOUT AGENESIS OF THE CORPUSCALLOSUM;;CORPUS CALLOSUM, AGENESIS OF, WITH NEURONOPATHY	0.028870442	1.4261302983980064
SECKEL SYNDROME 1; SCKL1	0.02875096	1.4202281753784423
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.028511942	1.4084212618693768
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.028151469999999998	1.3906148132904417
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.028027382000000003	1.3844851649647387
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.028021732000000004	1.3842060685731439
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.027737572	1.3701692489916222
Mulchandani-Bhoj-Conlin syndrome	0.02764753	1.3657213910638373
MECKEL SYNDROME, TYPE 1; MKS1	0.02752462	1.3596499331008418
OCULOSKELETODENTAL SYNDROME; OCSKD	0.027480071999999998	1.357449369197697
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.027472252	1.3570630800326933
MARDEN-WALKER SYNDROME	0.027439549999999997	1.3554476799976602
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.027438162	1.3553791161407518
#613603 CHROMOSOME 4q32.1-q32.2 TRIPLICATION SYNDROME	0.027380921999999995	1.352551598007143
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.027336259999999998	1.3503454027785748
MEND SYNDROME; MEND	0.027334922	1.3502793088012381
COHEN SYNDROME	0.027117999999999996	1.3395638844724695
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.026899792	1.328784934841119
#117550 SOTOS SYNDROME 1; SOTOS1;;SOTOS SYNDROME;;CEREBRAL GIGANTISM;;CHROMOSOME 5q35 DELETION SYNDROME	0.026318671999999998	1.3000790065077374
JOUBERT SYNDROME 1	0.026202052	1.2943182593948537
OROFACIODIGITAL SYNDROME IV; OFD4	0.02619147	1.2937955340823128
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.025837739999999998	1.276322124064817
SCHIZOPHRENIA 1; SCZD1	0.02542378	1.255873497115329
#212780 CENANI-LENZ SYNDACTYLY SYNDROME; CLSS;;CENANI SYNDACTYLISM;;CENANI-LENZ SYNDACTYLY;;SYNDACTYLY, TYPE VII	0.02542378	1.255873497115329
ADAMS-OLIVER SYNDROME 3; AOS3	0.025234082	1.246502872815725
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.025234082	1.246502872815725
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.025169601999999996	1.243317716120143
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.025123529999999995	1.241041870287655
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.02500691	1.2352811231747713
46,XX SEX REVERSAL WITH DYSGENESIS OF KIDNEYS, ADRENALS, AND LUNGS; SERKAL	0.02500242	1.2350593279892386
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.024893632	1.2296854628124556
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.024470481999999998	1.2087828719977007
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.0243902	1.2048171345622993
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.0243902	1.2048171345622993
BRACHYDACTYLY, TYPE A2; BDA2	0.0243902	1.2048171345622993
#123150 JACKSON-WEISS SYNDROME; JWS;;CRANIOSYNOSTOSIS, MIDFACIAL HYPOPLASIA, AND FOOT ABNORMALITIES	0.0243902	1.2048171345622993
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.024325719999999995	1.2016319778667173
BAKER-GORDON SYNDROME; BAGOS	0.024101212	1.1905418234093408
INFANTILE SIALIC ACID STORAGE DISEASE	0.024101212	1.1905418234093408
DESANTO-SHINAWI SYNDROME	0.024087172	1.1898482812256255
Aarskog-Scott syndrome	0.023943822	1.182767136493745
#616006 HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME 2; HKLLS2	0.023871	1.1791699050904316
CATEL-MANZKE SYNDROME; CATMANS	0.023642462	1.167880678339581
133705 EXTERNAL AUDITORY CANAL, BILATERAL ATRESIA OF, WITH CONGENITAL VERTICALTALUS;;RASMUSSEN SYNDROME	0.023592119999999998	1.1653939047916748
DUBOWITZ SYNDROME	0.023421489999999996	1.1569651937655099
DEAFNESS, CONGENITAL, AND ONYCHODYSTROPHY, AUTOSOMAL DOMINANT	0.02337783	1.1548084949235575
BEEMER LETHAL MALFORMATION SYNDROME	0.02324416	1.1482055188767462
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.02309994	1.1410813982403194
600736 VELOFACIOSKELETAL SYNDROME	0.023022689999999995	1.1372654343021416
JOUBERT SYNDROME 2	0.022944722	1.1334140028933157
ANDERSEN CARDIODYSRHYTHMIC PERIODIC PARALYSIS	0.02293414	1.1328912775807747
THORACOABDOMINAL SYNDROME	0.02290158	1.1312828920037254
MEGAEPIPHYSEAL DWARFISM	0.02286513	1.1294823497960027
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.022822902000000003	1.127396388304982
PITT-HOPKINS SYNDROME	0.02282208	1.1273557834848242
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.022720910000000004	1.1223582291595762
MECKEL SYNDROME 12; MKS12	0.022686400000000002	1.120653518279233
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIg; CDG2G	0.022571711999999997	1.114988207312997
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0224011	1.1065603854434782
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.022327939999999998	1.1029464576542605
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.02219186	1.096224433412096
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.02215233	1.0942717466227607
#608836 CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, LETHAL NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, NEONATAL;;CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, ANTENATAL;;CPT II DEFICIENCY, LETHAL NEONATAL;;CPT2 DEFICIENCY, LETHAL NEONATAL	0.02210084	1.09172826463989
601095 HARROD SYNDROME	0.022081379999999998	1.0907669875106092
#163950 NOONAN SYNDROME 1; NS1;;NOONAN SYNDROME;;MALE TURNER SYNDROME;;FEMALE PSEUDO-TURNER SYNDROME;;TURNER PHENOTYPE WITH NORMAL KARYOTYPEPTERYGIUM COLLI SYNDROME, INCLUDED	0.021930859999999996	1.0833316620481563
#608027 PONTOCEREBELLAR HYPOPLASIA, TYPE 3; PCH3;;CEREBELLAR ATROPHY WITH PROGRESSIVE MICROCEPHALY; CLAM;;PCH WITH OPTIC ATROPHY	0.021867021999999996	1.0801782186062745
OROFACIODIGITAL SYNDROME IX; OFD9	0.021677182	1.0708005798486873
ADAMS-OLIVER SYNDROME 1; AOS1	0.021677182	1.0708005798486873
KLIPPEL-FEIL SYNDROME, AUTOSOMAL RECESSIVE	0.02159906	1.0669415412107803
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.021541622	1.0641042423540679
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.021500222	1.0620591820687533
CHROMOSOME 3q13.31 DELETION SYNDROME	0.021487169999999996	1.0614144447053733
MOEBIUS SYNDROME; MBS	0.021440650000000002	1.0591164687519234
#615583 VERHEIJ SYNDROME; VRJS;;CHROMOSOME 8q24.3 DELETION SYNDROME	0.021429442000000003	1.0585628205471458
DEAFNESS, CONDUCTIVE, WITH MALFORMED EXTERNAL EAR	0.02115537	1.0450243238679973
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.021023139999999996	1.0384924803528488
Orofaciodigital syndrome XVII	0.021023139999999996	1.0384924803528488
SPLIT-HAND/FOOT MALFORMATION 1; SHFM1	0.02097662	1.036194504399399
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.020843882	1.0296375669078028
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.020843882	1.0296375669078028
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.020843882	1.0296375669078028
HAREL-YOON SYNDROME; HAYOS	0.020843882	1.0296375669078028
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.020843882	1.0296375669078028
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.020843882	1.0296375669078028
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.020843882	1.0296375669078028
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.020843882	1.0296375669078028
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.020843882	1.0296375669078028
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.020843882	1.0296375669078028
ULNAR/FIBULAR RAY DEFECT AND BRACHYDACTYLY	0.0208333	1.0291148415952616
SYNPOLYDACTYLY 2	0.0208333	1.0291148415952616
#103285 ADULT SYNDROME;;ACRO-DERMATO-UNGUAL-LACRIMAL-TOOTH SYNDROME	0.0208333	1.0291148415952616
DIAMOND-BLACKFAN ANEMIA 10	0.02079242	1.027095468057492
#102500 HAJDU-CHENEY SYNDROME; HJCYS;;ACROOSTEOLYSIS WITH OSTEOPOROSIS AND CHANGES IN SKULL AND MANDIBLE;;CHENEY SYNDROME;;ARTHRODENTOOSTEODYSPLASIA;;SERPENTINE FIBULA-POLYCYSTIC KIDNEY SYNDROME; SFPKS	0.02065634	1.0203734438153276
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.02065634	1.0203734438153276
HARTSFIELD SYNDROME; HRTFDS	0.020629012	1.0190235064366542
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.02061367	1.0182656485888937
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.020586382000000004	1.0169176871138779
BARDET-BIEDL SYNDROME 16; BBS16	0.020586382	1.0169176871138776
BAND HETEROTOPIA; BH	0.020451682000000002	1.0102638315478905
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.020451682000000002	1.0102638315478905
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.020451682000000002	1.0102638315478905
AYME-GRIPP SYNDROME; AYGRP	0.02042082	1.0087393230810937
KBG SYNDROME	0.020307462000000002	1.0031397109114637
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.02030649	1.0030916964525909
ACROCEPHALOPOLYSYNDACTYLY TYPE III	0.020284160000000002	1.0019886482358984
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.020230211999999997	0.9993237469732859
ROBERTS SYNDROME; RBS	0.02016416	0.9960609372639722
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.020013640000000003	0.9886256118015194
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.02	0.987951828654377
#200610 ACHONDROGENESIS, TYPE II; ACG2;;ACHONDROGENESIS, LANGER-SALDINO TYPE;;CHONDROGENESIS IMPERFECTA;;ACHONDROGENESIS, TYPE IB, FORMERLYHYPOCHONDROGENESIS, INCLUDED	0.02	0.987951828654377
MYASTHENIC SYNDROME, CONGENITAL, 23, PRESYNAPTIC; CMS23	0.02	0.987951828654377
SPASTIC PARAPLEGIA 73, AUTOSOMAL DOMINANT; SPG73	0.02	0.987951828654377
NEUROPATHY, HEREDITARY SENSORY, WITH SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE	0.02	0.987951828654377
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 19	0.02	0.987951828654377
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.02	0.987951828654377
NEUROMYOTONIA AND AXONAL NEUROPATHY, AUTOSOMAL RECESSIVE	0.02	0.987951828654377
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.02	0.987951828654377
EXOSTOSES, MULTIPLE, TYPE I	0.02	0.987951828654377
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.02	0.987951828654377
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.02	0.987951828654377
HYPOPHOSPHATASIA, ADULT	0.02	0.987951828654377
NEUROPATHY, CONGENITAL HYPOMYELINATING, 2; CHN2	0.02	0.987951828654377
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.02	0.987951828654377
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE C; CMTDIC	0.02	0.987951828654377
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IC; HSAN1C	0.02	0.987951828654377
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, RUSSE TYPE; HMSNR	0.02	0.987951828654377
PERIPHERAL NEUROPATHY, MYOPATHY, HOARSENESS, AND HEARING LOSS; PNMHH	0.02	0.987951828654377
MYOPATHY, DISTAL 3	0.02	0.987951828654377
139750 HAND AND FOOT DEFORMITY WITH FLAT FACIES	0.02	0.987951828654377
236640 HYDROCEPHALUS WITH ASSOCIATED MALFORMATIONS	0.02	0.987951828654377
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.01998353	0.9871382503234801
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.019898412	0.9829336261359101
#227645 FANCONI ANEMIA, COMPLEMENTATION GROUP C; FANCC;;FACC; FAC;;FANCONI PANCYTOPENIA, TYPE 3; FA3	0.019742500000000003	0.9752319488604521
#227646 FANCONI ANEMIA, COMPLEMENTATION GROUP D2; FANCD2;;FAD2;;FANCONI ANEMIA, COMPLEMENTATION GROUP D; FANCD; FACD;;FANCONI PANCYTOPENIA, TYPE 4; FA4	0.019742500000000003	0.9752319488604521
FANCONI ANEMIA	0.019742500000000003	0.9752319488604521
PACHYDERMODACTYLY, FAMILIAL	0.0196078	0.9685780932944646
#215300 CHONDROSARCOMA	0.0196078	0.9685780932944646
CIRCUMVALLATE PLACENTA SYNDROME	0.0196078	0.9685780932944646
COPPER DEFICIENCY, FAMILIAL BENIGN	0.0196078	0.9685780932944646
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0196078	0.9685780932944646
PUBIC BONE DYSPLASIA	0.0196078	0.9685780932944646
TRACHEOPATHIA OSTEOPLASTICA	0.0196078	0.9685780932944646
RAYNAUD DISEASE	0.0196078	0.9685780932944646
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0196078	0.9685780932944646
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0196078	0.9685780932944646
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0196078	0.9685780932944646
DOUBLE NAIL FOR FIFTH TOE	0.0196078	0.9685780932944646
LETTERER-SIWE DISEASE	0.0196078	0.9685780932944646
#615422 INCLUSION BODY MYOPATHY WITH EARLY-ONSET PAGET DISEASE WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA 2; IBMPFD2 ;;MULTISYSTEM PROTEINOPATHY 2; MSP2	0.0196078	0.9685780932944646
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0196078	0.9685780932944646
VESICOURETERAL REFLUX 1	0.0196078	0.9685780932944646
TOE, MISSHAPEN	0.0196078	0.9685780932944646
NEPHROSIALIDOSIS	0.0196078	0.9685780932944646
VAN DEN BOSCH SYNDROME	0.0196078	0.9685780932944646
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0196078	0.9685780932944646
SPINAL ARACHNOIDITIS	0.0196078	0.9685780932944646
CARPAL DISPLACEMENT	0.0196078	0.9685780932944646
THROMBOCYTOPENIA 3	0.0196078	0.9685780932944646
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0196078	0.9685780932944646
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0196078	0.9685780932944646
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.0196078	0.9685780932944646
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0196078	0.9685780932944646
MICROPHTHALMIA, SYNDROMIC 4	0.0196078	0.9685780932944646
TRACHEOBRONCHOMEGALY	0.0196078	0.9685780932944646
THUMBS, CONGENITAL CLASPED	0.0196078	0.9685780932944646
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.0196078	0.9685780932944646
#212840 CEREBELLAR ATAXIA AND HYPOGONADOTROPIC HYPOGONADISM; CAHH;;GORDON HOLMES SYNDROME;;LUTEINIZING HORMONE-RELEASING HORMONE, DEFICIENCY OF, WITH ATAXIA;;LHRH DEFICIENCY AND ATAXIA	0.0196078	0.9685780932944646
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0196078	0.9685780932944646
THROMBOCYTHEMIA, ESSENTIAL	0.0196078	0.9685780932944646
KNUCKLE PADS	0.0196078	0.9685780932944646
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.0196078	0.9685780932944646
MONOPHALANGY OF GREAT TOE	0.0196078	0.9685780932944646
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0196078	0.9685780932944646
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0196078	0.9685780932944646
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0196078	0.9685780932944646
248100 MACROSOMIA ADIPOSA CONGENITA	0.0196078	0.9685780932944646
THALIDOMIDE SUSCEPTIBILITY	0.0196078	0.9685780932944646
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0196078	0.9685780932944646
HHHH SYNDROME	0.0196078	0.9685780932944646
CHROMOSOME 16Q22 DELETION SYNDROME	0.019547152	0.9655822281692532
JOHANSON-BLIZZARD SYNDROME; JBS	0.01948591	0.9625570208747304
LEGIUS SYNDROME	0.019386329999999997	0.9576380087198603
TYSHCHENKO SYNDROME	0.019073721999999998	0.9421959264572609
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.019073721999999998	0.9421959264572609
HETEROTAXY, VISCERAL, 1, X-LINKED; HTX1	0.01905004	0.9410260926969514
FANCONI ANEMIA, COMPLEMENTATION GROUP B; FANCB	0.01905004	0.9410260926969514
#191830 RENAL HYPODYSPLASIA/APLASIA 1; RHDA1;;RENAL ADYSPLASIA;;RENAL AGENESIS;;RENAL APLASIA;;HEREDITARY RENAL APLASIA; HRA	0.01905004	0.9410260926969514
#273395 TETRAAMELIA, AUTOSOMAL RECESSIVE	0.01905004	0.9410260926969514
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ig; CDG1G	0.019049532	0.9410009987205037
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.01904222	0.9406398035319474
CLEIDOCRANIAL DYSPLASIA; CCD	0.018922299999999996	0.9347160443673357
RAPADILINO SYNDROME	0.018922299999999996	0.9347160443673357
#177980 PTERYGIA, MENTAL RETARDATION, AND DISTINCTIVE CRANIOFACIAL FEATURES;;HASPESLAGH SYNDROME	0.01891845	0.93452586364032
MECKEL SYNDROME, TYPE 10; MKS10	0.01891845	0.93452586364032
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.018704092000000002	0.9239370947359852
MICROTIA WITH MEATAL ATRESIA AND CONDUCTIVE DEAFNESS	0.01869158	0.923319032071979
DIAMOND-BLACKFAN ANEMIA 14 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA14	0.01869158	0.923319032071979
TREACHER COLLINS SYNDROME 2; TCS2	0.01869158	0.923319032071979
HEMIFACIAL MICROSOMIA WITH RADIAL DEFECTS	0.01869158	0.923319032071979
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.01869158	0.923319032071979
%147770 JOHNSON NEUROECTODERMAL SYNDROME;;JOHNSON-MCMILLIN SYNDROME; JMS;;ALOPECIA-ANOSMIA-DEAFNESS-HYPOGONADISM SYNDROME;;AADH SYNDROME	0.01869158	0.923319032071979
TREACHER COLLINS SYNDROME 3; TCS3	0.01869158	0.923319032071979
STICKLER SYNDROME, TYPE II	0.018673529999999997	0.9224274055466183
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.018471402	0.9124427691855058
AU-KLINE SYNDROME; AUKS	0.018386391999999998	0.9082434799378102
FRONTONASAL DYSPLASIA 1; FND1	0.01834032	0.9059676341053221
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.018262542000000003	0.9021255882388683
228940 FIBULOULNAR APLASIA OR HYPOPLASIA WITH RENAL ABNORMALITIES	0.018183320000000003	0.8982122122503855
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.018035132	0.8908920819711535
WIEDEMANN-STEINER SYNDROME; WDSTS	0.018035132	0.8908920819711535
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.017820370000000002	0.8802833564398802
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.017793082	0.8789353949648641
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.017793082	0.8789353949648641
RESTRICTIVE DERMOPATHY, LETHAL	0.01776196	0.8773980431242948
HYDROLETHALUS SYNDROME 1	0.01776196	0.8773980431242948
SHORT-RIB THORACIC DYSPLASIA 7 WITH OR WITHOUT POLYDACTYLY; SRTD7	0.01768429	0.8735613321977155
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.017570082	0.8679197320753677
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.017469110000000003	0.8629319584732233
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.01739901	0.8594691873137895
TRICHOHEPATOENTERIC SYNDROME 1	0.01739901	0.8594691873137895
RITSCHER-SCHINZEL SYNDROME 1	0.017371682000000003	0.8581192499351165
#129400 RAPP-HODGKIN SYNDROME; RHS;;ECTODERMAL DYSPLASIA, ANHIDROTIC, WITH CLEFT LIP/PALATEOROFACIAL CLEFT 8, INCLUDED; OFC8, INCLUDED;;CLEFT LIP WITH OR WITHOUT CLEFT PALATE, NONSYNDROMIC, 8, INCLUDED	0.01722026	0.8506393678451912
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.016972881999999998	0.8384194904717479
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.016972881999999998	0.8384194904717479
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.016971490000000002	0.8383507290244738
CRYPTORCHIDISM, UNILATERAL OR BILATERAL	0.0169492	0.8372496567114384
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.0169492	0.8372496567114384
UTERUS BICORNIS BICOLLIS WITH PARTIAL VAGINAL SEPTUM AND UNILATERAL HEMATOCOLPOS WITH IPSILATERAL RENAL AGENESIS	0.0169492	0.8372496567114384
HOLZGREVE SYNDROME	0.0169492	0.8372496567114384
274210 THYMIC APLASIA WITH FETAL DEATH	0.0169492	0.8372496567114384
120400 COLOBOMA OF MACULA WITH TYPE B BRACHYDACTYLY;;APICAL DYSTROPHY;;SORSBY SYNDROME	0.0169492	0.8372496567114384
RENAL HYPODYSPLASIA/APLASIA 3; RHDA3	0.0169492	0.8372496567114384
VENTRICULOMEGALY WITH DEFECTS OF THE RADIUS AND KIDNEY	0.0169492	0.8372496567114384
RADIAL-RENAL SYNDROME	0.0169492	0.8372496567114384
THYMIC-RENAL-ANAL-LUNG DYSPLASIA	0.0169492	0.8372496567114384
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.01694138	0.8368633675464344
HAMAMY SYNDROME; HMMS	0.01675631	0.8277213552999811
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.0167262	0.8262339938219421
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.016527800000000002	0.8164335116816906
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.016527800000000002	0.8164335116816906
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.016505002	0.8153073453922075
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.01634819	0.8075612102844598
OROFACIAL CLEFT 15	0.01634717	0.8075108247411986
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.01634717	0.8075108247411986
ZUNICH NEUROECTODERMAL SYNDROME	0.01623948	0.8021911981198091
%300712 CRANIOFACIOSKELETAL SYNDROME	0.016142052	0.7973784895817022
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.016142052	0.7973784895817022
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.016128999999999998	0.7967337522183222
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.016128999999999998	0.7967337522183222
%249650 MERCAPTOLACTATE-CYSTEINE DISULFIDURIA; MCDU;;DISULFIDURIA, MIXED	0.016128999999999998	0.7967337522183222
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.016128999999999998	0.7967337522183222
118980 CLAVICLE, PSEUDARTHROSIS OF, CONGENITAL	0.016128999999999998	0.7967337522183222
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.016128999999999998	0.7967337522183222
#614816 LOEYS-DIETZ SYNDROME, TYPE 4; LDS4;;ANEURYSM, AORTIC AND CEREBRAL, WITH ARTERIAL TORTUOSITY AND SKELETALMANIFESTATIONS	0.016128999999999998	0.7967337522183222
VAN DEN ENDE-GUPTA SYNDROME; VDEGS	0.016128999999999998	0.7967337522183222
248760 MARFANOID HABITUS WITH MICROCEPHALY AND GLOMERULONEPHRITIS	0.016128999999999998	0.7967337522183222
MYOPATHY, CONGENITAL, COMPTON-NORTH	0.016128999999999998	0.7967337522183222
KEPPEN-LUBINSKY SYNDROME; KPLBS	0.016128999999999998	0.7967337522183222
#300534 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CLAES-JENSEN TYPE; MRXSCJ;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, JARID1C-RELATED; MRXSJ	0.016128999999999998	0.7967337522183222
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.016128999999999998	0.7967337522183222
MARFANOID HYPERMOBILITY SYNDROME	0.016128999999999998	0.7967337522183222
%157700 MITRAL VALVE PROLAPSE 1; MVP1;;MITRAL VALVE PROLAPSE, MYXOMATOUS 1; MMVP1;;MYXOMATOUS MITRAL VALVE PROLAPSE 1;;MITRAL VALVE PROLAPSE, FAMILIAL; MVP PROLAPSED MITRAL VALVE; PMV;;MITRAL REGURGITATION, FAMILIAL;;FLOPPY MITRAL VALVE;;BARLOW SYNDROME;;MYXOMATOUS VALVULAR DISEASE, FAMILIAL;;CLICK-MURMUR SYNDROME	0.016128999999999998	0.7967337522183222
GAPO SYNDROME; GAPOS	0.016128999999999998	0.7967337522183222
ADDUCTED THUMBS SYNDROME	0.016128999999999998	0.7967337522183222
CHROMOSOME 14q11-q22 DELETION SYNDROME	0.015910792	0.7859548025869715
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.015910792	0.7859548025869715
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.015910792	0.7859548025869715
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.01566112	0.7736216071387819
RENPENNING SYNDROME 1; RENS1	0.01563937	0.7725472095251201
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.01563437	0.7723002215679566
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.015547842	0.7680259467764663
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.015446762000000001	0.7630328382344471
TRISOMY 18-LIKE SYNDROME	0.01544594	0.7629922334142893
FLOATING-HARBOR SYNDROME	0.01529817	0.7556927513282765
TOWNES-BROCKS SYNDROME 2; TBS2	0.01529817	0.7556927513282765
Mental retardation, autosomal dominant 21	0.015090212000000002	0.7454201270091113
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.015090212000000002	0.7454201270091113
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.015083812	0.7451039824239417
SHORT-RIB THORACIC DYSPLASIA 12; SRTD12	0.01506691	0.744269064333546
ACROCEPHALOPOLYDACTYLOUS DYSPLASIA	0.01506691	0.744269064333546
BOHRING-OPITZ SYNDROME	0.015055662000000001	0.7437134402251108
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.014992982	0.740617199194108
#276820 ULNA AND FIBULA, ABSENCE OF, WITH SEVERE LIMB DEFICIENCY;;LIMB/PELVIS-HYPOPLASIA/APLASIA SYNDROME; LPHAS;;AL-AWADI/RAAS-ROTHSCHILD SYNDROME; AARRS;;SCHINZEL PHOCOMELIA SYNDROME	0.014946909999999999	0.7383413533616197
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.014904240000000001	0.7362335581351857
138770 GMS SYNDROME;;GONIODYSGENESIS--MENTAL RETARDATION--SHORT STATURE SYNDROME	0.014703959999999999	0.7263402085230406
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.014703959999999999	0.7263402085230406
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.01462536	0.722457557836429
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIe; CDG2E	0.01460288	0.7213470999810214
BARDET-BIEDL SYNDROME 6; BBS6	0.01442696	0.7126570756961775
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.014377412000000001	0.7102095238358692
PEROXISOME BIOGENESIS DISORDER 3B	0.014377412000000001	0.7102095238358692
KEIPERT SYNDROME; KPTS	0.01435411	0.7090584611603039
LICHTENSTEIN SYNDROME	0.014246330000000001	0.7037343887556856
MENTAL RETARDATION, X-LINKED 104; MRX104	0.014188982000000001	0.700901535682202
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.014188982000000001	0.700901535682202
COFFIN-SIRIS SYNDROME 7; CSS7	0.013934742	0.6883426920363476
ADAMS-OLIVER SYNDROME 2; AOS2	0.013933722	0.6882923064930861
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.013933722	0.6882923064930861
TERMINAL OSSEOUS DYSPLASIA; TOD	0.013832750000000001	0.6833045328909417
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.013826032	0.6829726798716967
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.013809952	0.6821783666014586
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.01355489	0.6695789181354465
COFFIN-LOWRY SYNDROME; CLS	0.01353353	0.6685237855824435
3MC SYNDROME 2	0.013225922000000001	0.6533286912770079
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.01308984	0.6466065682396606
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.01308984	0.6466065682396606
113470 BRACHYMESOMELIA-RENAL SYNDROME	0.01308984	0.6466065682396606
STUVE-WIEDEMANN SYNDROME	0.01308984	0.6466065682396606
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE II	0.01308984	0.6466065682396606
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.01298215	0.6412869416182709
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.01298215	0.6412869416182709
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.01298215	0.6412869416182709
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.01298215	0.6412869416182709
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.01296607	0.6404926283480329
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.01296607	0.6404926283480329
#614701 CORNELIA DE LANGE SYNDROME 4; CDLS4	0.012954822000000001	0.6399370042395978
CODAS SYNDROME	0.012734202	0.6290389076177113
IMMUNODEFICIENCY 23; IMD23	0.012734202	0.6290389076177113
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.012676962	0.6262113894841024
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.012676962	0.6262113894841024
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.012653462	0.6250505460854335
OROFACIODIGITAL SYNDROME XIV; OFD14	0.012653462	0.6250505460854335
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.012631712	0.6239761484717719
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.012575792000000002	0.6212138351588544
#612626 CHROMOSOME 15q26-qter DELETION SYNDROME;;DRAYER SYNDROME	0.012533462	0.6191228351135072
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.012533462	0.6191228351135072
CHONDRODYSPLASIA PUNCTATA 2, X-LINKED DOMINANT; CDPX2	0.01250204	0.6175706639955084
3MC SYNDROME 3	0.01250204	0.6175706639955084
BRANCHIOOTIC SYNDROME 2	0.01250204	0.6175706639955084
184705 STEINFELD SYNDROME	0.01250204	0.6175706639955084
BARAITSER-WINTER SYNDROME 2; BRWS2	0.01250204	0.6175706639955084
NOONAN SYNDROME 6; NS6	0.012382942	0.6116875096510543
BARAITSER-WINTER SYNDROME 1; BRWS1	0.012382942	0.6116875096510543
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.012382942	0.6116875096510543
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.012297932000000001	0.607488220403359
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.012297932000000001	0.607488220403359
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.012290512	0.6071216902749282
LARSEN-LIKE SYNDROME	0.012290512	0.6071216902749282
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.012290512	0.6071216902749282
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.012290512	0.6071216902749282
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.012290512	0.6071216902749282
#133540 COCKAYNE SYNDROME, TYPE B; CSB;;CKN2	0.01225327	0.6052820251747909
COCKAYNE SYNDROME A; CSA	0.01225327	0.6052820251747909
COXOAURICULAR SYNDROME	0.01213909	0.5996418081850031
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.01213909	0.5996418081850031
OSTEOGENESIS IMPERFECTA, TYPE XVI; OI16	0.01213909	0.5996418081850031
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.012111762000000002	0.5982918708063298
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.01211094	0.5982512659861721
STICKLER SYNDROME, TYPE I	0.01189032	0.5873531693642855
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.01189032	0.5873531693642855
DEAFNESS, AUTOSOMAL DOMINANT 23; DFNA23	0.01189032	0.5873531693642855
CHANARIN-DORFMAN SYNDROME	0.01189032	0.5873531693642855
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA; FOP	0.01189032	0.5873531693642855
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.011833902	0.5845662560508345
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.011833902	0.5845662560508345
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ij; CDG1J	0.011832882000000001	0.5845158705075731
#615314 CRANIOSYNOSTOSIS 3; CRS3	0.011832882000000001	0.5845158705075731
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.011832882000000001	0.5845158705075731
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.011832882000000001	0.5845158705075731
ROIFMAN SYNDROME; RFMN	0.011832882000000001	0.5845158705075731
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.011832882000000001	0.5845158705075731
PREMATURE AGING SYNDROME, OKAMOTO TYPE	0.01180958	0.583364807832008
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.01180958	0.583364807832008
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.01180958	0.583364807832008
KNIEST-LIKE DYSPLASIA, LETHAL	0.01180958	0.583364807832008
NEU-LAXOVA SYNDROME 2; NLS2	0.01180958	0.583364807832008
FIBROCHONDROGENESIS 1; FBCG1	0.01180958	0.583364807832008
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.01180958	0.583364807832008
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.01180958	0.583364807832008
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.01178783	0.5822904102183462
#300337 HYPOMELANOSIS OF ITO; HMI;;INCONTINENTIA PIGMENTI ACHROMIANS; IPA;;ITO HYPOMELANOSIS; ITO;;INCONTINENTIA PIGMENTI, TYPE I, FORMERLY; IP1, FORMERLY	0.011731910000000002	0.5795280969054287
SHORT-RIB THORACIC DYSPLASIA 18 WITH POLYDACTYLY; SRTD18	0.011731910000000002	0.5795280969054287
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.011690402	0.5774777016802394
MENTAL RETARDATION, BUENOS AIRES TYPE	0.01168958	0.5774370968600816
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.01168958	0.5774370968600816
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.011585132	0.5722776172301169
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.01153906	0.5700017713976288
#156200 MENTAL RETARDATION, AUTOSOMAL DOMINANT 1; MRD1CHROMOSOME 2q23.1 DELETION SYNDROME, INCLUDED	0.01144663	0.5654359520215025
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.01144663	0.5654359520215025
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.01144663	0.5654359520215025
MEIER-GORLIN SYNDROME 8; MGORS8	0.01144663	0.5654359520215025
LATERAL MENINGOCELE SYNDROME	0.01144663	0.5654359520215025
GAUCHER DISEASE, PERINATAL LETHAL	0.01144663	0.5654359520215025
#613804 MEIER-GORLIN SYNDROME 4; MGORS4	0.01144663	0.5654359520215025
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.01144663	0.5654359520215025
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.01144663	0.5654359520215025
MEIER-GORLIN SYNDROME 5; MGORS5	0.01144663	0.5654359520215025
SHORT STATURE AND FACIOAURICULOTHORACIC MALFORMATIONS	0.01144663	0.5654359520215025
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.01144663	0.5654359520215025
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.011419302000000001	0.5640860146428293
JACOBSEN SYNDROME	0.011310549999999999	0.5587139277793381
HYPERTELORISM AND TETRALOGY OF FALLOT	0.011310549999999999	0.5587139277793381
#257300 MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 1; MVA1;;MVA SYNDROME	0.011310549999999999	0.5587139277793381
611961 STEVENSON-CAREY SYNDROME	0.011141442	0.5503603998873339
SCHAAF-YANG SYNDROME; SHFYNG	0.011141442	0.5503603998873339
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.011141442	0.5503603998873339
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.011141442	0.5503603998873339
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.011141442	0.5503603998873339
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.011141442	0.5503603998873339
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.011141442	0.5503603998873339
RADIOULNAR SYNOSTOSIS WITH AMEGAKARYOCYTIC THROMBOCYTOPENIA	0.01101911	0.5443174937321866
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.01099002	0.5428805177974088
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.01099002	0.5428805177974088
268650 RUDIGER SYNDROME	0.010989	0.5428301322541474
POSTAXIAL OLIGODACTYLY, TETRAMELIC	0.010989	0.5428301322541474
ACROMESOMELIC DYSPLASIA, HUNTER-THOMPSON TYPE	0.010989	0.5428301322541474
MACS SYNDROME	0.010989	0.5428301322541474
FACIOCARDIOMELIC DYSPLASIA, LETHAL	0.010989	0.5428301322541474
MCDONOUGH SYNDROME	0.010989	0.5428301322541474
113450 BRACHYDACTYLY-DISTAL SYMPHALANGISM SYNDROME	0.010989	0.5428301322541474
CRANIOSYNOSTOSIS WITH FIBULAR APLASIA	0.010989	0.5428301322541474
601957 ODONTOTRICHOUNGUAL-DIGITAL-PALMAR SYNDROME;;OTUDP SYNDROME	0.010989	0.5428301322541474
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.010989	0.5428301322541474
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.010741249999999999	0.5305918789766914
MITOCHONDRIAL DNA DEPLETION SYNDROME 1 (MNGIE TYPE); MTDPS1	0.010741249999999999	0.5305918789766914
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.01057542	0.5224002763894036
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.010552622000000001	0.5212741100999205
GABRIELE-DE VRIES SYNDROME; GADEVS	0.010552622000000001	0.5212741100999205
COFFIN-SIRIS SYNDROME 2; CSS2	0.010552622000000001	0.5212741100999205
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.010552622000000001	0.5212741100999205
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.010552622000000001	0.5212741100999205
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.010552622000000001	0.5212741100999205
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.010432622	0.5153463991279942
TONNE-KALSCHEUER SYNDROME; TOKAS	0.010432622	0.5153463991279942
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.010297559999999999	0.5086746616339083
CENTRAL HYPOVENTILATION SYNDROME, CONGENITAL; CCHS	0.010297559999999999	0.5086746616339083
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.010282102000000001	0.5079110736655414
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.010282102	0.5079110736655413
CHROMOSOME 1q41-q42 DELETION SYNDROME	0.010189672	0.5033452542894151
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.010189672	0.5033452542894151
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.010189672	0.5033452542894151
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.010189672	0.5033452542894151
KAGAMI-OGATA SYNDROME	0.010189672	0.5033452542894151
EVEN-PLUS SYNDROME	0.010189672	0.5033452542894151
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.010189672	0.5033452542894151
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.010189672	0.5033452542894151
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.010053592	0.4966232300472508
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.010053592	0.4966232300472508
JOUBERT SYNDROME 10	0.009838412000000001	0.4859938563227584
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.009838412	0.48599385632275827
LAMB-SHAFFER SYNDROME	0.009838412	0.48599385632275827
OGDEN SYNDROME; OGDNS	0.009838412	0.48599385632275827
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.009838412	0.48599385632275827
COHEN-GIBSON SYNDROME; COGIS	0.009838412	0.48599385632275827
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.009838412	0.48599385632275827
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.009838412	0.48599385632275827
#180700 ROBINOW SYNDROME, AUTOSOMAL DOMINANT; DRS;;ROBINOW DWARFISM;;FETAL FACE SYNDROME;;ACRAL DYSOSTOSIS WITH FACIAL AND GENITAL ABNORMALITIES	0.009838412	0.48599385632275827
CHROMOSOME 15q13.3 MICRODELETION SYNDROME	0.00970874	0.47958837184649483
AASE-SMITH SYNDROME I	0.00970874	0.47958837184649483
#246560 SPLIT-HAND/FOOT MALFORMATION 3; SHFM3;;SHSF3;;LIMB DEFICIENCIES, DISTAL, WITH MICROGNATHIA;;CHROMOSOME 10Q24 DUPLICATION SYNDROME	0.00970874	0.47958837184649483
MAXILLOFACIAL DYSOSTOSIS	0.00970874	0.47958837184649483
MULTIPLE ACYL-CoA DEHYDROGENASE DEFICIENCY; MADD	0.00970874	0.47958837184649483
CRANIAL NERVES, CONGENITAL PARESIS OF	0.00970874	0.47958837184649483
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.00970874	0.47958837184649483
MANDIBULOFACIAL DYSOSTOSIS WITH MENTAL RETARDATION	0.00970874	0.47958837184649483
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00970874	0.47958837184649483
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.00970874	0.47958837184649483
VAN BOGAERT-HOZAY SYNDROME	0.00970874	0.47958837184649483
TETRAMELIC DEFICIENCIES, ECTODERMAL DYSPLASIA, DEFORMED EARS, ANDOTHER ABNORMALITIES	0.00970874	0.47958837184649483
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.00968699	0.47851397423283315
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.00958874	0.4736606608745686
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.009374382	0.46307189197023385
#602471 SHORT STATURE, AUDITORY CANAL ATRESIA, MANDIBULAR HYPOPLASIA, ANDSKELETAL ABNORMALITIES; SAMS	0.00934579	0.4616595160359895
ACROFACIAL DYSOSTOSIS, CINCINNATI TYPE; AFDCIN	0.00934579	0.4616595160359895
DEAFNESS, CONDUCTIVE, WITH PTOSIS AND SKELETAL ANOMALIES	0.00934579	0.4616595160359895
124490 DEAFNESS, CONDUCTIVE STAPEDIAL, WITH EAR MALFORMATION AND FACIAL PALSY	0.00934579	0.4616595160359895
#132450 EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH MYOPIA AND CONDUCTIVE DEAFNESS;EDMMD	0.00934579	0.4616595160359895
243440 ISOTRETINOIN EMBRYOPATHY-LIKE SYNDROME;;MICROTIA-AORTIC ARCH SYNDROME	0.00934579	0.4616595160359895
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00934579	0.4616595160359895
RHYNS SYNDROME; RHYNS	0.00934579	0.4616595160359895
PARAGANGLIOMAS 1	0.00934579	0.4616595160359895
MICROTIA - EYE COLOBOMA - IMPERFORATION OF THE NASOLACRIMAL DUCT	0.00934579	0.4616595160359895
PARIETAL FORAMINA WITH CLEIDOCRANIAL DYSPLASIA	0.00934579	0.4616595160359895
SECKEL SYNDROME 7; SCKL7	0.00934579	0.4616595160359895
FAMILIAL EXPANSILE OSTEOLYSIS	0.00934579	0.4616595160359895
CILIARY DYSKINESIA, PRIMARY, 38; CILD38	0.00934579	0.4616595160359895
OTOFACIOCERVICAL SYNDROME	0.00934579	0.4616595160359895
269870 SHORT STATURE-OBESITY SYNDROME; SSOS	0.00934579	0.4616595160359895
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.00934579	0.4616595160359895
OTOSCLEROSIS	0.00934579	0.4616595160359895
#244400 CILIARY DYSKINESIA, PRIMARY, 1; CILD1;;PCD;;CILIARY DYSKINESIA, PRIMARY, 1, WITH OR WITHOUT SITUS INVERSUS;;IMMOTILE CILIA SYNDROME; ICS;;POLYNESIAN BRONCHIECTASISKARTAGENER SYNDROME, INCLUDED;;DEXTROCARDIA, BRONCHIECTASIS, AND SINUSITIS, INCLUDED;;SIEWERT SYNDROME, INCLUDED	0.00934579	0.4616595160359895
CROUZON SYNDROME	0.00934579	0.4616595160359895
123560 CRYPTOMICROTIA-BRACHYDACTYLY SYNDROME	0.00934579	0.4616595160359895
#607842 AURAL ATRESIA, CONGENITAL; CAA;;AURAL ATRESIA, CONGENITAL, WITH HYPOSMIA	0.00934579	0.4616595160359895
CILIARY DYSKINESIA, PRIMARY, 33	0.00934579	0.4616595160359895
#100800 ACHONDROPLASIA; ACH	0.00934579	0.4616595160359895
#185800 SYMPHALANGISM, PROXIMAL, 1A; SYM1A;;SYM1;;CUSHING SYMPHALANGISM;;HEREDITARY ABSENCE OF THE PROXIMAL INTERPHALANGEAL JOINTS	0.00934579	0.4616595160359895
3MC SYNDROME 1	0.00934579	0.4616595160359895
MICROTIA-ANOTIA	0.00934579	0.4616595160359895
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.00934579	0.4616595160359895
OSTEOPETROSIS, AUTOSOMAL DOMINANT 1; OPTA1	0.00934579	0.4616595160359895
CDAGS SYNDROME	0.009340792	0.4614126268740088
MICROPHTHALMIA, SYNDROMIC 3	0.009340792	0.4614126268740088
PRADER-WILLI SYNDROME; PWS	0.009318462000000001	0.46030957865731625
#614970 JOUBERT SYNDROME 20; JBTS20	0.009318462000000001	0.46030957865731625
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.009318462000000001	0.46030957865731625
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.009318462000000001	0.46030957865731625
JOUBERT SYNDROME 17; JBTS17	0.009318462000000001	0.46030957865731625
#610168 LOEYS-DIETZ SYNDROME 2; LDS2;;AORTIC ANEURYSM, FAMILIAL THORACIC 3; AAT3;;MARFAN SYNDROME, TYPE II, FORMERLY	0.009318462000000001	0.46030957865731625
OROFACIODIGITAL SYNDROME VIII; OFD8	0.009318462000000001	0.46030957865731625
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.009318462000000001	0.46030957865731625
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.009318462000000001	0.46030957865731625
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.009318462000000001	0.46030957865731625
#615665 JOUBERT SYNDROME 22; JBTS22	0.009318462000000001	0.46030957865731625
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.009318462000000001	0.46030957865731625
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00920971	0.4549374917938251
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.009040602	0.4465839639018209
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.009040602	0.4465839639018209
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.009040602	0.4465839639018209
#300672 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 2; EIEE2;;INFANTILE SPASM SYNDROME, X-LINKED 2; ISSX2	0.009040602	0.4465839639018209
#615033 SPASTIC PARAPLEGIA 54, AUTOSOMAL RECESSIVE; SPG54	0.009040602	0.4465839639018209
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.009040602	0.4465839639018209
HOLOPROSENCEPHALY 2; HPE2	0.009040602	0.4465839639018209
PROPIONIC ACIDEMIA	0.009040602	0.4465839639018209
CHROMOSOME 19p13.13 DELETION SYNDROME	0.009040602	0.4465839639018209
Glycosylphosphatidylinositol biosynthesis defect 18	0.009040602	0.4465839639018209
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.009040602	0.4465839639018209
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.009040602	0.4465839639018209
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.009040602	0.4465839639018209
NIEMANN-PICK DISEASE, TYPE A	0.009040602	0.4465839639018209
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.009040602	0.4465839639018209
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.009040602	0.4465839639018209
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.009040602	0.4465839639018209
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.009040602	0.4465839639018209
ANGELMAN SYNDROME	0.009040602	0.4465839639018209
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.009040602	0.4465839639018209
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.009040602	0.4465839639018209
Xq28 (MECP2) duplication	0.009040602	0.4465839639018209
#300867 KABUKI SYNDROME 2; KABUK2	0.008995352	0.44434872288949034
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.008995352	0.44434872288949034
JOUBERT SYNDROME 3; JBTS3	0.00899453	0.44430811806933274
SCARF SYNDROME	0.00899453	0.44430811806933274
#278250 WRINKLY SKIN SYNDROME; WSS	0.00899453	0.44430811806933274
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.00899453	0.44430811806933274
DIAMOND-BLACKFAN ANEMIA 5	0.008897102	0.4394954095312258
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.008897102	0.4394954095312258
#614732 INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIACONGENITA, AND GENITAL ANOMALIES;;IMAGE SYNDROME	0.008897102	0.4394954095312258
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.008897102	0.4394954095312258
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.008897102	0.4394954095312258
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.008746582	0.43206008406877283
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.008746582	0.43206008406877283
CHARGE-LIKE SYNDROME, X-LINKED	0.00874568	0.4320155274413006
ANUS, IMPERFORATE	0.00874568	0.4320155274413006
N SYNDROME	0.00874568	0.4320155274413006
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.00874568	0.4320155274413006
#309801 MICROPHTHALMIA, SYNDROMIC 7; MCOPS7;;MICROPHTHALMIA WITH LINEAR SKIN DEFECTS; MLS;;MICROPHTHALMIA, DERMAL APLASIA, AND SCLEROCORNEA;;MIDAS SYNDROME	0.00874568	0.4320155274413006
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.008595160000000001	0.4245802019788478
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00849691	0.41972688862058316
WAHAB SYNDROME	0.00847458	0.41862384040389056
EPIDERMOLYSIS BULLOSA, LETHAL ACANTHOLYTIC; EBLA	0.00847458	0.41862384040389056
MENTAL RETARDATION, AUTOSOMAL DOMINANT 4; MRD4	0.00847458	0.41862384040389056
#236700 MCKUSICK-KAUFMAN SYNDROME; MKKS;;HYDROMETROCOLPOS SYNDROME;;HYDROMETROCOLPOS, POSTAXIAL POLYDACTYLY, AND CONGENITAL HEART MALFORMATION;HMCS;;KAUFMAN-MCKUSICK SYNDROME	0.00847458	0.41862384040389056
SUMMITT SYNDROME	0.00847458	0.41862384040389056
BARDET-BIEDL SYNDROME 4; BBS4	0.00847458	0.41862384040389056
BARDET-BIEDL SYNDROME 5; BBS5	0.00847458	0.41862384040389056
#615503 SHORT RIB-POLYDACTYLY SYNDROME, TYPE VI; SRPS6	0.00847458	0.41862384040389056
#224120 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ia; CDAN1A;;DYSERYTHROPOIETIC ANEMIA, CONGENITAL, TYPE Ia;;CDA Ia;;ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE I	0.00847458	0.41862384040389056
ADAMS-OLIVER SYNDROME 6; AOS6	0.00847458	0.41862384040389056
CAMPTOBRACHYDACTYLY	0.00847458	0.41862384040389056
FIBULAR APLASIA, TIBIAL CAMPOMELIA, AND OLIGOSYNDACTYLY SYNDROME	0.00847458	0.41862384040389056
HOLT-ORAM SYNDROME	0.00847458	0.41862384040389056
GRANGE SYNDROME; GRNG	0.00847458	0.41862384040389056
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00847458	0.41862384040389056
CHROMOSOME Xp11.23-p11.22 DUPLICATION SYNDROME	0.00847458	0.41862384040389056
POLYDACTYLY, POSTAXIAL, TYPE A1; PAPA1	0.00847458	0.41862384040389056
#610140 HEART-HAND SYNDROME, SLOVENIAN TYPE	0.00847458	0.41862384040389056
SPINAL MUSCULAR ATROPHY WITH MENTAL RETARDATION	0.00847458	0.41862384040389056
CRANIOECTODERMAL DYSPLASIA 3	0.00847458	0.41862384040389056
SPLIT-HAND/FOOT MALFORMATION 4; SHFM4	0.00847458	0.41862384040389056
#603543 LIMB-MAMMARY SYNDROME; LMS	0.00847458	0.41862384040389056
BLOOM SYNDROME	0.00847458	0.41862384040389056
ULNAR HYPOPLASIA WITH LOBSTER-CLAW DEFORMITY OF FEET	0.00847458	0.41862384040389056
201020 ACROCEPHALOPOLYSYNDACTYLY TYPE IV;;ACPS IV;;GOODMAN SYNDROME	0.00847458	0.41862384040389056
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 33	0.00847458	0.41862384040389056
%263630 POLYSYNDACTYLY WITH CARDIAC MALFORMATION;;BONNEAU SYNDROME	0.00847458	0.41862384040389056
%173800 POLAND SYNDROME;;POLAND SYNDACTYLY;;POLAND ANOMALY;;POLAND SEQUENCEPECTORALIS MUSCLE, ABSENCE OF, INCLUDED	0.00847458	0.41862384040389056
CLEFT-LIMB-HEART MALFORMATION SYNDROME	0.00847458	0.41862384040389056
#174500 POLYDACTYLY, PREAXIAL II; PPD2;;POLYDACTYLY OF TRIPHALANGEAL THUMB;;TRIPHALANGEAL THUMB-POLYDACTYLY SYNDROMETRIPHALANGEAL THUMB WITH POLYSYNDACTYLY, INCLUDED;;TRIPHALANGEAL THUMB-POLYSYNDACTYLY SYNDROME, INCLUDED;;TPT-PS SYNDROME, INCLUDED;;TRIPHALANGEAL THUMB, INCLUDED; TPT, INCLUDED	0.00847458	0.41862384040389056
#615631 ANEMIA, CONGENITAL DYSERYTHROPOIETIC, TYPE Ib; CDAN1B;;CDA, TYPE Ib	0.00847458	0.41862384040389056
ADAMS-OLIVER SYNDROME 5; AOS5	0.00847458	0.41862384040389056
613005 SANTOS SYNDROME;;FIBULAR AGENESIS/HYPOPLASIA, OLIGODACTYLOUS CLUBFEET, AND ANONYCHIA/NAILHYPOPLASIA SYNDROME	0.00847458	0.41862384040389056
ECTODERMAL DYSPLASIA, ECTRODACTYLY, AND MACULAR DYSTROPHY SYNDROME	0.00847458	0.41862384040389056
%613576 ECTODERMAL DYSPLASIA-SYNDACTYLY SYNDROME 2; EDSS2	0.00847458	0.41862384040389056
TUKEL SYNDROME	0.00847458	0.41862384040389056
HALLUX VARUS AND PREAXIAL POLYSYNDACTYLY	0.00847458	0.41862384040389056
%135750 LAURIN-SANDROW SYNDROME;;LSS;;SANDROW SYNDROME;;MIRROR HANDS AND FEET WITH NASAL DEFECTS;;TETRAMELIC MIRROR-IMAGE POLYDACTYLY; TMIP;;MIRROR-IMAGE POLYDACTYLY; MIP;;FIBULA AND ULNA, DUPLICATION OF, WITH ABSENCE OF TIBIA AND RADIUSLAURIN-SANDROW SYNDROME, SEGMENTAL, INCLUDED	0.00847458	0.41862384040389056
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.00847458	0.41862384040389056
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.00847458	0.41862384040389056
%217100 CONSTRICTING BANDS, CONGENITAL;;AMNIOTIC BAND SEQUENCE; ABS;;STREETER ANOMALYADAM COMPLEX, INCLUDED;;TERMINAL TRANSVERSE DEFECTS OF ARM, INCLUDED;;AMPUTATION, CONGENITAL, INCLUDED	0.00847458	0.41862384040389056
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.00828173	0.40909751489609064
#600072 FATAL FAMILIAL INSOMNIA; FFI;;INSOMNIA, FATAL FAMILIAL	0.00819672	0.4048982256483953
RETT SYNDROME; RTT	0.00819672	0.4048982256483953
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.00819672	0.4048982256483953
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00819672	0.4048982256483953
MYXEDEMA	0.00819672	0.4048982256483953
#121300 COPROPORPHYRIA, HEREDITARY; HCP;;COPROPORPHYRINOGEN OXIDASE DEFICIENCY;;CPOX DEFICIENCY;;CPO DEFICIENCY;;CPX DEFICIENCYHARDEROPORPHYRIA, INCLUDED	0.00819672	0.4048982256483953
HIRSCHSPRUNG DISEASE, SUSCEPTIBILITY TO, 1; HSCR1	0.00819672	0.4048982256483953
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.00819672	0.4048982256483953
THYROID HORMONOGENESIS, GENETIC DEFECT IN, 1	0.00819672	0.4048982256483953
PARKINSON DISEASE, LATE-ONSET; PD	0.00819672	0.4048982256483953
UROFACIAL SYNDROME	0.00819672	0.4048982256483953
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 6; CHNG6	0.00819672	0.4048982256483953
PORPHYRIA VARIEGATA	0.00819672	0.4048982256483953
AUTISM, SUSCEPTIBILITY TO, 18	0.00819672	0.4048982256483953
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00819672	0.4048982256483953
GITELMAN SYNDROME	0.00819672	0.4048982256483953
ADIPOSIS DOLOROSA	0.00819672	0.4048982256483953
LOWE OCULOCEREBRORENAL SYNDROME	0.00819672	0.4048982256483953
ERYTHERMALGIA, PRIMARY	0.00819672	0.4048982256483953
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.00819672	0.4048982256483953
SACRAL DEFECT WITH ANTERIOR MENINGOCELE	0.00819672	0.4048982256483953
ANAL SPHINCTER MYOPATHY, INTERNAL	0.00819672	0.4048982256483953
RETT SYNDROME, CONGENITAL VARIANT	0.00819672	0.4048982256483953
#226600 EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE; RDEB;;DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE;;EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE; EBR1EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE, LOCALISATAVARIANT, INCLUDED;;EPIDERMOLYSIS BULLOSA DYSTROPHICA INVERSA, AUTOSOMAL RECESSIVE, INCLUDED	0.00819672	0.4048982256483953
#606764 GASTROINTESTINAL STROMAL TUMOR; GIST	0.00819672	0.4048982256483953
THYROTROPIN-RELEASING HORMONE DEFICIENCY	0.00819672	0.4048982256483953
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.00819672	0.4048982256483953
FG SYNDROME 2; FGS2	0.00819672	0.4048982256483953
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.00819672	0.4048982256483953
HYPOPHOSPHATASIA, INFANTILE	0.00819672	0.4048982256483953
#176000 PORPHYRIA, ACUTE INTERMITTENT;;AIP;;PORPHYRIA, SWEDISH TYPE;;PORPHOBILINOGEN DEAMINASE DEFICIENCY;;PBGD DEFICIENCY;;UROPORPHYRINOGEN SYNTHASE DEFICIENCY;;UPS DEFICIENCYPORPHYRIA, ACUTE INTERMITTENT, NONERYTHROID VARIANT, INCLUDED;;PORPHYRIA, CHESTER TYPE, INCLUDED; PORC, INCLUDED	0.00819672	0.4048982256483953
VISCERAL MYOPATHY; VSCM	0.00819672	0.4048982256483953
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VII; HSAN7	0.00819672	0.4048982256483953
PARKINSON DISEASE 22, AUTOSOMAL DOMINANT; PARK22	0.00819672	0.4048982256483953
MYOPATHY, MYOFIBRILLAR, 1; MFM1	0.00819672	0.4048982256483953
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.00819672	0.4048982256483953
DIASTASIS RECTI AND WEAKNESS OF THE LINEA ALBA	0.00819672	0.4048982256483953
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.00819672	0.4048982256483953
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.00819672	0.4048982256483953
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.00819672	0.4048982256483953
UROFACIAL SYNDROME 2	0.00819672	0.4048982256483953
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.008151470000000001	0.40266298463606476
SIFRIM-HITZ-WEISS SYNDROME	0.008151470000000001	0.40266298463606476
#166250 OSTEOGLOPHONIC DYSPLASIA; OGD;;OSTEOGLOPHONIC DWARFISM	0.00805322	0.3978096712778001
GENITOPALATOCARDIAC SYNDROME	0.00805322	0.3978096712778001
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.0079027	0.39037434581534725
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0079027	0.39037434581534725
#154780 MARSHALL SYNDROME; MRSHS	0.0079027	0.39037434581534725
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.007737572	0.38221742033724526
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.007737572	0.38221742033724526
OCULOECTODERMAL SYNDROME; OES	0.007737572	0.38221742033724526
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Id; CDG1D	0.007737572	0.38221742033724526
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.007737572	0.38221742033724526
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.007737572	0.38221742033724526
CHROMOSOME 1p35 DELETION SYNDROME	0.007273542	0.35929545598472074
#300895 OHDO SYNDROME, X-LINKED; OHDOX;;BLEPHAROPHIMOSIS-MENTAL RETARDATION SYNDROME, MAAT-KIEVIT-BRUNNERTYPE	0.007273542	0.35929545598472074
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.007273542	0.35929545598472074
#300422 FG SYNDROME 4; FGS4MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT NYSTAGMUS, INCLUDED	0.007024772	0.3470068171640033
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.007024772	0.3470068171640033
#609528 CEREBRAL DYSGENESIS, NEUROPATHY, ICHTHYOSIS, AND PALMOPLANTAR KERATODERMASYNDROME;;CEDNIK SYNDROME	0.007024772	0.3470068171640033
STEEL SYNDROME; STLS	0.007024772	0.3470068171640033
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.006894512	0.34057228690397734
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.006894512	0.34057228690397734
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.006894512	0.34057228690397734
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00689369	0.3405316820838196
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00689369	0.3405316820838196
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.00689369	0.3405316820838196
OMODYSPLASIA 1; OMOD1	0.00689369	0.3405316820838196
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.00689369	0.3405316820838196
SHPRINTZEN OMPHALOCELE SYNDROME	0.00689369	0.3405316820838196
METAPHYSEAL ACROSCYPHODYSPLASIA	0.00689369	0.3405316820838196
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.00689369	0.3405316820838196
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.006796262	0.3357189735457127
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.006796262	0.3357189735457127
MENTAL RETARDATION, X-LINKED 106; MRX106	0.006796262	0.3357189735457127
#300004 CORPUS CALLOSUM, AGENESIS OF, WITH ABNORMAL GENITALIA;;ACC WITH ABNORMAL GENITALIA;;PROUD SYNDROME	0.006796262	0.3357189735457127
BARDET-BIEDL SYNDROME 8; BBS8	0.006796262	0.3357189735457127
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.006796262	0.3357189735457127
MIRAGE SYNDROME; MIRAGE	0.006796262	0.3357189735457127
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iy; CDG1Y	0.006796262	0.3357189735457127
THAUVIN-ROBINET-FAIVRE SYNDROME	0.006645742	0.3282836480832598
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.006645742	0.3282836480832598
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.006645742	0.3282836480832598
GOLDBERG-SHPRINTZEN SYNDROME	0.006581082	0.3250895998212202
#267000 PERLMAN SYNDROME; PRLMNS;;RENAL HAMARTOMAS, NEPHROBLASTOMATOSIS, AND FETAL GIGANTISM;;NEPHROBLASTOMATOSIS, FETAL ASCITES, MACROSOMIA, AND WILMS TUMOR	0.006581082	0.3250895998212202
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.006581082	0.3250895998212202
ALAZAMI SYNDROME; ALAZS	0.006581082	0.3250895998212202
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.006581082	0.3250895998212202
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.006581082	0.3250895998212202
#268310 ROBINOW SYNDROME, AUTOSOMAL RECESSIVE; RRS;;COSTOVERTEBRAL SEGMENTATION DEFECT WITH MESOMELIA, FORMERLY;;COVESDEM SYNDROME, FORMERLYROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH APLASIA/HYPOPLASIA OFPHALANGES AND METACARPALS/METATARSALS, INCLUDED;;ROBINOW SYNDROME, AUTOSOMAL RECESSIVE, WITH BRACHY-SYN-POLYDACTYLY,INCLUDED	0.006581082	0.3250895998212202
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.006581082	0.3250895998212202
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.006581082	0.3250895998212202
DEAFNESS-CRANIOFACIAL SYNDROME	0.00642966	0.3176097177312951
ZIMMERMANN-LABAND SYNDROME 1	0.00642966	0.3176097177312951
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00642966	0.3176097177312951
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00642966	0.3176097177312951
DEAFNESS, X-LINKED 7; DFNX7	0.00642966	0.3176097177312951
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.006202052	0.3063664307404768
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.006202052	0.3063664307404768
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.006202052	0.3063664307404768
RING CHROMOSOME 14 SYNDROME	0.006202052	0.3063664307404768
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.0062020519999999996	0.30636643074047676
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.0062020519999999996	0.30636643074047676
NOONAN SYNDROME 5; NS5	0.0062020519999999996	0.30636643074047676
JOUBERT SYNDROME 14	0.0062020519999999996	0.30636643074047676
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.0062020519999999996	0.30636643074047676
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0062020519999999996	0.30636643074047676
NOONAN SYNDROME 3; NS3	0.0062020519999999996	0.30636643074047676
FRONTOOCULAR SYNDROME	0.0062020519999999996	0.30636643074047676
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0062020519999999996	0.30636643074047676
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.0062020519999999996	0.30636643074047676
HADZISELIMOVIC SYNDROME	0.0062020519999999996	0.30636643074047676
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.0062020519999999996	0.30636643074047676
#602398 DESMOSTEROLOSIS	0.0062020519999999996	0.30636643074047676
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.0062020519999999996	0.30636643074047676
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.0062020519999999996	0.30636643074047676
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0062020519999999996	0.30636643074047676
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.0062020519999999996	0.30636643074047676
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.0062020519999999996	0.30636643074047676
Muenke syndrome	0.006181712000000001	0.30536168373073536
RICHARDS-RUNDLE SYNDROME; RRNS	0.006181712000000001	0.30536168373073536
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00618089	0.3053210789105776
SHORT SYNDROME	0.00618089	0.3053210789105776
FRONTOMETAPHYSEAL DYSPLASIA	0.00618089	0.3053210789105776
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.00618089	0.3053210789105776
BRITTLE CORNEA SYNDROME	0.00605063	0.29888654865055164
#101800 ACRODYSOSTOSIS 1, WITH OR WITHOUT HORMONE RESISTANCE; ACRDYS1;;ADOHR	0.00605063	0.29888654865055164
46,XY SEX REVERSAL 6; SRXY6	0.00595238	0.29403323529228703
HAND-FOOT-GENITAL SYNDROME; HFG	0.00595238	0.29403323529228703
HEMOLYTIC ANEMIA, LETHAL CONGENITAL NONSPHEROCYTIC, WITH GENITAL AND OTHER ABNORMALITIES	0.00595238	0.29403323529228703
RADIAL HYPOPLASIA, TRIPHALANGEAL THUMBS, HYPOSPADIAS, AND MAXILLARYDIASTEMA	0.00595238	0.29403323529228703
LAMBERT SYNDROME	0.00595238	0.29403323529228703
SECKEL SYNDROME 2; SCKL2	0.00595238	0.29403323529228703
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.00595238	0.29403323529228703
#194072 WILMS TUMOR, ANIRIDIA, GENITOURINARY ANOMALIES, AND MENTAL RETARDATIONSYNDROME; WAGR;;WAGR SYNDROME;;CHROMOSOME 11p13 DELETION SYNDROME	0.00595238	0.29403323529228703
#273750 THREE M SYNDROME 1; 3M1;;3@M SYNDROME;;LE MERRER SYNDROME;;DOLICHOSPONDYLIC DYSPLASIA;;GLOOMY FACE SYNDROMEYAKUT SHORT STATURE SYNDROME, INCLUDED	0.00595238	0.29403323529228703
METHEMOGLOBINEMIA AND AMBIGUOUS GENITALIA; METAG	0.00595238	0.29403323529228703
46,XX SEX REVERSAL 1; SRXX1	0.00595238	0.29403323529228703
%146450 HYPOSPADIAS 3, AUTOSOMAL; HYSP3	0.00595238	0.29403323529228703
HYPOSPADIAS-MENTAL RETARDATION SYNDROME	0.00595238	0.29403323529228703
ELLIS-VAN CREVELD SYNDROME	0.00595238	0.29403323529228703
LIPOID CONGENITAL ADRENAL HYPERPLASIA	0.00595238	0.29403323529228703
HYPOGONADISM, MALEHYPOGONADISM AND TESTICULAR ATROPHY, INCLUDED	0.00595238	0.29403323529228703
#610198 3-@METHYLGLUTACONIC ACIDURIA, TYPE V; MGCA5;;CARDIOMYOPATHY, DILATED, WITH ATAXIA; DCMA;;MGA, TYPE V; MGA5	0.00595238	0.29403323529228703
MARTINEZ-FRIAS SYNDROME	0.00595238	0.29403323529228703
PALMOPLANTAR HYPERKERATOSIS WITH SQUAMOUS CELL CARCINOMA OF SKIN AND 46,XX SEX REVERSAL	0.00595238	0.29403323529228703
OMODYSPLASIA	0.00595238	0.29403323529228703
191482 UNCOMBABLE HAIR, RETINAL PIGMENTARY DYSTROPHY, DENTAL ANOMALIES, ANDBRACHYDACTYLY;;BORK SYNDROME	0.00595238	0.29403323529228703
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.00595238	0.29403323529228703
15q24 recurrent microdeletion syndrome	0.00595238	0.29403323529228703
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY	0.00595238	0.29403323529228703
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE 2 DEFICIENCY	0.00595238	0.29403323529228703
#301830 SPINAL MUSCULAR ATROPHY, X-LINKED 2; SMAX2;;SPINAL MUSCULAR ATROPHY, X-LINKED LETHAL INFANTILE;;SPINAL MUSCULAR ATROPHY, INFANTILE X-LINKED; XLSMA;;ARTHROGRYPOSIS MULTIPLEX CONGENITA, DISTAL, X-LINKED;;AMC, DISTAL, X-LINKED;;ARTHROGRYPOSIS, X-LINKED, TYPE I; AMCX1	0.00595238	0.29403323529228703
NASODIGITOACOUSTIC SYNDROME	0.005801860000000001	0.28659790982983424
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.005738022000000001	0.28344446638795234
RECOMBINANT CHROMOSOME 8 SYNDROME	0.005738022000000001	0.28344446638795234
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.005738022000000001	0.28344446638795234
#610127 CEROID LIPOFUSCINOSIS, NEURONAL, 10; CLN10;;CEROID LIPOFUSCINOSIS, NEURONAL, CATHEPSIN D-DEFICIENT;;NEURONAL CEROID LIPOFUSCINOSIS DUE TO CATHEPSIN D DEFICIENCYNEURONAL CEROID LIPOFUSCINOSIS, CONGENITAL, INCLUDED	0.0057372	0.28340386156779457
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.0057372	0.28340386156779457
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.0057372	0.28340386156779457
#608233 HERMANSKY-PUDLAK SYNDROME 2; HPS2	0.0057372	0.28340386156779457
GLUTAMINE DEFICIENCY, CONGENITAL	0.0057372	0.28340386156779457
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.0057372	0.28340386156779457
SPINOCEREBELLAR ATAXIA 47; SCA47	0.0057372	0.28340386156779457
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.0057372	0.28340386156779457
LISSENCEPHALY, X-LINKED, 2	0.0057372	0.28340386156779457
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.0057372	0.28340386156779457
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.0057372	0.28340386156779457
STROMME SYNDROME; STROMS	0.0057372	0.28340386156779457
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.0057372	0.28340386156779457
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.0057372	0.28340386156779457
VICI SYNDROME; VICIS	0.005489252	0.2711558275672348
NOONAN SYNDROME 11; NS11	0.005489252	0.2711558275672348
#222448 DONNAI-BARROW SYNDROME;;FACIOOCULOACOUSTICORENAL SYNDROME;;DBS/FOAR SYNDROME;;DIAPHRAGMATIC HERNIA, EXOMPHALOS, ABSENT CORPUS CALLOSUM, HYPERTELORISM,MYOPIA, SENSORINEURAL DEAFNESS, AND PROTEINURIA	0.005489252	0.2711558275672348
CEREBROOCULONASAL SYNDROME	0.005358170000000001	0.26468069248705123
%312150 MULTIPLE PTERYGIUM SYNDROME, X-LINKED;;PTERYGIUM SYNDROME, MULTIPLE, X-LINKED	0.005358170000000001	0.26468069248705123
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME	0.005358170000000001	0.26468069248705123
#614069 IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME2; ICF2	0.005358170000000001	0.26468069248705123
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.005358170000000001	0.26468069248705123
SHORT-RIB THORACIC DYSPLASIA 15 WITH POLYDACTYLY; SRTD15	0.005358170000000001	0.26468069248705123
#611554 LEOPARD SYNDROME 2	0.005358170000000001	0.26468069248705123
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.005358170000000001	0.26468069248705123
#162100 AMYOTROPHY, HEREDITARY NEURALGIC; HNA;;NEURITIS WITH BRACHIAL PREDILECTION; NAPB;;BRACHIAL PLEXUS NEUROPATHY, HEREDITARY;;AMYOTROPHY, HEREDITARY NEURALGIC, WITH PREDILECTION FOR BRACHIAL PLEXUS	0.005358170000000001	0.26468069248705123
#253290 MULTIPLE PTERYGIUM SYNDROME, LETHAL TYPE; LMPS;;PTERYGIUM SYNDROME, MULTIPLE, LETHAL TYPE	0.005358170000000001	0.26468069248705123
#613506 AGAMMAGLOBULINEMIA 5, AUTOSOMAL DOMINANT; AGM5;;AGAMMAGLOBULINEMIA, AUTOSOMAL DOMINANT, DUE TO LRRC8A DEFECT	0.005358170000000001	0.26468069248705123
NOONAN SYNDROME 8; NS8	0.005358170000000001	0.26468069248705123
COFFIN-SIRIS SYNDROME 10; CSS10	0.005358170000000001	0.26468069248705123
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.005358170000000001	0.26468069248705123
DEAFNESS, AUTOSOMAL RECESSIVE 20; DFNB20	0.00533783	0.26367594547730966
COWCHOCK SYNDROME; COWCK	0.00533783	0.26367594547730966
DEAFNESS, AUTOSOMAL RECESSIVE 29	0.00533783	0.26367594547730966
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED RECESSIVE, 5	0.00533783	0.26367594547730966
CAMPOMELIC DYSPLASIA	0.00489414	0.24175872813452662
156620 MICROCEPHALY-DEAFNESS SYNDROME	0.00489414	0.24175872813452662
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.00489414	0.24175872813452662
#252940 MUCOPOLYSACCHARIDOSIS, TYPE IIID; MPS3D;;MPS IIID;;SANFILIPPO SYNDROME D;;N-ACETYLGLUCOSAMINE-6-SULFATASE DEFICIENCY	0.00489414	0.24175872813452662
MARSHALL-SMITH SYNDROME; MRSHSS	0.00489414	0.24175872813452662
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00464537	0.2294700893138092
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.00464537	0.2294700893138092
#613707 LEOPARD SYNDROME 3; LPRD3	0.00464537	0.2294700893138092
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.00464537	0.2294700893138092
122430 CORNEAL HYPESTHESIA WITH RETINAL ABNORMALITIES, SENSORINEURAL DEAFNESS,UNUSUAL FACIES, PERSISTENT DUCTUS ARTERIOSUS, AND MENTAL RETARDATION;;RAMOS-ARROYO SYNDROME	0.00464537	0.2294700893138092
SPONDYLOOCULAR SYNDROME; SOS	0.00464537	0.2294700893138092
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.004480242	0.22131316383570712
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.004480242	0.22131316383570712
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.004480242	0.22131316383570712
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.004480242	0.22131316383570712
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.004480242	0.22131316383570712
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.004480242	0.22131316383570712
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.004480242	0.22131316383570712
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.004480242	0.22131316383570712
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.004480242	0.22131316383570712
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.004480242	0.22131316383570712
CHROMOSOME 18P DELETION SYNDROME	0.004480242	0.22131316383570712
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.004480242	0.22131316383570712
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.004480242	0.22131316383570712
Helsmoortel-van der Aa syndrome	0.004480242	0.22131316383570712
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIm; CDG2M	0.004480242	0.22131316383570712
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.004480242	0.22131316383570712
#611936 CHROMOSOME 3q29 DUPLICATION SYNDROME;;MICRODUPLICATION 3q29 SYNDROME	0.004480242	0.22131316383570712
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.004480242	0.22131316383570712
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.004480242	0.22131316383570712
ROIFMAN-CHITAYAT SYNDROME	0.004480242	0.22131316383570712
#614202 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 15; MRT15	0.004480242	0.22131316383570712
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.004480242	0.22131316383570712
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.004480242	0.22131316383570712
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.004480242	0.22131316383570712
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.004480242	0.22131316383570712
#613744 SPASTIC PARAPLEGIA 51, AUTOSOMAL RECESSIVE; SPG51;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 4, FORMERLY; CPSQ4, FORMERLY	0.004480242	0.22131316383570712
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.004480242	0.22131316383570712
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.004480242	0.22131316383570712
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.004101212	0.20258999475496375
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.004101212	0.20258999475496375
#252500 MUCOLIPIDOSIS II ALPHA/BETA;;MUCOLIPIDOSIS II; ML II;;ML II ALPHA/BETA;;I-CELL DISEASE; ICD	0.004101212	0.20258999475496375
XQ25 DUPLICATION SYNDROME	0.004101212	0.20258999475496375
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.004101212	0.20258999475496375
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.004101212	0.20258999475496375
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIl; CDG2L	0.004101212	0.20258999475496375
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.004101212	0.20258999475496375
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.004101212	0.20258999475496375
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.004101212	0.20258999475496375
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.004101212	0.20258999475496375
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.004101212	0.20258999475496375
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.004101212	0.20258999475496375
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.004101212	0.20258999475496375
TEMPLE-BARAITSER SYNDROME; TMBTS	0.004101212	0.20258999475496375
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.004101212	0.20258999475496375
CHROMOSOME 17P13.1 DELETION SYNDROME	0.004101212	0.20258999475496375
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.004101212	0.20258999475496375
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.004101212	0.20258999475496375
PEHO-LIKE SYNDROME; PEHOL	0.004101212	0.20258999475496375
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.004101212	0.20258999475496375
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.004101212	0.20258999475496375
PEHO SYNDROME; PEHO	0.004101212	0.20258999475496375
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.004101212	0.20258999475496375
MENTAL RETARDATION, X-LINKED 91; MRX91	0.004101212	0.20258999475496375
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.004101212	0.20258999475496375
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.004101212	0.20258999475496375
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.004101212	0.20258999475496375
Congenital disorder of glycosylation, type IIh	0.004101212	0.20258999475496375
CHROMOSOME 17q23.1-q23.2 DELETION SYNDROME	0.003637182	0.17966803040243923
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.003637182	0.17966803040243923
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.003637182	0.17966803040243923
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.003637182	0.17966803040243923
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.003637182	0.17966803040243923
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.003637182	0.17966803040243923
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.003637182	0.17966803040243923
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.003637182	0.17966803040243923
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.003637182	0.17966803040243923
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.003637182	0.17966803040243923
MITOCHONDRIAL SHORT-CHAIN ENOYL-CoA HYDRATASE 1 DEFICIENCY; ECHS1D	0.003637182	0.17966803040243923
HURLER SYNDROME	0.003637182	0.17966803040243923
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.003637182	0.17966803040243923
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.003637182	0.17966803040243923
OPTIC ATROPHY 11; OPA11	0.003637182	0.17966803040243923
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.003637182	0.17966803040243923
#272200 MULTIPLE SULFATASE DEFICIENCY; MSD;;MUCOSULFATIDOSIS;;SULFATIDOSIS, JUVENILE, AUSTIN TYPE	0.003637182	0.17966803040243923
#245400 MITOCHONDRIAL DNA DEPLETION SYNDROME 9 (ENCEPHALOMYOPATHIC TYPE WITHMETHYLMALONIC ACIDURIA); MTDPS9;;LACTIC ACIDOSIS, FATAL INFANTILE, FORMERLY	0.003637182	0.17966803040243923
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.003637182	0.17966803040243923
Pierpont syndrome	0.003637182	0.17966803040243923
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.003637182	0.17966803040243923
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.003637182	0.17966803040243923
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.003637182	0.17966803040243923
HYDROXYKYNURENINURIA	0.003637182	0.17966803040243923
#301835 ARTS SYNDROME; ARTS;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARTS TYPE; MRXSARTS;;ATAXIA, FATAL X-LINKED, WITH DEAFNESS AND LOSS OF VISION;;MENTAL RETARDATION, X-LINKED, SYNDROMIC 18; MRXS18	0.003637182	0.17966803040243923
GENITOPATELLAR SYNDROME; GTPTS	0.003637182	0.17966803040243923
#300868 MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 2; MCAHS2	0.003637182	0.17966803040243923
CHOPS SYNDROME; CHOPS	0.003637182	0.17966803040243923
COFFIN-SIRIS SYNDROME 3; CSS3	0.003637182	0.17966803040243923
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.003637182	0.17966803040243923
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.003637182	0.17966803040243923
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.003637182	0.17966803040243923
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.003637182	0.17966803040243923
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.003637182	0.17966803040243923
COFFIN-SIRIS SYNDROME 4; CSS4	0.003637182	0.17966803040243923
PELIZAEUS-MERZBACHER DISEASE	0.003637182	0.17966803040243923
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.003637182	0.17966803040243923
YOU-HOOVER-FONG SYNDROME; YHFS	0.003637182	0.17966803040243923
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.003637182	0.17966803040243923
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.003637182	0.17966803040243923
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.00363636	0.17962742558228154
#615663 WARBURG MICRO SYNDROME 4; WARBM4	0.00363636	0.17962742558228154
#613456 FRONTONASAL DYSPLASIA 3; FND3	0.00363636	0.17962742558228154
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.00363636	0.17962742558228154
DIAMOND-BLACKFAN ANEMIA 8	0.00363636	0.17962742558228154
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00363636	0.17962742558228154
#612713 KAHRIZI SYNDROME; KHRZ;;MENTAL RETARDATION, CATARACT, COLOBOMA, AND KYPHOSIS, AUTOSOMAL RECESSIVE	0.00363636	0.17962742558228154
#253250 MULIBREY NANISM;;MUSCLE-LIVER-BRAIN-EYE NANISM;;PERICARDIAL CONSTRICTION AND GROWTH FAILURE;;PERHEENTUPA SYNDROME	0.00363636	0.17962742558228154
608028 THAI SYMPHALANGISM SYNDROME	0.00363636	0.17962742558228154
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00363636	0.17962742558228154
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.00363636	0.17962742558228154
OROFACIODIGITAL SYNDROME XV; OFD15	0.00363636	0.17962742558228154
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.00363636	0.17962742558228154
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00363636	0.17962742558228154
FRONTONASAL DYSPLASIA 2; FND2	0.00363636	0.17962742558228154
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.00363636	0.17962742558228154
BOOMERANG DYSPLASIA	0.00363636	0.17962742558228154
CRANIOLENTICULOSUTURAL DYSPLASIA	0.00363636	0.17962742558228154
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.00363636	0.17962742558228154
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00363636	0.17962742558228154
HYPERTELORISM, TEEBI TYPE; TBHS	0.00363636	0.17962742558228154
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00363636	0.17962742558228154
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00363636	0.17962742558228154
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00363636	0.17962742558228154
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00363636	0.17962742558228154
BASAL CELL NEVUS SYNDROME	0.00363636	0.17962742558228154
311450 PALLISTER W SYNDROME;;W SYNDROME	0.00363636	0.17962742558228154
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00363636	0.17962742558228154
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00363636	0.17962742558228154
MICROPHTHALMIA, SYNDROMIC 12	0.00363636	0.17962742558228154
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00363636	0.17962742558228154
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00363636	0.17962742558228154
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.00363636	0.17962742558228154
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.0033884120000000004	0.16737939158172177
#612938 GROWTH RETARDATION, DEVELOPMENTAL DELAY, COARSE FACIES, AND EARLYDEATH; GDFD	0.0033884120000000004	0.16737939158172177
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.0033884120000000004	0.16737939158172177
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0033884120000000004	0.16737939158172177
HYPERTRYPTOPHANEMIA; HYPTRP	0.0033884120000000004	0.16737939158172177
WAARDENBURG-SHAH SYNDROME	0.0033884120000000004	0.16737939158172177
#615066 OSTEOGENESIS IMPERFECTA, TYPE XIV; OI14 ;;OI, TYPE XIV	0.0033884120000000004	0.16737939158172177
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.0033884120000000004	0.16737939158172177
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.0033884120000000004	0.16737939158172177
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.0033884120000000004	0.16737939158172177
#249270 THIAMINE-RESPONSIVE MEGALOBLASTIC ANEMIA SYNDROME; TRMA;;THIAMINE METABOLISM DYSFUNCTION SYNDROME 1 (MEGALOBLASTIC ANEMIA,DIABETES MELLITUS, AND DEAFNESS TYPE); THMD1;;MEGALOBLASTIC ANEMIA, THIAMINE-RESPONSIVE, WITH DIABETES MELLITUSAND SENSORINEURAL DEAFNESS;;ROGERS SYNDROME;;THIAMINE-RESPONSIVE ANEMIA SYNDROME;;THIAMINE-RESPONSIVE MYELODYSPLASIA	0.0033884120000000004	0.16737939158172177
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ip; CDG1P	0.0033884120000000004	0.16737939158172177
#613076 MYOPATHY, MITOCHONDRIAL PROGRESSIVE, WITH CONGENITAL CATARACT, HEARINGLOSS, AND DEVELOPMENTAL DELAY;;MYOPATHY WITH CATARACT AND COMBINED RESPIRATORY CHAIN DEFICIENCY;;MITOCHONDRIAL COMPLEX DEFICIENCY, COMBINED	0.0033884120000000004	0.16737939158172177
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.0033884120000000004	0.16737939158172177
#220120 D-GLYCERIC ACIDURIA;;D-GLYCERIC ACIDEMIA;;GLYCERATE KINASE DEFICIENCY	0.0033884120000000004	0.16737939158172177
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.0033884120000000004	0.16737939158172177
CHROMOSOME 2q37 DELETION SYNDROME	0.0033884120000000004	0.16737939158172177
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.0033884120000000004	0.16737939158172177
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0033884120000000004	0.16737939158172177
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.0033884120000000004	0.16737939158172177
LEIGH SYNDROME; LS	0.0033884120000000004	0.16737939158172177
GALACTOSE EPIMERASE DEFICIENCY	0.0033884120000000004	0.16737939158172177
Pontine tegmental cap dysplasia	0.0033884120000000004	0.16737939158172177
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0033884120000000004	0.16737939158172177
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.0033884120000000004	0.16737939158172177
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.0033884120000000004	0.16737939158172177
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.0033884120000000004	0.16737939158172177
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.0033884120000000004	0.16737939158172177
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0033884120000000004	0.16737939158172177
INFANTILE LIVER FAILURE SYNDROME 1	0.0033884120000000004	0.16737939158172177
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0033884120000000004	0.16737939158172177
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.0033884120000000004	0.16737939158172177
JOUBERT SYNDROME 21	0.0033884120000000004	0.16737939158172177
CRANIOSYNOSTOSIS 6; CRS6	0.0033884120000000004	0.16737939158172177
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.0033884120000000004	0.16737939158172177
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0033884120000000004	0.16737939158172177
#614873 PEROXISOME BIOGENESIS DISORDER 7B; PBD7B	0.0033884120000000004	0.16737939158172177
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.0033884120000000004	0.16737939158172177
PEROXISOME BIOGENESIS DISORDER 6B	0.0033884120000000004	0.16737939158172177
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0033884120000000004	0.16737939158172177
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.0033884120000000004	0.16737939158172177
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.0033884120000000004	0.16737939158172177
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.0033884120000000004	0.16737939158172177
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0033884120000000004	0.16737939158172177
PEROXISOME BIOGENESIS DISORDER 5B	0.0033884120000000004	0.16737939158172177
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.0033884120000000004	0.16737939158172177
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.0033884120000000004	0.16737939158172177
#604804 MICROCEPHALY 3, PRIMARY, AUTOSOMAL RECESSIVE; MCPH3	0.0033884120000000004	0.16737939158172177
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.0033884120000000004	0.16737939158172177
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.0033884120000000004	0.16737939158172177
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.0033884120000000004	0.16737939158172177
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00325733	0.1609042565015381
LYMPHEDEMA, PRIMARY, WITH MYELODYSPLASIA	0.00325733	0.1609042565015381
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.00325733	0.1609042565015381
#309548 MENTAL RETARDATION, X-LINKED, ASSOCIATED WITH FRAGILE SITE FRAXE;;FRAXE MENTAL RETARDATION SYNDROME	0.00325733	0.1609042565015381
#108145 ARTHROGRYPOSIS, DISTAL, TYPE 5; DA5;;ARTHROGRYPOSIS WITH OCULOMOTOR LIMITATION AND ELECTRORETINAL ABNORMALITIES;;OCULOMELIC AMYOPLASIA;;ARTHROGRYPOSIS, DISTAL, TYPE IIB; DAIIB	0.00325733	0.1609042565015381
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.00325733	0.1609042565015381
PTERYGIUM COLLI, ISOLATED	0.00325733	0.1609042565015381
#611881 GLYCOGEN STORAGE DISEASE XII; GSD12;;GSD XII;;ALDOLASE A DEFICIENCY;;ALDOA DEFICIENCY;;ALDOLASE DEFICIENCY, RED CELL;;RED CELL ALDOLASE DEFICIENCY	0.00325733	0.1609042565015381
#225410 EHLERS-DANLOS SYNDROME, TYPE VII, AUTOSOMAL RECESSIVE;;EHLERS-DANLOS SYNDROME, DERMATOSPARAXIS TYPE;;DERMATOSPARAXIS;;EDS VIIC;;EDS7C	0.00325733	0.1609042565015381
EHLERS-DANLOS SYNDROME, TYPE I	0.00325733	0.1609042565015381
CHROMOSOME 13q14 DELETION SYNDROME	0.00325733	0.1609042565015381
115645 CATARACT, ABERRANT ORAL FRENULA, AND GROWTH RETARDATION	0.00325733	0.1609042565015381
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.00325733	0.1609042565015381
SCHOLTE SYNDROME; SHLTS	0.00325733	0.1609042565015381
#610832 FANCONI ANEMIA, COMPLEMENTATION GROUP N; FANCN	0.00325733	0.1609042565015381
EHLERS-DANLOS SYNDROME, TYPE VI	0.00325733	0.1609042565015381
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.00325733	0.1609042565015381
HYPERTRICHOSIS, CONGENITAL GENERALIZED, WITH OR WITHOUT GINGIVAL HYPERPLASIA	0.00325733	0.1609042565015381
NOONAN SYNDROME 4; NS4	0.00325733	0.1609042565015381
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.00325733	0.1609042565015381
HYPOGLOSSIA-HYPODACTYLIA	0.00325733	0.1609042565015381
EPICANTHUS	0.00325733	0.1609042565015381
PFEIFFER-PALM-TELLER SYNDROME	0.00325733	0.1609042565015381
Diamond-Blackfan anemia 1	0.00325733	0.1609042565015381
EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 2; EDSCL2	0.00325733	0.1609042565015381
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.0029447220000000003	0.14546217423893873
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.0029447220000000003	0.14546217423893873
Retinitis pigmentosa with or without skeletal anomalies	0.0029447220000000003	0.14546217423893873
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.0029447220000000003	0.14546217423893873
XIA-GIBBS SYNDROME	0.0029447220000000003	0.14546217423893873
#300845 MOYAMOYA DISEASE 4 WITH SHORT STATURE, HYPERGONADOTROPIC HYPOGONADISM,AND FACIAL DYSMORPHISM; MYMY4;;CHROMOSOME XQ28 DELETION SYNDROME, 3.4-KB;;SYNDROMIC MOYAMOYA DISEASE	0.0029447220000000003	0.14546217423893873
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.0029447220000000003	0.14546217423893873
SHASHI-PENA SYNDROME; SHAPNS	0.0029447220000000003	0.14546217423893873
PEROXISOME BIOGENESIS DISORDER 10B	0.0029447220000000003	0.14546217423893873
CHROMOSOME 16p13.2 DELETION SYNDROME	0.0029447220000000003	0.14546217423893873
WIEACKER-WOLFF SYNDROME	0.0029447220000000003	0.14546217423893873
JABERI-ELAHI SYNDROME; JABELS	0.0029447220000000003	0.14546217423893873
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Il; CDG1L	0.0029447220000000003	0.14546217423893873
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.0029447220000000003	0.14546217423893873
TEMTAMY SYNDROME; TEMTYS	0.0029447220000000003	0.14546217423893873
FORSYTHE-WAKELING SYNDROME; FWS	0.0029447220000000003	0.14546217423893873
#609425 CHROMOSOME 3q29 DELETION SYNDROME;;MICRODELETION 3q29 SYNDROME	0.0029447220000000003	0.14546217423893873
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.0029447220000000003	0.14546217423893873
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.0029447220000000003	0.14546217423893873
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.0029447220000000003	0.14546217423893873
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.0029447220000000003	0.14546217423893873
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.0029447220000000003	0.14546217423893873
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.0029447220000000003	0.14546217423893873
CHROMOSOME 15Q14 DELETION SYNDROME	0.0029447220000000003	0.14546217423893873
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.0029447220000000003	0.14546217423893873
#251290 BAND-LIKE CALCIFICATION WITH SIMPLIFIED GYRATION AND POLYMICROGYRIA;BLCPMG;;PSEUDO-TORCH SYNDROME	0.0029447220000000003	0.14546217423893873
AL-RAQAD SYNDROME; ARS	0.0029447220000000003	0.14546217423893873
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.0029447220000000003	0.14546217423893873
#615278 CARDIOFACIOCUTANEOUS SYNDROME 2; CFC2	0.0029447220000000003	0.14546217423893873
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.0029447220000000003	0.14546217423893873
ADENYLOSUCCINASE DEFICIENCY	0.0029447220000000003	0.14546217423893873
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.0029447220000000003	0.14546217423893873
MEVALONIC ACIDURIA; MEVA	0.0029447220000000003	0.14546217423893873
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.0029447220000000003	0.14546217423893873
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.0029447220000000003	0.14546217423893873
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.0029447220000000003	0.14546217423893873
CEREBELLOFACIODENTAL SYNDROME	0.0029447220000000003	0.14546217423893873
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.0029447220000000003	0.14546217423893873
GLASS SYNDROME	0.0029447220000000003	0.14546217423893873
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, cblC TYPE; MAHCC	0.0029447220000000003	0.14546217423893873
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0029447220000000003	0.14546217423893873
GLYCEROL KINASE DEFICIENCY; GKD	0.0029447220000000003	0.14546217423893873
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.0029447220000000003	0.14546217423893873
JOUBERT SYNDROME 35; JBTS35	0.0029447220000000003	0.14546217423893873
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.0029447220000000003	0.14546217423893873
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.0029447220000000003	0.14546217423893873
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.0029447220000000003	0.14546217423893873
CHAR SYNDROME	0.0029447220000000003	0.14546217423893873
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.0029447220000000003	0.14546217423893873
OROFACIODIGITAL SYNDROME XVI; OFD16	0.0029447220000000003	0.14546217423893873
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.0029447220000000003	0.14546217423893873
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.0029447220000000003	0.14546217423893873
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.0029447220000000003	0.14546217423893873
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.0029447220000000003	0.14546217423893873
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.0029447220000000003	0.14546217423893873
CONE-ROD DYSTROPHY 1; CORD1	0.0027933000000000003	0.13798229214901356
PRIMROSE SYNDROME; PRIMS	0.0027933000000000003	0.13798229214901356
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0027933000000000003	0.13798229214901356
#300755 AGAMMAGLOBULINEMIA, X-LINKED; XLA;;BRUTON-TYPE AGAMMAGLOBULINEMIA;;AGAMMAGLOBULINEMIA, X-LINKED, TYPE 1; AGMX1;;IMMUNODEFICIENCY 1; IMD1HYPOGAMMAGLOBULINEMIA, X-LINKED, INCLUDED	0.0027933000000000003	0.13798229214901356
MENTAL RETARDATION, X-LINKED 102	0.0027933000000000003	0.13798229214901356
KERATODERMA, PALMOPLANTAR, WITH DEAFNESS	0.0027933000000000003	0.13798229214901356
SPASTIC QUADRIPLEGIA, RETINITIS PIGMENTOSA, AND MENTAL RETARDATION	0.0027933000000000003	0.13798229214901356
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.0027933000000000003	0.13798229214901356
MENIERE DISEASE	0.0027933000000000003	0.13798229214901356
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 2	0.0027933000000000003	0.13798229214901356
CARDIOAUDITORY SYNDROME OF SANCHEZ CASCOS	0.0027933000000000003	0.13798229214901356
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.0027933000000000003	0.13798229214901356
#613558 DEAFNESS, AUTOSOMAL DOMINANT 51; DFNA51;;CHROMOSOME 9Q21.11 DUPLICATION SYNDROME	0.0027933000000000003	0.13798229214901356
KNUCKLE PADS, LEUKONYCHIA, AND SENSORINEURAL DEAFNESS	0.0027933000000000003	0.13798229214901356
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.0027933000000000003	0.13798229214901356
#600971 DEAFNESS, AUTOSOMAL RECESSIVE 6; DFNB6;;NEUROSENSORY NONSYNDROMIC RECESSIVE DEAFNESS 6; NSRD6	0.0027933000000000003	0.13798229214901356
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.0027933000000000003	0.13798229214901356
Adrenoleukodystrophy	0.0027933000000000003	0.13798229214901356
#602459 DEAFNESS, AUTOSOMAL DOMINANT 15; DFNA15	0.0027933000000000003	0.13798229214901356
THYROID HORMONE RESISTANCE, GENERALIZED, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.13798229214901356
%615649 DEAFNESS, AUTOSOMAL DOMINANT 54; DFNA54	0.0027933000000000003	0.13798229214901356
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.0027933000000000003	0.13798229214901356
#158901 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2; FSHD2;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 2, DIGENIC;;FSHD2, DIGENIC;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 2;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1B; FSHD1B	0.0027933000000000003	0.13798229214901356
#252930 MUCOPOLYSACCHARIDOSIS TYPE IIIC;;MPS IIIC; MPS3C;;SANFILIPPO SYNDROME C;;ACETYL-CoA:ALPHA-GLUCOSAMINIDE N-ACETYLTRANSFERASE DEFICIENCY	0.0027933000000000003	0.13798229214901356
CONTRACTURES, PTERYGIA, AND VARIABLE SKELETAL FUSIONS SYNDROME 1A; CPSKF1A	0.0027933000000000003	0.13798229214901356
DEAFNESS, CONGENITAL, WITH TOTAL ALBINISM	0.0027933000000000003	0.13798229214901356
#239100 HYPEROSTOSIS CORTICALIS GENERALISATA;;VAN BUCHEM DISEASE; VBCH;;HYPERPHOSPHATASEMIA TARDA;;ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.13798229214901356
DEMENTIA, FAMILIAL DANISH	0.0027933000000000003	0.13798229214901356
#174800 MCCUNE-ALBRIGHT SYNDROME; MAS;;ALBRIGHT SYNDROMEPOLYOSTOTIC FIBROUS DYSPLASIA, INCLUDED; PFD, INCLUDED; POFD, INCLUDED	0.0027933000000000003	0.13798229214901356
OPTIC ATROPHY 3, AUTOSOMAL DOMINANT	0.0027933000000000003	0.13798229214901356
MORQUIO SYNDROME A	0.0027933000000000003	0.13798229214901356
MUCOPOLYSACCHARIDOSIS, TYPE VI; MPS6	0.0027933000000000003	0.13798229214901356
RETINAL VENOUS BEADING	0.0027933000000000003	0.13798229214901356
%613916 DEAFNESS, AUTOSOMAL RECESSIVE 89; DFNB89	0.0027933000000000003	0.13798229214901356
OTOSCLEROSIS 3; OTSC3	0.0027933000000000003	0.13798229214901356
%614617 DEAFNESS, AUTOSOMAL RECESSIVE 86; DFNB86	0.0027933000000000003	0.13798229214901356
#614899 DEAFNESS, AUTOSOMAL RECESSIVE 93; DFNB93	0.0027933000000000003	0.13798229214901356
#612645 DEAFNESS, AUTOSOMAL RECESSIVE 1B; DFNB1B	0.0027933000000000003	0.13798229214901356
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 3	0.0027933000000000003	0.13798229214901356
ABCD SYNDROME	0.0027933000000000003	0.13798229214901356
FETAL IODINE DEFICIENCY DISORDER	0.0027933000000000003	0.13798229214901356
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.13798229214901356
DEAFNESS, AUTOSOMAL RECESSIVE 55	0.0027933000000000003	0.13798229214901356
DEAFNESS, AUTOSOMAL RECESSIVE 33	0.0027933000000000003	0.13798229214901356
BONE MARROW FAILURE SYNDROME 1; BMFS1	0.0027933000000000003	0.13798229214901356
DEAFNESS, AUTOSOMAL DOMINANT 73; DFNA73	0.0027933000000000003	0.13798229214901356
#614934 DEAFNESS, AUTOSOMAL RECESSIVE 70; DFNB70	0.0027933000000000003	0.13798229214901356
CHIARI MALFORMATION TYPE I	0.0027933000000000003	0.13798229214901356
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.0027933000000000003	0.13798229214901356
XYLOSIDASE DEFICIENCY	0.0027933000000000003	0.13798229214901356
CANAVAN DISEASE	0.0027933000000000003	0.13798229214901356
LISSENCEPHALY 5; LIS5	0.0027933000000000003	0.13798229214901356
DEAFNESS, AUTOSOMAL RECESSIVE 18B; DFNB18B	0.0027933000000000003	0.13798229214901356
MUCOPOLYSACCHARIDOSIS, TYPE II	0.0027933000000000003	0.13798229214901356
%615654 DEAFNESS, AUTOSOMAL DOMINANT 58; DFNA58	0.0027933000000000003	0.13798229214901356
DEAFNESS, CONGENITAL, AND FAMILIAL MYOCLONIC EPILEPSY	0.0027933000000000003	0.13798229214901356
XFE PROGEROID SYNDROME; XFEPS	0.0027933000000000003	0.13798229214901356
HYPERLIPOPROTEINEMIA, TYPE II, AND DEAFNESS	0.0027933000000000003	0.13798229214901356
HYPOGONADOTROPIC HYPOGONADISM 19 WITH OR WITHOUT ANOSMIA; HH19	0.0027933000000000003	0.13798229214901356
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.0027933000000000003	0.13798229214901356
DEAFNESS, AUTOSOMAL RECESSIVE 32, WITH OR WITHOUT IMMOTILE SPERM; DFNB32	0.0027933000000000003	0.13798229214901356
#222600 DIASTROPHIC DYSPLASIA;;DTD;;DDDIASTROPHIC DYSPLASIA, BROAD BONE-PLATYSPONDYLIC VARIANT, INCLUDED	0.0027933000000000003	0.13798229214901356
DYSOSTEOSCLEROSIS	0.0027933000000000003	0.13798229214901356
AUDITORY NEUROPATHY AND OPTIC ATROPHY; ANOA	0.0027933000000000003	0.13798229214901356
SPASTIC PARAPARESIS AND DEAFNESS	0.0027933000000000003	0.13798229214901356
#606763 CILIARY DYSKINESIA, PRIMARY, 2; CILD2;;CILIARY DYSKINESIA, PRIMARY, 2, WITH OR WITHOUT SITUS INVERSUS	0.0027933000000000003	0.13798229214901356
121450 CORNEAL DEGENERATION, RIBBONLIKE, WITH DEAFNESS;;BAND KERATOPATHY WITH DEAFNESS	0.0027933000000000003	0.13798229214901356
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.0027933000000000003	0.13798229214901356
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.0027933000000000003	0.13798229214901356
PULMONIC STENOSIS AND DEAFNESS	0.0027933000000000003	0.13798229214901356
DEAFNESS, X-LINKED 5; DFNX5	0.0027933000000000003	0.13798229214901356
%607683 DEAFNESS, AUTOSOMAL DOMINANT 52; DFNA52;;DEAFNESS, AUTOSOMAL DOMINANT 42; DFNA42	0.0027933000000000003	0.13798229214901356
SCHIMKE X-LINKED MENTAL RETARDATION SYNDROME	0.0027933000000000003	0.13798229214901356
#610896 BRANCHIOOTORENAL SYNDROME 2; BOR2	0.0027933000000000003	0.13798229214901356
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.0027933000000000003	0.13798229214901356
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.0027933000000000003	0.13798229214901356
DEAFNESS, AUTOSOMAL DOMINANT 24	0.0027933000000000003	0.13798229214901356
EHLERS-DANLOS SYNDROME, BEASLEY-COHEN TYPE	0.0027933000000000003	0.13798229214901356
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, AUTOSOMAL RECESSIVE, TYPE 2A2B; CMT2A2B	0.0027933000000000003	0.13798229214901356
HARDIKAR SYNDROME	0.0027933000000000003	0.13798229214901356
KRABBE DISEASE	0.0027933000000000003	0.13798229214901356
%300719 DEAFNESS, CATARACT, RETINITIS PIGMENTOSA, AND SPERM ABNORMALITIES	0.0027933000000000003	0.13798229214901356
OPTICOCOCHLEODENTATE DEGENERATION	0.0027933000000000003	0.13798229214901356
DWARFISM, LOW-BIRTH-WEIGHT TYPE, WITH UNRESPONSIVENESS TO GROWTH HORMONE	0.0027933000000000003	0.13798229214901356
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.0027933000000000003	0.13798229214901356
NEURODEGENERATION WITH ATAXIA, DYSTONIA, AND GAZE PALSY, CHILDHOOD-ONSET	0.0027933000000000003	0.13798229214901356
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.0027933000000000003	0.13798229214901356
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0027933000000000003	0.13798229214901356
BRITTLE CORNEA SYNDROME 2; BCS2	0.0027933000000000003	0.13798229214901356
#307200 ISOLATED GROWTH HORMONE DEFICIENCY, TYPE III; IGHD3;;IGHD III;;GROWTH HORMONE DEFICIENCY WITH HYPOGAMMAGLOBULINEMIA;;HYPOGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;AGAMMAGLOBULINEMIA AND ISOLATED GROWTH HORMONE DEFICIENCY, X-LINKED;;FLEISHER SYNDROME	0.0027933000000000003	0.13798229214901356
DEAFNESS, CONGENITAL, WITH KERATOPACHYDERMIA AND CONSTRICTIONS OFFINGERS AND TOES	0.0027933000000000003	0.13798229214901356
%614414 DEAFNESS, AUTOSOMAL RECESSIVE 96; DFNB96	0.0027933000000000003	0.13798229214901356
DEAFNESS, AUTOSOMAL RECESSIVE 84; DFNB84	0.0027933000000000003	0.13798229214901356
EAR EXOSTOSES	0.0027933000000000003	0.13798229214901356
CEREBRAL SCLEROSIS, DIFFUSE, SCHOLZ TYPE	0.0027933000000000003	0.13798229214901356
#615629 DEAFNESS, AUTOSOMAL DOMINANT 56; DFNA56	0.0027933000000000003	0.13798229214901356
#300914 DEAFNESS, X-LINKED 6; DFNX6	0.0027933000000000003	0.13798229214901356
WOLFRAM-LIKE SYNDROME, AUTOSOMAL DOMINANT; WFSL	0.0027933000000000003	0.13798229214901356
USHER SYNDROME, TYPE ID	0.0027933000000000003	0.13798229214901356
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4C; CMT4C	0.0027933000000000003	0.13798229214901356
#612438 LEUKODYSTROPHY, HYPOMYELINATING, 6; HLD6;;LEUKODYSTROPHY, HYPOMYELINATING, WITH ATROPHY OF THE BASAL GANGLIAAND CEREBELLUM; HABC	0.0027933000000000003	0.13798229214901356
FACIAL PARESIS, HEREDITARY CONGENITAL, 2; HCFP2	0.0027933000000000003	0.13798229214901356
FRAGILE X TREMOR/ATAXIA SYNDROME; FXTAS	0.0027933000000000003	0.13798229214901356
DEAFNESS, CONGENITAL, WITH VITILIGO AND ACHALASIA	0.0027933000000000003	0.13798229214901356
#615429 DEAFNESS, AUTOSOMAL RECESSIVE 88; DFNB88	0.0027933000000000003	0.13798229214901356
MYASTHENIC SYNDROME, CONGENITAL, 7, PRESYNAPTIC; CMS7	0.0027933000000000003	0.13798229214901356
HYPOGONADOTROPIC HYPOGONADISM 18 WITH OR WITHOUT ANOSMIA; HH18	0.0027933000000000003	0.13798229214901356
MYOCLONUS, CEREBELLAR ATAXIA, AND DEAFNESS	0.0027933000000000003	0.13798229214901356
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.0027933000000000003	0.13798229214901356
CHOLESTASIS, BENIGN RECURRENT INTRAHEPATIC 1	0.0027933000000000003	0.13798229214901356
KEUTEL SYNDROME; KTLS	0.0027933000000000003	0.13798229214901356
EPIPHYSEAL DYSPLASIA OF FEMORAL HEAD, MYOPIA, AND DEAFNESS	0.0027933000000000003	0.13798229214901356
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.0027933000000000003	0.13798229214901356
#601455 CHARCOT-MARIE-TOOTH DISEASE, TYPE 4D; CMT4D;;NEUROPATHY, HEREDITARY MOTOR AND SENSORY, LOM TYPE; HMSNL;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, AUTOSOMAL RECESSIVE, TYPE4D;;CHARCOT-MARIE-TOOTH NEUROPATHY, TYPE 4D;;HMSN4D	0.0027933000000000003	0.13798229214901356
IVIC SYNDROME	0.0027933000000000003	0.13798229214901356
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.0027933000000000003	0.13798229214901356
#614614 DEAFNESS, AUTOSOMAL DOMINANT 4B; DFNA4B	0.0027933000000000003	0.13798229214901356
MUCOPOLYSACCHARIDOSIS, TYPE VII; MPS7	0.0027933000000000003	0.13798229214901356
PAGET DISEASE OF BONE 3; PDB3	0.0027933000000000003	0.13798229214901356
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2A2; CMT2A2	0.0027933000000000003	0.13798229214901356
GLYCOGEN STORAGE DISEASE II	0.0027933000000000003	0.13798229214901356
DEAFNESS, AUTOSOMAL RECESSIVE 107; DFNB107	0.0027933000000000003	0.13798229214901356
#259420 OSTEOGENESIS IMPERFECTA, TYPE III;;OI, TYPE III;;OI3;;OSTEOGENESIS IMPERFECTA, PROGRESSIVELY DEFORMING, WITH NORMAL SCLERAE	0.0027933000000000003	0.13798229214901356
HYPOGONADOTROPIC HYPOGONADISM 21 WITH OR WITHOUT ANOSMIA; HH21	0.0027933000000000003	0.13798229214901356
NEUROFIBROMATOSIS, TYPE II	0.0027933000000000003	0.13798229214901356
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.0027933000000000003	0.13798229214901356
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.0027933000000000003	0.13798229214901356
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.0027933000000000003	0.13798229214901356
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.0027933000000000003	0.13798229214901356
#613718 DEAFNESS, AUTOSOMAL RECESSIVE 74; DFNB74	0.0027933000000000003	0.13798229214901356
CAMURATI-ENGELMANN DISEASE	0.0027933000000000003	0.13798229214901356
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.0027933000000000003	0.13798229214901356
#614944 DEAFNESS, AUTOSOMAL RECESSIVE 84B; DFNB84B	0.0027933000000000003	0.13798229214901356
PIEBALD TRAIT WITH NEUROLOGIC DEFECTS	0.0027933000000000003	0.13798229214901356
DEAFNESS, AUTOSOMAL DOMINANT 74; DFNA74	0.0027933000000000003	0.13798229214901356
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.0027933000000000003	0.13798229214901356
RAMON SYNDROME	0.0027933000000000003	0.13798229214901356
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0027933000000000003	0.13798229214901356
DEAFNESS, AUTOSOMAL RECESSIVE 106; DFNB106	0.0027933000000000003	0.13798229214901356
DIAMOND-BLACKFAN ANEMIA 7; DBA7	0.0027933000000000003	0.13798229214901356
#236792 L-2-HYDROXYGLUTARIC ACIDURIA;;L-2-HYDROXYGLUTARIC ACIDEMIA	0.0027933000000000003	0.13798229214901356
#230000 FUCOSIDOSIS;;ALPHA-L-FUCOSIDASE DEFICIENCY	0.0027933000000000003	0.13798229214901356
USHER SYNDROME, TYPE IID; USH2D	0.0027933000000000003	0.13798229214901356
TUNE DEAFNESS	0.0027933000000000003	0.13798229214901356
HYPOGONADOTROPIC HYPOGONADISM 17 WITH OR WITHOUT ANOSMIA; HH17	0.0027933000000000003	0.13798229214901356
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.0027933000000000003	0.13798229214901356
CYCLIC VOMITING SYNDROME	0.0027933000000000003	0.13798229214901356
#614896 SINOATRIAL NODE DYSFUNCTION AND DEAFNESS; SANDD	0.0027933000000000003	0.13798229214901356
DEAFNESS, AUTOSOMAL RECESSIVE 65; DFNB65	0.0027933000000000003	0.13798229214901356
#253010 MUCOPOLYSACCHARIDOSIS TYPE IVB;;MORQUIO SYNDROME B;;MPS IVB; MPS4B	0.0027933000000000003	0.13798229214901356
OTOSCLEROSIS 8; OTSC8	0.0027933000000000003	0.13798229214901356
DEAFNESS, AUTOSOMAL RECESSIVE 47	0.0027933000000000003	0.13798229214901356
PAGET DISEASE OF BONE 4; PDB4	0.0027933000000000003	0.13798229214901356
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.0027933000000000003	0.13798229214901356
#614153 SPINOCEREBELLAR ATAXIA 36; SCA36	0.0027933000000000003	0.13798229214901356
#614504 USHER SYNDROME, TYPE IIIB; USH3B	0.0027933000000000003	0.13798229214901356
SPINOCEREBELLAR ATAXIA 13	0.0027933000000000003	0.13798229214901356
OSTEOGENESIS IMPERFECTA, TYPE IV	0.0027933000000000003	0.13798229214901356
CILIARY DYSKINESIA, PRIMARY, 37; CILD37	0.0027933000000000003	0.13798229214901356
OSTEOGENESIS IMPERFECTA, TYPE I	0.0027933000000000003	0.13798229214901356
%614187 HYPERTELORISM, PREAURICULAR SINUS, PUNCTAL PITS, AND DEAFNESS; HPPD	0.0027933000000000003	0.13798229214901356
NEPHROSIS WITH DEAFNESS AND URINARY TRACT AND DIGITAL MALFORMATIONS	0.0027933000000000003	0.13798229214901356
DEAFNESS, AUTOSOMAL DOMINANT 59	0.00254453	0.1256936533282961
#118300 CHARCOT-MARIE-TOOTH DISEASE AND DEAFNESS;;CHARCOT-MARIE-TOOTH NEUROPATHY AND DEAFNESS, AUTOSOMAL DOMINANT;;CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1E; CMT1E	0.00254453	0.1256936533282961
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00254453	0.1256936533282961
WOODHOUSE-SAKATI SYNDROME	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL DOMINANT 53	0.00254453	0.1256936533282961
#220600 SPLIT-HAND/FOOT MALFORMATION 1 WITH SENSORINEURAL HEARING LOSS; SHFM1D;;DEAFNESS, CONGENITAL, AND SPLIT HANDS AND FEET	0.00254453	0.1256936533282961
#606705 DEAFNESS, AUTOSOMAL DOMINANT 36; DFNA36	0.00254453	0.1256936533282961
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL RECESSIVE 23	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL DOMINANT 68	0.00254453	0.1256936533282961
#607841 DEAFNESS, AUTOSOMAL DOMINANT 48; DFNA48	0.00254453	0.1256936533282961
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00254453	0.1256936533282961
#262000 BJORNSTAD SYNDROME; BJS;;PILI TORTI AND NERVE DEAFNESS;;PTD	0.00254453	0.1256936533282961
ENDOSTEAL HYPEROSTOSIS, AUTOSOMAL DOMINANT	0.00254453	0.1256936533282961
DEAFNESS, X-LINKED 1	0.00254453	0.1256936533282961
#614134 STICKLER SYNDROME, TYPE IV; STL4	0.00254453	0.1256936533282961
PAGET DISEASE OF BONE 5, JUVENILE-ONSET	0.00254453	0.1256936533282961
OPTIC ATROPHY 8	0.00254453	0.1256936533282961
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 7	0.00254453	0.1256936533282961
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.00254453	0.1256936533282961
REFSUM DISEASE	0.00254453	0.1256936533282961
WAARDENBURG SYNDROME, TYPE IIB	0.00254453	0.1256936533282961
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.00254453	0.1256936533282961
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 33; COXPD33	0.00254453	0.1256936533282961
#104200 ALPORT SYNDROME, AUTOSOMAL DOMINANT	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL RECESSIVE 115; DFNB115	0.00254453	0.1256936533282961
STICKLER SYNDROME, TYPE III	0.00254453	0.1256936533282961
HYPERLEUCINE-ISOLEUCINEMIA	0.00254453	0.1256936533282961
KEARNS-SAYRE SYNDROME; KSS	0.00254453	0.1256936533282961
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 2; PEOA2	0.00254453	0.1256936533282961
THYROCEREBRORETINAL SYNDROME	0.00254453	0.1256936533282961
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 5	0.00254453	0.1256936533282961
SPASTIC PARAPLEGIA 29, AUTOSOMAL DOMINANT	0.00254453	0.1256936533282961
FAMILIAL COLD AUTOINFLAMMATORY SYNDROME 2; FCAS2	0.00254453	0.1256936533282961
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.00254453	0.1256936533282961
#193300 VON HIPPEL-LINDAU SYNDROME; VHLVON HIPPEL-LINDAU SYNDROME, MODIFIERS OF, INCLUDED	0.00254453	0.1256936533282961
#602482 AXENFELD-RIEGER SYNDROME, TYPE 3; RIEG3;;AXENFELD-RIEGER ANOMALY WITH OR WITHOUT CARDIAC DEFECTS AND/OR SENSORINEURALHEARING LOSS;;ANTERIOR SEGMENT MESENCHYMAL DYSGENESIS;;ANTERIOR CHAMBER CLEAVAGE SYNDROME;;RIEGER SYNDROME, TYPE 3AXENFELD ANOMALY, INCLUDED;;RIEGER ANOMALY, INCLUDED;;AXENFELD-RIEGER ANOMALY, INCLUDED	0.00254453	0.1256936533282961
SPASTIC PARAPLEGIA 5A, AUTOSOMAL RECESSIVE; SPG5A	0.00254453	0.1256936533282961
NAIL-PATELLA SYNDROME	0.00254453	0.1256936533282961
USHER SYNDROME, TYPE IG	0.00254453	0.1256936533282961
SPONDYLOPERIPHERAL DYSPLASIA	0.00254453	0.1256936533282961
ERMINE PHENOTYPE	0.00254453	0.1256936533282961
CEREBELLAR ATAXIA AND NEUROSENSORY DEAFNESS	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL RECESSIVE 103; DFNB103	0.00254453	0.1256936533282961
HYPOPARATHYROIDISM, SENSORINEURAL DEAFNESS, AND RENAL DISEASE	0.00254453	0.1256936533282961
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 18	0.00254453	0.1256936533282961
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00254453	0.1256936533282961
#613266 WAARDENBURG SYNDROME, TYPE 4C; WS4C;;WAARDENBURG SYNDROME WITH HIRSCHSPRUNG DISEASE, TYPE 4C;;WAARDENBURG SYNDROME, TYPE IVC	0.00254453	0.1256936533282961
#607039 DEAFNESS, AUTOSOMAL RECESSIVE 22; DFNB22	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 28	0.00254453	0.1256936533282961
MITOCHONDRIAL DNA DEPLETION SYNDROME 14	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL DOMINANT 66	0.00254453	0.1256936533282961
#609706 DEAFNESS, AUTOSOMAL RECESSIVE 53; DFNB53	0.00254453	0.1256936533282961
PAPILLORENAL SYNDROME	0.00254453	0.1256936533282961
#614861 DEAFNESS, AUTOSOMAL RECESSIVE 98; DFNB98	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL RECESSIVE 114; DFNB114	0.00254453	0.1256936533282961
#276900 USHER SYNDROME, TYPE I; USH1;;US1;;RETINITIS PIGMENTOSA AND CONGENITAL DEAFNESSUSHER SYNDROME, TYPE IB, INCLUDED; USH1B, INCLUDED;;USHER SYNDROME, TYPE IA, FORMERLY, INCLUDED; USH1A, FORMERLY, INCLUDED;;USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY, INCLUDED	0.00254453	0.1256936533282961
PRUNE BELLY SYNDROME WITH PULMONIC STENOSIS, MENTAL RETARDATION, ANDDEAFNESS	0.00254453	0.1256936533282961
LEBER CONGENITAL AMAUROSIS, TYPE I	0.00254453	0.1256936533282961
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00254453	0.1256936533282961
CRANIOFACIAL-DEAFNESS-HAND SYNDROME; CDHS	0.00254453	0.1256936533282961
HYPEROSTOSIS CRANIALIS INTERNA; HCIN	0.00254453	0.1256936533282961
#610220 DEAFNESS, AUTOSOMAL RECESSIVE 59; DFNB59	0.00254453	0.1256936533282961
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 13; COXPD13	0.00254453	0.1256936533282961
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00254453	0.1256936533282961
ENLARGED VESTIBULAR AQUEDUCT	0.00254453	0.1256936533282961
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00254453	0.1256936533282961
NEUROPATHY, HEREDITARY SENSORY, TYPE IE; HSN1E	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 12	0.00254453	0.1256936533282961
#234580 HEIMLER SYNDROME 1; HMLR1;;HEARING LOSS, SENSORINEURAL, WITH ENAMEL HYPOPLASIA AND NAIL DEFECTS;;PEROXISOME BIOGENESIS DISORDER 1C; PBD1C	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 3	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL DOMINANT 69	0.00254453	0.1256936533282961
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.00254453	0.1256936533282961
#215100 RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 1; RCDP1;;PEROXISOME BIOGENESIS DISORDER 9; PBD9;;CHONDRODYSPLASIA PUNCTATA, RHIZOMELIC FORM; CDPR;;CHONDRODYSTROPHIA CALCIFICANS PUNCTATA	0.00254453	0.1256936533282961
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 50; MRT50	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL RECESSIVE 100; DFNB100	0.00254453	0.1256936533282961
DEAFNESS, Y-LINKED 1	0.00254453	0.1256936533282961
ARTHROGRYPOSIS-LIKE HAND ANOMALY AND SENSORINEURAL DEAFNESS	0.00254453	0.1256936533282961
#233400 PERRAULT SYNDROME 1; PRLTS1;;OVARIAN DYSGENESIS WITH SENSORINEURAL DEAFNESS;;GONADAL DYSGENESIS, XX TYPE, WITH DEAFNESS	0.00254453	0.1256936533282961
#220290 DEAFNESS, AUTOSOMAL RECESSIVE 1A; DFNB1ADEAFNESS, DIGENIC, GJB2/GJB6, INCLUDED;;DEAFNESS, DIGENIC, GJB2/GJB3, INCLUDED	0.00254453	0.1256936533282961
PEROXISOME BIOGENESIS DISORDER 9B; PBD9B	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL DOMINANT 43	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL RECESSIVE 51	0.00254453	0.1256936533282961
#148210 KERATITIS-ICHTHYOSIS-DEAFNESS SYNDROME, AUTOSOMAL DOMINANT;;KID SYNDROME, AUTOSOMAL DOMINANT	0.00254453	0.1256936533282961
#609242 KANZAKI DISEASE;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, TYPE II;;ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY, ADULT-ONSET;;NAGA DEFICIENCY, TYPE II;;SCHINDLER DISEASE, TYPE II	0.00254453	0.1256936533282961
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL DOMINANT 27	0.00254453	0.1256936533282961
CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 6; CMTX6	0.00254453	0.1256936533282961
WT LIMB-BLOOD SYNDROME	0.00254453	0.1256936533282961
Deafness, autosomal recessive 113	0.00254453	0.1256936533282961
CONE-ROD DYSTROPHY AND HEARING LOSS 2; CRDHL2	0.00254453	0.1256936533282961
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP A; XPA	0.00254453	0.1256936533282961
ATAXIA, DEAFNESS, AND CARDIOMYOPATHY	0.00254453	0.1256936533282961
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.00254453	0.1256936533282961
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00254453	0.1256936533282961
DEAFNESS, NERVE TYPE, WITH MESENTERIC DIVERTICULA OF SMALL BOWEL ANDPROGRESSIVE SENSORY NEUROPATHY	0.00254453	0.1256936533282961
RETINITIS PIGMENTOSA INVERSA WITH DEAFNESS	0.00254453	0.1256936533282961
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.00254453	0.1256936533282961
ATHEROSCLEROSIS, PREMATURE, WITH DEAFNESS, NEPHROPATHY, DIABETES MELLITUS,PHOTOMYOCLONUS, AND DEGENERATIVE NEUROLOGIC DISEASE	0.00254453	0.1256936533282961
#608389 BRANCHIOOTIC SYNDROME 3; BOS3;;BO SYNDROME 3	0.00254453	0.1256936533282961
OTODENTAL DYSPLASIA	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL RECESSIVE 110; DFNB110	0.00254453	0.1256936533282961
#613865 DEAFNESS, AUTOSOMAL RECESSIVE 61; DFNB61	0.00254453	0.1256936533282961
#602540 ICHTHYOSIS, HYSTRIX-LIKE, WITH DEAFNESS;;HID SYNDROME	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL RECESSIVE 9	0.00254453	0.1256936533282961
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, WITH DEAFNESS, MENTAL RETARDATION,AND ABSENT SENSORY LARGE MYELINATED FIBERS	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL DOMINANT 47	0.00254453	0.1256936533282961
CARDIOMYOPATHY, DILATED, 1J; CMD1J	0.00254453	0.1256936533282961
FOUNTAIN SYNDROME	0.00254453	0.1256936533282961
SPONDYLOMEGAEPIPHYSEAL DYSPLASIA WITH UPPER LIMB MESOMELIA, PUNCTATECALCIFICATIONS, AND DEAFNESS	0.00254453	0.1256936533282961
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.00254453	0.1256936533282961
%614211 DEAFNESS, AUTOSOMAL DOMINANT 33; DFNA33	0.00254453	0.1256936533282961
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL RECESSIVE 26	0.00254453	0.1256936533282961
115250 COLLAGENOMA, FAMILIAL CUTANEOUS	0.00254453	0.1256936533282961
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP D; XPD	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL RECESSIVE 97	0.00254453	0.1256936533282961
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.00254453	0.1256936533282961
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.00254453	0.1256936533282961
#608747 INSULIN-LIKE GROWTH FACTOR I DEFICIENCY;;IGF1 DEFICIENCY;;GROWTH RETARDATION WITH SENSORINEURAL DEAFNESS AND MENTAL RETARDATION	0.00254453	0.1256936533282961
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.00254453	0.1256936533282961
#103470 ALBINISM, OCULAR, WITH SENSORINEURAL DEAFNESS;;WAARDENBURG SYNDROME, TYPE 2, WITH OCULAR ALBINISM, AUTOSOMAL RECESSIVE;WS2-OA	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL RECESSIVE 68	0.00254453	0.1256936533282961
WAARDENBURG SYNDROME, TYPE 4B; WS4B	0.00254453	0.1256936533282961
NEURAMINIDASE DEFICIENCY	0.00254453	0.1256936533282961
CEREBELLAR ATAXIA, DEAFNESS, AND NARCOLEPSY, AUTOSOMAL DOMINANT; ADCADN	0.00254453	0.1256936533282961
DEAFNESS, SENSORINEURAL, WITH PITUITARY DWARFISM	0.00254453	0.1256936533282961
ALPORT SYNDROME, X-LINKED; ATS	0.00254453	0.1256936533282961
%607017 DEAFNESS, AUTOSOMAL DOMINANT 21; DFNA21	0.00254453	0.1256936533282961
Deafness, autosomal recessive 99	0.00254453	0.1256936533282961
CHARCOT-MARIE-TOOTH DISEASE, DOMINANT INTERMEDIATE G; CMTDIG	0.00254453	0.1256936533282961
256120 NEPHROPATHY, DEAFNESS, AND HYPERPARATHYROIDISM	0.00254453	0.1256936533282961
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2N	0.00254453	0.1256936533282961
SPINOCEREBELLAR ATAXIA 31	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL DOMINANT 72; DFNA72	0.00254453	0.1256936533282961
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00254453	0.1256936533282961
DYSTONIA, JUVENILE-ONSET	0.00254453	0.1256936533282961
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 2	0.00254453	0.1256936533282961
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.00254453	0.1256936533282961
STICKLER SYNDROME, TYPE V; STL5	0.00254453	0.1256936533282961
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE IA; HSAN1A	0.00254453	0.1256936533282961
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP B	0.00254453	0.1256936533282961
DE SANCTIS-CACCHIONE SYNDROME	0.00254453	0.1256936533282961
#302800 CHARCOT-MARIE-TOOTH DISEASE, X-LINKED DOMINANT, 1; CMTX1;;CMTX;;CHARCOT-MARIE-TOOTH PERONEAL MUSCULAR ATROPHY, X-LINKED;;HEREDITARY MOTOR AND SENSORY NEUROPATHY, X-LINKED;;HMSN, X-LINKED;;CHARCOT-MARIE-TOOTH NEUROPATHY, X-LINKED, 1;;CMT2, FORMERLY	0.00254453	0.1256936533282961
DEAFNESS, Y-LINKED 2; DFNY2	0.00254453	0.1256936533282961
#616340 DEAFNESS, AUTOSOMAL DOMINANT 67; DFNA67	0.00254453	0.1256936533282961
#616357 DEAFNESS, AUTOSOMAL DOMINANT 40; DFNA40	0.00254453	0.1256936533282961
CORNEAL DYSTROPHY AND PERCEPTIVE DEAFNESS	0.00254453	0.1256936533282961
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.00254453	0.1256936533282961
WOLFRAM SYNDROME 2; WFS2	0.00254453	0.1256936533282961
NEUROENDOCRINE CARCINOMA OF SALIVARY GLANDS, SENSORINEURAL HEARING LOSS, AND ENAMEL HYPOPLASIA	0.00254453	0.1256936533282961
PREMATURE AGING SYNDROME, PENTTINEN TYPE	0.00254453	0.1256936533282961
IMMUNODEFICIENCY 47	0.00254453	0.1256936533282961
#520000 DIABETES AND DEAFNESS, MATERNALLY INHERITED; MIDD;;DIABETES-DEAFNESS SYNDROME, MATERNALLY TRANSMITTED;;BALLINGER-WALLACE SYNDROME;;DIABETES MELLITUS, TYPE II, WITH DEAFNESS;;NONINSULIN-DEPENDENT DIABETES MELLITUS WITH DEAFNESS;;NIDDM WITH DEAFNESS	0.00254453	0.1256936533282961
CONE-ROD DYSTROPHY AND HEARING LOSS; CRDHL	0.00254453	0.1256936533282961
#608565 DEAFNESS, AUTOSOMAL RECESSIVE 35; DFNB35	0.00254453	0.1256936533282961
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00254453	0.1256936533282961
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.00254453	0.1256936533282961
#603629 DEAFNESS, AUTOSOMAL RECESSIVE 21; DFNB21	0.00254453	0.1256936533282961
#601536 ATHABASKAN BRAINSTEM DYSGENESIS SYNDROME; ABDS;;NAVAJO BRAINSTEM SYNDROMEBOSLEY-SALIH-ALORAINY SYNDROME, INCLUDED; BSAS, INCLUDED	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL DOMINANT 25	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL RECESSIVE 16; DFNB16	0.00254453	0.1256936533282961
#310600 NORRIE DISEASE; ND;;ATROPHIA BULBORUM HEREDITARIA;;EPISKOPI BLINDNESS	0.00254453	0.1256936533282961
HYPOPHOSPHATEMIC RICKETS, AUTOSOMAL RECESSIVE	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL RECESSIVE 14	0.00254453	0.1256936533282961
#609057 NEPHROPATHY WITH PRETIBIAL EPIDERMOLYSIS BULLOSA AND DEAFNESS	0.00254453	0.1256936533282961
#612951 LEUKOENCEPHALOPATHY, CYSTIC, WITHOUT MEGALENCEPHALY	0.00254453	0.1256936533282961
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00254453	0.1256936533282961
RETINITIS PIGMENTOSA 59; RP59	0.00254453	0.1256936533282961
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL RECESSIVE 13	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL DOMINANT 71; DFNA71	0.00254453	0.1256936533282961
DEAFNESS, CHILDHOOD-ONSET NEUROSENSORY, AUTOSOMAL RECESSIVE 8	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL RECESSIVE 57; DFNB57	0.00254453	0.1256936533282961
#158900 FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY 1; FSHD1;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1;;FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FSHD; FMD;;MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL, TYPE 1A; FSHD1A;;LANDOUZY-DEJERINE MUSCULAR DYSTROPHYFACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY, INFANTILE, INCLUDED;;FACIOSCAPULOHUMERAL DYSTROPHY WITH SENSORINEURAL HEARING LOSS ANDTORTUOSITY OF RETINAL ARTERIOLES, INCLUDED	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL DOMINANT 64; DFNA64	0.00254453	0.1256936533282961
GROWTH RETARDATION, DEAFNESS, FEMORAL EPIPHYSEAL DYSPLASIA, AND LACRIMAL DUCT OBSTRUCTION	0.00254453	0.1256936533282961
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL RECESSIVE 17; DFNB17	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 13	0.00254453	0.1256936533282961
HISTIOCYTOSIS-LYMPHADENOPATHY PLUS SYNDROME	0.00254453	0.1256936533282961
%605818 DEAFNESS, AUTOSOMAL RECESSIVE 27; DFNB27	0.00254453	0.1256936533282961
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.00254453	0.1256936533282961
DEAFNESS, NEUROSENSORY, AUTOSOMAL RECESSIVE 42	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL RECESSIVE 66; DFNB66	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL DOMINANT 30	0.00254453	0.1256936533282961
#607453 DEAFNESS, AUTOSOMAL DOMINANT 44; DFNA44	0.00254453	0.1256936533282961
AUDITORY NEUROPATHY, AUTOSOMAL DOMINANT, 1	0.00254453	0.1256936533282961
RENAL TUBULAR ACIDOSIS, DISTAL, WITH PROGRESSIVE NERVE DEAFNESS	0.00254453	0.1256936533282961
%223200 DISORGANIZATION, MOUSE, HOMOLOG OF;;DS	0.00254453	0.1256936533282961
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00254453	0.1256936533282961
DEAFNESS, NEURAL, WITH ATYPICAL ATOPIC DERMATITIS	0.00254453	0.1256936533282961
ECTODERMAL DYSPLASIA AND NEUROSENSORY DEAFNESS	0.00254453	0.1256936533282961
#609006 DEAFNESS, AUTOSOMAL RECESSIVE 36, WITH OR WITHOUT VESTIBULAR INVOLVEMENT;DFNB36DEAFNESS, AUTOSOMAL DOMINANT, WITHOUT VESTIBULAR INVOLVEMENT, INCLUDED	0.00254453	0.1256936533282961
DEAFNESS, AUTOSOMAL DOMINANT NONSYNDROMIC SENSORINEURAL 10	0.00254453	0.1256936533282961
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00254453	0.1256936533282961
#614650 COENZYME Q10 DEFICIENCY, PRIMARY, 6; COQ10D6	0.00254453	0.1256936533282961
FRIEDREICH ATAXIA, SO-CALLED, WITH OPTIC ATROPHY AND SENSORINEURALDEAFNESS	0.00254453	0.1256936533282961
#607084 DEAFNESS, AUTOSOMAL RECESSIVE 31; DFNB31;;WHIRLER, MOUSE, HOMOLOG OF	0.00254453	0.1256936533282961
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.00254453	0.1256936533282961
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIa; CDG2A	0.00254453	0.1256936533282961
#612674 POLYNEUROPATHY, HEARING LOSS, ATAXIA, RETINITIS PIGMENTOSA, AND CATARACT;PHARC	0.00254453	0.1256936533282961
PERRAULT SYNDROME 2; PRLTS2	0.00254453	0.1256936533282961
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00254453	0.1256936533282961
#222300 WOLFRAM SYNDROME 1; WFS1;;WFS;;DIABETES INSIPIDUS AND MELLITUS WITH OPTIC ATROPHY AND DEAFNESS; DIDMOAD	0.00254453	0.1256936533282961
MENTAL RETARDATION, X-LINKED 46	0.00254453	0.1256936533282961
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.00254453	0.1256936533282961
ATAXIA, COMBINED CEREBELLAR AND PERIPHERAL, WITH HEARING LOSS AND DIABETES MELLITUS; ACPHD	0.00254453	0.1256936533282961
DEAFNESS, NEURAL, CONGENITAL MODERATE	0.00254453	0.1256936533282961
USHER SYNDROME, TYPE IIIA	0.00254453	0.1256936533282961
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00210084	0.10377643598551307
FANCONI ANEMIA, COMPLEMENTATION GROUP Q; FANCQ	0.00210084	0.10377643598551307
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.00210084	0.10377643598551307
TRANSALDOLASE DEFICIENCY	0.00210084	0.10377643598551307
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.00210084	0.10377643598551307
#614653 NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE VI; HSAN6;;HSAN VI	0.00210084	0.10377643598551307
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.00210084	0.10377643598551307
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.00210084	0.10377643598551307
CRANIOMETADIAPHYSEAL DYSPLASIA; CRMDD	0.00210084	0.10377643598551307
KYPHOMELIC DYSPLASIA	0.00210084	0.10377643598551307
WIDOW&#39;S PEAK SYNDROME	0.00210084	0.10377643598551307
TEETH, NONERUPTION OF, WITH MAXILLARY HYPOPLASIA AND GENU VALGUM	0.00210084	0.10377643598551307
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.00210084	0.10377643598551307
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.00210084	0.10377643598551307
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.00210084	0.10377643598551307
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.00210084	0.10377643598551307
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.00210084	0.10377643598551307
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00210084	0.10377643598551307
#613885 MECKEL SYNDROME, TYPE 8; MKS8	0.00210084	0.10377643598551307
OROFACIODIGITAL SYNDROME III	0.00210084	0.10377643598551307
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00210084	0.10377643598551307
MENTAL RETARDATION, AUTOSOMAL DOMINANT 27	0.00210084	0.10377643598551307
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.00210084	0.10377643598551307
AURICULOCONDYLAR SYNDROME 2; ARCND2	0.00210084	0.10377643598551307
TETRAAMELIA SYNDROME 2; TETAMS2	0.00210084	0.10377643598551307
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.00210084	0.10377643598551307
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.00210084	0.10377643598551307
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.00210084	0.10377643598551307
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.00210084	0.10377643598551307
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.00210084	0.10377643598551307
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.00210084	0.10377643598551307
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.00210084	0.10377643598551307
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.00210084	0.10377643598551307
NOONAN SYNDROME 7; NS7	0.00210084	0.10377643598551307
VERVERI-BRADY SYNDROME; VERBRAS	0.00210084	0.10377643598551307
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.00210084	0.10377643598551307
MEMBRANOUS CRANIAL OSSIFICATION, DELAYED	0.00210084	0.10377643598551307
DWARFISM, FAMILIAL, WITH MUSCLE SPASMS	0.00210084	0.10377643598551307
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00210084	0.10377643598551307
STRUCTURAL HEART DEFECTS AND RENAL ANOMALIES SYNDROME	0.00210084	0.10377643598551307
#246200 DONOHUE SYNDROME;;LEPRECHAUNISMINSULIN RECEPTOR, DEFECT IN, INCLUDED	0.00210084	0.10377643598551307
SECKEL SYNDROME 4	0.00210084	0.10377643598551307
LETHAL CONGENITAL CONTRACTURE SYNDROME 9; LCCS9	0.00210084	0.10377643598551307
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00210084	0.10377643598551307
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.00210084	0.10377643598551307
URUGUAY FACIOCARDIOMUSCULOSKELETAL SYNDROME; FCMSU	0.00210084	0.10377643598551307
DIARRHEA 3, SECRETORY SODIUM, CONGENITAL, WITH OR WITHOUT OTHER CONGENITAL ANOMALIES	0.00210084	0.10377643598551307
BENT BONE DYSPLASIA SYNDROME; BBDS	0.00210084	0.10377643598551307
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.00210084	0.10377643598551307
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.00210084	0.10377643598551307
NEMALINE MYOPATHY 2; NEM2	0.00210084	0.10377643598551307
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 2; VCRL2	0.00210084	0.10377643598551307
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.00210084	0.10377643598551307
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.00210084	0.10377643598551307
HYPOGLOSSIA WITH SITUS INVERSUS	0.00210084	0.10377643598551307
FRANK-TER HAAR SYNDROME; FTHS	0.00210084	0.10377643598551307
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.00210084	0.10377643598551307
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ih; CDG1H	0.00210084	0.10377643598551307
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00210084	0.10377643598551307
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.00210084	0.10377643598551307
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.00210084	0.10377643598551307
CHONDRODYSPLASIA WITH PLATYSPONDYLY, DISTINCTIVE BRACHYDACTYLY, HYDROCEPHALY, AND MICROPHTHALMIA	0.00210084	0.10377643598551307
#215140 GREENBERG DYSPLASIA; GRBGD;;HYDROPS-ECTOPIC CALCIFICATION-MOTH-EATEN SKELETAL DYSPLASIA;;HEM SKELETAL DYSPLASIA;;MOTH-EATEN SKELETAL DYSPLASIA;;CHONDRODYSTROPHY, HYDROPIC AND PRENATALLY LETHAL TYPE	0.00210084	0.10377643598551307
BRACHIAL AMELIA, CLEFT LIP, AND HOLOPROSENCEPHALY; ACLH	0.00210084	0.10377643598551307
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.00210084	0.10377643598551307
LOWRY-MACLEAN SYNDROME	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.000843882	0.04168573825342565
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.000843882	0.04168573825342565
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.000843882	0.04168573825342565
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000843882	0.04168573825342565
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.000843882	0.04168573825342565
JOUBERT SYNDROME 33; JBTS33	0.000843882	0.04168573825342565
#612936 SPASTIC PARAPLEGIA 50, AUTOSOMAL RECESSIVE; SPG50;;CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3, FORMERLY; CPSQ3, FORMERLY	0.000843882	0.04168573825342565
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.000843882	0.04168573825342565
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.000843882	0.04168573825342565
SEPTOOPTIC DYSPLASIA	0.000843882	0.04168573825342565
JOUBERT SYNDROME 7	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000843882	0.04168573825342565
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.000843882	0.04168573825342565
CULLER-JONES SYNDROME; CJS	0.000843882	0.04168573825342565
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.000843882	0.04168573825342565
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.000843882	0.04168573825342565
#610915 OSTEOGENESIS IMPERFECTA, TYPE VIII; OI8;;OI, TYPE VIII	0.000843882	0.04168573825342565
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000843882	0.04168573825342565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.000843882	0.04168573825342565
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000843882	0.04168573825342565
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000843882	0.04168573825342565
#275900 SPASTIC PARAPLEGIA 20, AUTOSOMAL RECESSIVE; SPG20;;TROYER SYNDROME;;SPASTIC PARAPARESIS, CHILDHOOD-ONSET, WITH DISTAL MUSCLE WASTING;;SPASTIC PARAPLEGIA, AUTOSOMAL RECESSIVE, TROYER TYPE	0.000843882	0.04168573825342565
MACROCEPHALY/AUTISM SYNDROME	0.000843882	0.04168573825342565
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.000843882	0.04168573825342565
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.000843882	0.04168573825342565
CHROMOSOME 4q21 DELETION SYNDROME	0.000843882	0.04168573825342565
AUSTRALIA ANTIGEN	0.000843882	0.04168573825342565
MUCOLIPIDOSIS IV; ML4	0.000843882	0.04168573825342565
COFFIN-SIRIS SYNDROME 5	0.000843882	0.04168573825342565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.000843882	0.04168573825342565
LISSENCEPHALY 1; LIS1	0.000843882	0.04168573825342565
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.000843882	0.04168573825342565
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.000843882	0.04168573825342565
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.000843882	0.04168573825342565
WEBB-DATTANI SYNDROME; WEDAS	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000843882	0.04168573825342565
CHROMOSOME 5Q12 DELETION SYNDROME	0.000843882	0.04168573825342565
JOUBERT SYNDROME 24	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.000843882	0.04168573825342565
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.000843882	0.04168573825342565
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.000843882	0.04168573825342565
#612714 EXOCRINE PANCREATIC INSUFFICIENCY, DYSERYTHROPOIETIC ANEMIA, AND CALVARIALHYPEROSTOSIS	0.000843882	0.04168573825342565
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.000843882	0.04168573825342565
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000843882	0.04168573825342565
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.000843882	0.04168573825342565
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.000843882	0.04168573825342565
JOUBERT SYNDROME 26	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.000843882	0.04168573825342565
MENTAL RETARDATION, X-LINKED 88	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.000843882	0.04168573825342565
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.000843882	0.04168573825342565
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000843882	0.04168573825342565
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.000843882	0.04168573825342565
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.000843882	0.04168573825342565
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.000843882	0.04168573825342565
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.000843882	0.04168573825342565
JOUBERT SYNDROME 31; JBTS31	0.000843882	0.04168573825342565
#300555 DENT DISEASE 2	0.000843882	0.04168573825342565
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.000843882	0.04168573825342565
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.000843882	0.04168573825342565
THANATOPHORIC DYSPLASIA, TYPE I	0.000843882	0.04168573825342565
Cerebral creatine deficiency syndrome 3	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.000843882	0.04168573825342565
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000843882	0.04168573825342565
#600638 FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 3A, WITH OR WITHOUT EXTRAOCULARINVOLVEMENT; CFEOM3A;;FEOM3 LOCUS	0.000843882	0.04168573825342565
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.000843882	0.04168573825342565
NOONAN SYNDROME 9; NS9	0.000843882	0.04168573825342565
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.000843882	0.04168573825342565
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.000843882	0.04168573825342565
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000843882	0.04168573825342565
#613730 HEMORRHAGIC DESTRUCTION OF THE BRAIN, SUBEPENDYMAL CALCIFICATION,AND CATARACTS; HDBSCC	0.000843882	0.04168573825342565
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.000843882	0.04168573825342565
OROTIC ACIDURIA	0.000843882	0.04168573825342565
CHROMOSOME 22q11.2 DELETION SYNDROME, DISTAL	0.000843882	0.04168573825342565
#615516 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 38; MRT38	0.000843882	0.04168573825342565
#614728 SECKEL SYNDROME 6; SCKL6	0.000843882	0.04168573825342565
WAISMAN SYNDROME; WSMN	0.000843882	0.04168573825342565
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000843882	0.04168573825342565
EPILEPSY, PYRIDOXINE-DEPENDENT	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.000843882	0.04168573825342565
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.000843882	0.04168573825342565
#607694 LEUKODYSTROPHY, HYPOMYELINATING, 7, WITH OR WITHOUT OLIGODONTIA AND/ORHYPOGONADOTROPIC HYPOGONADISM; HLD7;;LEUKOENCEPHALOPATHY, HYPOMYELINATING, WITH ATAXIA AND DELAYED DENTITION;;ATAXIA, DELAYED DENTITION, AND HYPOMYELINATION; ADDH;;LEUKODYSTROPHY, HYPOMYELINATING, WITH HYPODONTIA AND HYPOGONADOTROPICHYPOGONADISM;;4H SYNDROME	0.000843882	0.04168573825342565
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.000843882	0.04168573825342565
AICARDI-GOUTIERES SYNDROME 6	0.000843882	0.04168573825342565
#231050 GELEOPHYSIC DYSPLASIA 1; GPHYSD1	0.000843882	0.04168573825342565
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.000843882	0.04168573825342565
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.000843882	0.04168573825342565
FRIAS SYNDROME	0.000843882	0.04168573825342565
RAHMAN SYNDROME	0.000843882	0.04168573825342565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ii; CDG1I	0.000843882	0.04168573825342565
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.000843882	0.04168573825342565
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.000843882	0.04168573825342565
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.000843882	0.04168573825342565
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.000843882	0.04168573825342565
#615280 CARDIOFACIOCUTANEOUS SYNDROME 4; CFC4	0.000843882	0.04168573825342565
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000843882	0.04168573825342565
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.000843882	0.04168573825342565
#615541 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 39; MRT39	0.000843882	0.04168573825342565
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.000843882	0.04168573825342565
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.000843882	0.04168573825342565
MEHMO SYNDROME; MEHMO	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000843882	0.04168573825342565
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.000843882	0.04168573825342565
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.000843882	0.04168573825342565
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000843882	0.04168573825342565
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.000843882	0.04168573825342565
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.000843882	0.04168573825342565
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.000843882	0.04168573825342565
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.000843882	0.04168573825342565
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.000843882	0.04168573825342565
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.000843882	0.04168573825342565
PELGER-HUET ANOMALY; PHA	0.000843882	0.04168573825342565
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000843882	0.04168573825342565
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.000843882	0.04168573825342565
SCHINDLER DISEASE, TYPE I	0.000843882	0.04168573825342565
REVESZ SYNDROME	0.000843882	0.04168573825342565
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.000843882	0.04168573825342565
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.000843882	0.04168573825342565
#614483 PORENCEPHALY 2; POREN2	0.000843882	0.04168573825342565
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000843882	0.04168573825342565
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000843882	0.04168573825342565
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.000843882	0.04168573825342565
#610185 CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME2; CAMRQ2;;CEREBELLAR ATAXIA AND MENTAL RETARDATION WITH OR WITHOUT QUADRUPEDALLOCOMOTION 2	0.000843882	0.04168573825342565
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.000843882	0.04168573825342565
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000843882	0.04168573825342565
#613657 D-2-@HYDROXYGLUTARIC ACIDURIA 2;;D2HGA2	0.000843882	0.04168573825342565
#300848 MENTAL RETARDATION, X-LINKED 89; MRX89	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000843882	0.04168573825342565
KLEEFSTRA SYNDROME 2; KLEFS2	0.000843882	0.04168573825342565
MACDERMOT-WINTER SYNDROME	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.000843882	0.04168573825342565
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.000843882	0.04168573825342565
#611718 HYPOMAGNESEMIA 4, RENAL; HOMG4;;HYPOMAGNESEMIA, RENAL, NORMOCALCIURIC	0.000843882	0.04168573825342565
LISSENCEPHALY 2; LIS2	0.000843882	0.04168573825342565
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.000843882	0.04168573825342565
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.000843882	0.04168573825342565
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000843882	0.04168573825342565
GRISCELLI SYNDROME, TYPE 1	0.000843882	0.04168573825342565
#615473 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 17; EIEE17	0.000843882	0.04168573825342565
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000843882	0.04168573825342565
ALAZAMI-YUAN SYNDROME	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.000843882	0.04168573825342565
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.000843882	0.04168573825342565
JOUBERT SYNDROME 25	0.000843882	0.04168573825342565
SECKEL SYNDROME 9; SCKL9	0.000843882	0.04168573825342565
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.000843882	0.04168573825342565
NAVAJO NEUROHEPATOPATHY	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.000843882	0.04168573825342565
#615182 COMBINED D-2- AND L-2-HYDROXYGLUTARIC ACIDURIA; D2L2AD	0.000843882	0.04168573825342565
#300673 ENCEPHALOPATHY, NEONATAL SEVERE, DUE TO MECP2 MUTATIONS	0.000843882	0.04168573825342565
JOUBERT SYNDROME 6	0.000843882	0.04168573825342565
JOUBERT SYNDROME 28	0.000843882	0.04168573825342565
JOUBERT SYNDROME 8	0.000843882	0.04168573825342565
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.000843882	0.04168573825342565
#613180 POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.000843882	0.04168573825342565
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.000843882	0.04168573825342565
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.000843882	0.04168573825342565
#604317 MICROCEPHALY 2, PRIMARY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT CORTICALMALFORMATIONS; MCPH2	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.000843882	0.04168573825342565
#300653 PHOSPHOGLYCERATE KINASE 1 DEFICIENCY;;PGK1 DEFICIENCY	0.000843882	0.04168573825342565
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000843882	0.04168573825342565
#121200 SEIZURES, BENIGN FAMILIAL NEONATAL, 1; BFNS1EPILEPSY, BENIGN NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED;;SEIZURES, BENIGN FAMILIAL NEONATAL, 1, AND/OR MYOKYMIA, INCLUDED	0.000843882	0.04168573825342565
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000843882	0.04168573825342565
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.000843882	0.04168573825342565
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000843882	0.04168573825342565
#606777 GLUT1 DEFICIENCY SYNDROME 1; GLUT1DS1;;GLUCOSE TRANSPORT DEFECT, BLOOD-BRAIN BARRIERGLUT1 DEFICIENCY SYNDROME 1, AUTOSOMAL RECESSIVE, INCLUDED	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.000843882	0.04168573825342565
#170100 PROLIDASE DEFICIENCY	0.000843882	0.04168573825342565
#236250 HOMOCYSTINURIA DUE TO DEFICIENCY OF N(5,10)-METHYLENETETRAHYDROFOLATEREDUCTASE ACTIVITY;;METHYLENETETRAHYDROFOLATE REDUCTASE DEFICIENCY;;MTHFR DEFICIENCYMTHFR DEFICIENCY, THERMOLABILE TYPE, INCLUDED	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.000843882	0.04168573825342565
AICARDI-GOUTIERES SYNDROME 5	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.000843882	0.04168573825342565
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.000843882	0.04168573825342565
3-HYDROXY-3-METHYLGLUTARYL-CoA LYASE DEFICIENCY; HMGCLD	0.000843882	0.04168573825342565
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000843882	0.04168573825342565
MARINESCO-SJOGREN SYNDROME; MSS	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000843882	0.04168573825342565
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.000843882	0.04168573825342565
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.000843882	0.04168573825342565
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.000843882	0.04168573825342565
PELLAGRA-LIKE SYNDROME	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.000843882	0.04168573825342565
SECKEL SYNDROME 8; SCKL8	0.000843882	0.04168573825342565
SPINOCEREBELLAR ATAXIA 5; SCA5	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000843882	0.04168573825342565
BETA-UREIDOPROPIONASE DEFICIENCY	0.000843882	0.04168573825342565
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.000843882	0.04168573825342565
MELANOSIS, NEUROCUTANEOUS; NCMS	0.000843882	0.04168573825342565
HOLOPROSENCEPHALY 1; HPE1	0.000843882	0.04168573825342565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ix; CDG1X	0.000843882	0.04168573825342565
#614322 SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 12; SCAR12;;SPINOCEREBELLAR ATAXIA WITH MENTAL RETARDATION AND EPILEPSY	0.000843882	0.04168573825342565
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.000843882	0.04168573825342565
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.000843882	0.04168573825342565
CITRULLINEMIA, CLASSIC	0.000843882	0.04168573825342565
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.000843882	0.04168573825342565
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.000843882	0.04168573825342565
MENTAL RETARDATION, X-LINKED 41	0.000843882	0.04168573825342565
SALLA DISEASE	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000843882	0.04168573825342565
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.000843882	0.04168573825342565
LANDAU-KLEFFNER SYNDROME	0.000843882	0.04168573825342565
CHROMOSOME 10q22.3-q23.2 DELETION SYNDROME	0.000843882	0.04168573825342565
#227810 FANCONI-BICKEL SYNDROME; FBS;;HEPATORENAL GLYCOGENOSIS WITH RENAL FANCONI SYNDROME;;HEPATIC GLYCOGENOSIS WITH FANCONI NEPHROPATHY;;HEPATIC GLYCOGENOSIS WITH AMINO ACIDURIA AND GLUCOSURIA;;FANCONI SYNDROME WITH INTESTINAL MALABSORPTION AND GALACTOSE INTOLERANCE;;PSEUDO-PHLORIZIN DIABETES;;GLYCOGENOSIS, FANCONI TYPE;;GLYCOGEN STORAGE DISEASE XI	0.000843882	0.04168573825342565
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000843882	0.04168573825342565
#300894 NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 5; NBIA5;;BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION; BPAN;;STATIC ENCEPHALOPATHY OF CHILDHOOD WITH NEURODEGENERATION IN ADULTHOOD;SENDA	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.000843882	0.04168573825342565
LISSENCEPHALY 8; LIS8	0.000843882	0.04168573825342565
SAUL-WILSON SYNDROME; SWILS	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000843882	0.04168573825342565
MENTAL RETARDATION, X-LINKED 103	0.000843882	0.04168573825342565
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.000843882	0.04168573825342565
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.000843882	0.04168573825342565
#610758 CEREBROOCULOFACIOSKELETAL SYNDROME 4; COFS4	0.000843882	0.04168573825342565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iw; CDG1W	0.000843882	0.04168573825342565
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.000843882	0.04168573825342565
IMMUNODEFICIENCY 49; IMD49	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.000843882	0.04168573825342565
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.000843882	0.04168573825342565
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000843882	0.04168573825342565
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.000843882	0.04168573825342565
3-METHYLCROTONYL-CoA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.000843882	0.04168573825342565
RETINITIS PIGMENTOSA 80; RP80	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.000843882	0.04168573825342565
#612716 DYSTONIA, DOPA-RESPONSIVE, DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY;;SEPIAPTERIN REDUCTASE DEFICIENCY;;SPR DEFICIENCY	0.000843882	0.04168573825342565
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000843882	0.04168573825342565
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.000843882	0.04168573825342565
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.000843882	0.04168573825342565
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000843882	0.04168573825342565
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.000843882	0.04168573825342565
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.000843882	0.04168573825342565
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.000843882	0.04168573825342565
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000843882	0.04168573825342565
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.000843882	0.04168573825342565
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.000843882	0.04168573825342565
#615401 IMMUNODEFICIENCY 8; IMD8	0.000843882	0.04168573825342565
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.000843882	0.04168573825342565
2,4-DIENOYL-CoA REDUCTASE DEFICIENCY; DECRD	0.000843882	0.04168573825342565
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.000843882	0.04168573825342565
METHYLMALONIC ACIDURIA, CBLB TYPE	0.000843882	0.04168573825342565
CHROMOSOME 15q25 DELETION SYNDROME	0.000843882	0.04168573825342565
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.000843882	0.04168573825342565
#607208 DRAVET SYNDROME;;EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 6; EIEE6;;SEVERE MYOCLONIC EPILEPSY OF INFANCY; SMEI	0.000843882	0.04168573825342565
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.000843882	0.04168573825342565
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.000843882	0.04168573825342565
#603387 MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME;MPPH;;MEGALENCEPHALY, POLYMICROGYRIA, MEGA CORPUS CALLOSUM SYNDROME;;MEG-PMG-MEGACC SYNDROME;;MEGALENCEPHALY, MEGA CORPUS CALLOSUM, AND COMPLETE LACK OF MOTOR DEVELOPMENT	0.000843882	0.04168573825342565
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.000843882	0.04168573825342565
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.000843882	0.04168573825342565
JOUBERT SYNDROME 32; JBTS32	0.000843882	0.04168573825342565
JOUBERT SYNDROME 15	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.000843882	0.04168573825342565
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.000843882	0.04168573825342565
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000843882	0.04168573825342565
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.000843882	0.04168573825342565
JOUBERT SYNDROME 23; JBTS23	0.000843882	0.04168573825342565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIf; CDG2F	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.000843882	0.04168573825342565
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.000843882	0.04168573825342565
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.000843882	0.04168573825342565
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000843882	0.04168573825342565
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.000843882	0.04168573825342565
MENTAL RETARDATION, X-LINKED 98; MRX98	0.000843882	0.04168573825342565
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.000843882	0.04168573825342565
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.000843882	0.04168573825342565
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.000843882	0.04168573825342565
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.000843882	0.04168573825342565
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME c OXIDASE DEFICIENCY 1; CEMCOX1	0.000843882	0.04168573825342565
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000843882	0.04168573825342565
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.000843882	0.04168573825342565
HOLOPROSENCEPHALY 11	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.000843882	0.04168573825342565
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.000843882	0.04168573825342565
#609054 FANCONI ANEMIA, COMPLEMENTATION GROUP J; FANCJ	0.000843882	0.04168573825342565
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000843882	0.04168573825342565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIq; CDG2Q	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.000843882	0.04168573825342565
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000843882	0.04168573825342565
HOLOPROSENCEPHALY 5; HPE5	0.000843882	0.04168573825342565
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.000843882	0.04168573825342565
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.000843882	0.04168573825342565
SULFOCYSTEINURIA	0.000843882	0.04168573825342565
#610951 CEROID LIPOFUSCINOSIS, NEURONAL, 7; CLN7	0.000843882	0.04168573825342565
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.000843882	0.04168573825342565
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.000843882	0.04168573825342565
3-METHYLCROTONYL-CoA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.000843882	0.04168573825342565
MENTAL RETARDATION, X-LINKED 9	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.000843882	0.04168573825342565
CRANIOTELENCEPHALIC DYSPLASIA	0.000843882	0.04168573825342565
#610829 HOLOPROSENCEPHALY 9; HPE9;;PITUITARY ANOMALIES WITH HOLOPROSENCEPHALY-LIKE FEATURES;;HOLOPROSENCEPHALY WITH MICROPHTHALMIA AND FIRST BRANCHIAL ARCH ANOMALIES	0.000843882	0.04168573825342565
JOUBERT SYNDROME 30; JBTS30	0.000843882	0.04168573825342565
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.000843882	0.04168573825342565
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.000843882	0.04168573825342565
NETHERTON SYNDROME; NETH	0.000843882	0.04168573825342565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ic; CDG1C	0.000843882	0.04168573825342565
#226750 KOHLSCHUTTER-TONZ SYNDROME; KTZS;;EPILEPSY AND YELLOW TEETH;;EPILEPSY, DEMENTIA, AND AMELOGENESIS IMPERFECTA;;KOHLSCHUTTER SYNDROME	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.000843882	0.04168573825342565
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.000843882	0.04168573825342565
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.000843882	0.04168573825342565
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.000843882	0.04168573825342565
NOONAN SYNDROME 2; NS2	0.000843882	0.04168573825342565
#300123 MENTAL RETARDATION, X-LINKED, WITH PANHYPOPITUITARISMMENTAL RETARDATION, X-LINKED, WITH ISOLATED GROWTH HORMONE DEFICIENCY,INCLUDED; MRGH, INCLUDED	0.000843882	0.04168573825342565
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000843882	0.04168573825342565
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.000843882	0.04168573825342565
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.000843882	0.04168573825342565
HYPERPROLINEMIA, TYPE I	0.000843882	0.04168573825342565
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.000843882	0.04168573825342565
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.000843882	0.04168573825342565
#225750 AICARDI-GOUTIERES SYNDROME 1; AGS1;;AGS;;ENCEPHALOPATHY, FAMILIAL INFANTILE, WITH INTRACRANIAL CALCIFICATIONAND CHRONIC CEREBROSPINAL FLUID LYMPHOCYTOSIS;;CREE ENCEPHALITIS;;PSEUDOTOXOPLASMOSIS SYNDROMEAICARDI-GOUTIERES SYNDROME 1, AUTOSOMAL DOMINANT, INCLUDED	0.000843882	0.04168573825342565
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.000843882	0.04168573825342565
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.000843882	0.04168573825342565
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.000843882	0.04168573825342565
#243500 ISOVALERIC ACIDEMIA; IVA;;ISOVALERIC ACID CoA DEHYDROGENASE DEFICIENCY;;IVD DEFICIENCY	0.000843882	0.04168573825342565
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000843882	0.04168573825342565
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.000843882	0.04168573825342565
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.000843882	0.04168573825342565
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.000843882	0.04168573825342565
#607454 SPINOCEREBELLAR ATAXIA 21; SCA21	0.000843882	0.04168573825342565
PYRUVATE CARBOXYLASE DEFICIENCY	0.000843882	0.04168573825342565
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.000843882	0.04168573825342565
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.000843882	0.04168573825342565
BARDET-BIEDL SYNDROME 17; BBS17	0.000843882	0.04168573825342565
GRACILE BONE DYSPLASIA; GCLEB	0.000843882	0.04168573825342565
#614213 NEUROPATHY, HEREDITARY SENSORY, TYPE IIC; HSN2C	0.000843882	0.04168573825342565
GABA-TRANSAMINASE DEFICIENCY	0.000843882	0.04168573825342565
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000843882	0.04168573825342565
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.000843882	0.04168573825342565
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.000843882	0.04168573825342565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIc; CDG2C	0.000843882	0.04168573825342565
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.000843882	0.04168573825342565
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.000843882	0.04168573825342565
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.000843882	0.04168573825342565
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000843882	0.04168573825342565
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.000843882	0.04168573825342565
NEPHRONOPHTHISIS 11; NPHP11	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.000843882	0.04168573825342565
#614265 COMBINED MALONIC AND METHYLMALONIC ACIDURIA; CMAMMA	0.000843882	0.04168573825342565
BARDET-BIEDL SYNDROME 14; BBS14	0.000843882	0.04168573825342565
#613721 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 11; EIEE11	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.000843882	0.04168573825342565
DYSTONIA 28, CHILDHOOD-ONSET	0.000843882	0.04168573825342565
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.000843882	0.04168573825342565
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000843882	0.04168573825342565
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.000843882	0.04168573825342565
#613641 CHARCOT-MARIE-TOOTH DISEASE, RECESSIVE INTERMEDIATE B; CMTRIB;;CHARCOT-MARIE-TOOTH NEUROPATHY, RECESSIVE INTERMEDIATE B; RI-CMTB	0.000843882	0.04168573825342565
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.000843882	0.04168573825342565
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.000843882	0.04168573825342565
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.000843882	0.04168573825342565
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.000843882	0.04168573825342565
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.000843882	0.04168573825342565
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000843882	0.04168573825342565
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.000843882	0.04168573825342565
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.000843882	0.04168573825342565
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000843882	0.04168573825342565
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.000843882	0.04168573825342565
ELEJALDE DISEASE	0.000843882	0.04168573825342565
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.000843882	0.04168573825342565
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000843882	0.04168573825342565
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.000843882	0.04168573825342565
ARGININOSUCCINIC ACIDURIA	0.000843882	0.04168573825342565
RAYNAUD-CLAES SYNDROME; MRXSRC	0.000843882	0.04168573825342565
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.000843882	0.04168573825342565
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000843882	0.04168573825342565
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.000843882	0.04168573825342565
#614845 NEPHRONOPHTHISIS 15; NPHP15	0.000843882	0.04168573825342565
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.000843882	0.04168573825342565
POPOV-CHANG SYNDROME; POPCHAS	0.000843882	0.04168573825342565
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.000843882	0.04168573825342565
HYDROCEPHALUS, NORMAL-PRESSURE	0.000843882	0.04168573825342565
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.000843882	0.04168573825342565
PHACE ASSOCIATION	0.000843882	0.04168573825342565
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.000843882	0.04168573825342565
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.000843882	0.04168573825342565
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.000843882	0.04168573825342565
Cerebral creatine deficiency syndrome 2	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.000843882	0.04168573825342565
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.000843882	0.04168573825342565
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000843882	0.04168573825342565
FUMARASE DEFICIENCY; FMRD	0.000843882	0.04168573825342565
#269000 SC PHOCOMELIA SYNDROME;;SC PSEUDOTHALIDOMIDE SYNDROME	0.000843882	0.04168573825342565
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.000843882	0.04168573825342565
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000843882	0.04168573825342565
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.000843882	0.04168573825342565
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000843882	0.04168573825342565
AICARDI-GOUTIERES SYNDROME 7	0.000843882	0.04168573825342565
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.000843882	0.04168573825342565
#615279 CARDIOFACIOCUTANEOUS SYNDROME 3; CFC3	0.000843882	0.04168573825342565
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.000843882	0.04168573825342565
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.000843882	0.04168573825342565
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.000843882	0.04168573825342565
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.000843882	0.04168573825342565
GAUCHER DISEASE, TYPE II	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.000843882	0.04168573825342565
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.000843882	0.04168573825342565
ARIMA SYNDROME	0.000843882	0.04168573825342565
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.000843882	0.04168573825342565
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.000843882	0.04168573825342565
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000843882	0.04168573825342565
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.000843882	0.04168573825342565
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.000843882	0.04168573825342565
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.000843882	0.04168573825342565
Leukotriene C4 synthase deficiency	0.000843882	0.04168573825342565
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.000843882	0.04168573825342565
#615369 EPILEPTIC ENCEPHALOPATHY, CHILDHOOD-ONSET; EEOC	0.000843882	0.04168573825342565
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.000843882	0.04168573825342565
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.000843882	0.04168573825342565
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.000843882	0.04168573825342565
#300257 DANON DISEASE;;VACUOLAR CARDIOMYOPATHY AND MYOPATHY, X-LINKED;;PSEUDOGLYCOGENOSIS II;;ANTOPOL DISEASE;;LYSOSOMAL GLYCOGEN STORAGE DISEASE WITHOUT ACID MALTASE DEFICIENCY,FORMERLY;;GLYCOGEN STORAGE DISEASE IIb; GSD2B, FORMERLY;;GSD IIb, FORMERLY	0.000843882	0.04168573825342565
#614457 ICHTHYOSIS, SPASTIC QUADRIPLEGIA, AND MENTAL RETARDATION; ISQMR	0.000843882	0.04168573825342565
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.000843882	0.04168573825342565
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000843882	0.04168573825342565
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000843882	0.04168573825342565
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.000843882	0.04168573825342565
LIG4 SYNDROME	0.000843882	0.04168573825342565
#207800 ARGININEMIA;;ARGINASE DEFICIENCY;;HYPERARGININEMIA;;ARG1 DEFICIENCY	0.000843882	0.04168573825342565
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.000843882	0.04168573825342565
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.000843882	0.04168573825342565
#311250 ORNITHINE TRANSCARBAMYLASE DEFICIENCY, HYPERAMMONEMIA DUE TO;;ORNITHINE CARBAMOYLTRANSFERASE DEFICIENCY;;OTC DEFICIENCYVALPROATE SENSITIVITY, INCLUDED	0.000843882	0.04168573825342565
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.000843882	0.04168573825342565
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.000843882	0.04168573825342565
HYPOTONIA-CYSTINURIA SYNDROME	0.000843882	0.04168573825342565
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.000843882	0.04168573825342565
BARDET-BIEDL SYNDROME 3; BBS3	0.000843882	0.04168573825342565
FOLATE MALABSORPTION, HEREDITARY	0.000843882	0.04168573825342565
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.000843882	0.04168573825342565
#614582 COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 9; COXPD9	0.000843882	0.04168573825342565
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.000843882	0.04168573825342565
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000843882	0.04168573825342565
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.000843882	0.04168573825342565
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.000843882	0.04168573825342565
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.000843882	0.04168573825342565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Iu; CDG1U	0.000843882	0.04168573825342565
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.000843882	0.04168573825342565
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.000843882	0.04168573825342565
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.000843882	0.04168573825342565
METHYLMALONIC ACIDURIA, CBLA TYPE	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.000843882	0.04168573825342565
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.000843882	0.04168573825342565
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.000843882	0.04168573825342565
#136570 CHROMOSOME 16p12.1 DELETION SYNDROME, 520-KBFRAGILE SITE 16p12, INCLUDED	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.000843882	0.04168573825342565
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.000843882	0.04168573825342565
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.000843882	0.04168573825342565
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.000843882	0.04168573825342565
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000843882	0.04168573825342565
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.000843882	0.04168573825342565
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.000843882	0.04168573825342565
MENTAL RETARDATION, X-LINKED 99	0.000843882	0.04168573825342565
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000843882	0.04168573825342565
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.000843882	0.04168573825342565
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.000843882	0.04168573825342565
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000843882	0.04168573825342565
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.000843882	0.04168573825342565
#608443 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 3; MRT3	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.000843882	0.04168573825342565
HYPEREKPLEXIA 4; HKPX4	0.000843882	0.04168573825342565
MENTAL RETARDATION, X-LINKED 90	0.000843882	0.04168573825342565
COACH SYNDROME	0.000843882	0.04168573825342565
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.000843882	0.04168573825342565
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.000843882	0.04168573825342565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ik; CDG1K	0.000843882	0.04168573825342565
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.000843882	0.04168573825342565
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.000843882	0.04168573825342565
#613752 HYPERMETHIONINEMIA WITH S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.000843882	0.04168573825342565
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.000843882	0.04168573825342565
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.000843882	0.04168573825342565
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000843882	0.04168573825342565
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.000843882	0.04168573825342565
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.000843882	0.04168573825342565
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.000843882	0.04168573825342565
#237300 CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY, HYPERAMMONEMIA DUE TO;;CARBAMOYL PHOSPHATE SYNTHETASE I DEFICIENCY;;CPS I DEFICIENCY	0.000843882	0.04168573825342565
KETOADIPICACIDURIA	0.000843882	0.04168573825342565
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.000843882	0.04168573825342565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.000843882	0.04168573825342565
Bardet-Biedl syndrome 2	0.000843882	0.04168573825342565
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.000843882	0.04168573825342565
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.000843882	0.04168573825342565
N-ACETYLASPARTATE DEFICIENCY; NACED	0.000843882	0.04168573825342565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE Ia; CDG1A	0.000843882	0.04168573825342565
CHROMOSOME 22q13 DUPLICATION SYNDROME	0.000843882	0.04168573825342565
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000843882	0.04168573825342565
#614402 MICROPHTHALMIA, SYNDROMIC 11; MCOPS11	0.000843882	0.04168573825342565
CHROMOSOME 19q13.11 DELETION SYNDROME, PROXIMAL	0.000843882	0.04168573825342565
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.000843882	0.04168573825342565
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.000843882	0.04168573825342565
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.000843882	0.04168573825342565
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000843882	0.04168573825342565
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.000843882	0.04168573825342565
#608804 LEUKODYSTROPHY, HYPOMYELINATING, 2; HLD2;;PELIZAEUS-MERZBACHER-LIKE DISEASE, 1; PMLD1	0.000843882	0.04168573825342565
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.000843882	0.04168573825342565
#615220 OSTEOGENESIS IMPERFECTA, TYPE XV; OI15;;OI, TYPE XV	0.000843882	0.04168573825342565
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.000843882	0.04168573825342565
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.000843882	0.04168573825342565
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000843882	0.04168573825342565
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.000843882	0.04168573825342565
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.000843882	0.04168573825342565
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.000843882	0.04168573825342565
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000843882	0.04168573825342565
NIEMANN-PICK DISEASE, TYPE C2	0.000843882	0.04168573825342565
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000843882	0.04168573825342565
MENTAL RETARDATION, X-LINKED 72	0.000843882	0.04168573825342565
CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB	0.000843882	0.04168573825342565
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.000843882	0.04168573825342565
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000843882	0.04168573825342565
HARTNUP DISORDER	0.000843882	0.04168573825342565
#300886 MENTAL RETARDATION, X-LINKED, SYNDROMIC 32; MRXS32	0.000843882	0.04168573825342565
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.000843882	0.04168573825342565
LISSENCEPHALY 4	0.000843882	0.04168573825342565
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.000843882	0.04168573825342565
HOLOPROSENCEPHALY 7	0.000843882	0.04168573825342565
#616341 EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 30; EIEE30	0.000843882	0.04168573825342565
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.000843882	0.04168573825342565
GM2-GANGLIOSIDOSIS, AB VARIANT	0.000843882	0.04168573825342565
CHROMOSOME Xq27.3-q28 DUPLICATION SYNDROME	0.000843882	0.04168573825342565
LUSCAN-LUMISH SYNDROME; LLS	0.000843882	0.04168573825342565
SENIOR-LOKEN SYNDROME 9	0.000843882	0.04168573825342565
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.000843882	0.04168573825342565
#615432 SPECIFIC LANGUAGE IMPAIRMENT 5; SLI5	0.000843882	0.04168573825342565
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.000843882	0.04168573825342565
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000843882	0.04168573825342565
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.000843882	0.04168573825342565
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000843882	0.04168573825342565
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.000843882	0.04168573825342565
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.000843882	0.04168573825342565
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.000843882	0.04168573825342565
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.000843882	0.04168573825342565
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.000843882	0.04168573825342565
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000843882	0.04168573825342565
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.000843882	0.04168573825342565
JOUBERT SYNDROME 27	0.000843882	0.04168573825342565
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000843882	0.04168573825342565
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.000843882	0.04168573825342565
SHUKLA-VERNON SYNDROME; SHUVER	0.000843882	0.04168573825342565
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000843882	0.04168573825342565
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.000843882	0.04168573825342565
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.000843882	0.04168573825342565
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.000843882	0.04168573825342565
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.000843882	0.04168573825342565
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000843882	0.04168573825342565
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.000843882	0.04168573825342565
BARDET-BIEDL SYNDROME 13; BBS13	0.000843882	0.04168573825342565
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.000843882	0.04168573825342565
MENTAL RETARDATION, X-LINKED 101; MRX101	0.000843882	0.04168573825342565
HOLOPROSENCEPHALY 3; HPE3	0.000843882	0.04168573825342565
#231550 ACHALASIA-ADDISONIANISM-ALACRIMA SYNDROME; AAAS;;TRIPLE-A SYNDROME;;ALACRIMA-ACHALASIA-ADRENAL INSUFFICIENCY NEUROLOGIC DISORDER;;GLUCOCORTICOID DEFICIENCY AND ACHALASIA;;ALLGROVE SYNDROME;;ADDISONIAN-ACHALASIA SYNDROME;;HYPOADRENALISM WITH ACHALASIA;;ALACRIMA-ACHALASIA-ADDISONIANISM;;ACTH-RESISTANT ADRENAL INSUFFICIENCY, ACHALASIA AND ALACRIMAACHALASIA-ALACRIMA SYNDROME, INCLUDED	0.000843882	0.04168573825342565
MECKEL SYNDROME 13; MKS13	0.000843882	0.04168573825342565
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.000843882	0.04168573825342565
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.000843882	0.04168573825342565
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.000843882	0.04168573825342565
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000843882	0.04168573825342565
#613668 MICROCEPHALY, POSTNATAL PROGRESSIVE, WITH SEIZURES AND BRAIN ATROPHY	0.000843882	0.04168573825342565
